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ABSTRACT 
Myocardial infarction (MI) remains the leading cause of mortality and morbidity in the U.S., 
accounting for nearly 140,000 deaths per year. Heart transplantation and implantation of 
mechanical assist devices are the options of last resort for intractable heart failure, but these are 
limited by lack of organ donors and potential surgical complications. In this regard, there is an 
urgent need for developing new effective therapeutic strategies to induce regeneration and 
restore the loss contractility of infarcted myocardium. Over the past decades, regenerative 
medicine has emerged as a promising strategy to develop scaffold-free cell therapies and 
scaffold-based cardiac patches as potential approaches for MI treatment. Despite the progress, 
there are still critical shortcomings associated with these approaches regarding low cell retention, 
lack of global cardiomyocytes (CMs) synchronicity, as well as poor maturation and engraftment of 
the transplanted cells within the native myocardium. The overarching objective of this dissertation 
was to develop two classes of nanoengineered cardiac patches and scaffold-free microtissues 
with superior electrical, structural, and biological characteristics to address the limitations of 
previously developed tissue models. An integrated strategy, based on micro- and nanoscale 
technologies, was utilized to fabricate the proposed tissue models using functionalized gold 
nanomaterials (GNMs). Furthermore, comprehensive mechanistic studies were carried out to 
assess the influence of conductive GNMs on the electrophysiology and maturity of the 
engineered cardiac tissues. Specifically, the role of mechanical stiffness and nano-scale 
topographies of the scaffold, due to the incorporation of GNMs, on cardiac cells phenotype, 
contractility, and excitability were dissected from the scaffold’s electrical conductivity. In addition, 
the influence of GNMs on conduction velocity of CMs was investigated in both coupled and 
uncoupled gap junctions using microelectrode array technology. Overall, the key contributions of 
this work were to generate new classes of electrically conductive cardiac patches and scaffold-
free microtissues and to mechanistically investigate the influence of conductive GNMs on 
maturation and electrophysiology of the engineered tissues.  
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CHAPTER 1 
INTRODUCTION 
1.1. Myocardial Infarction Statistics and Burden 
Myocardial infarction (MI), commonly referred to as “heart attack”, is one of the major 
leading causes of death in the United States (Benjamin, 2017). The deteriorating impact of MI on 
the heart often involves decreased contractility and cardiac output, abnormal remodeling and 
stress distribution throughout the heart muscle, and ultimately catastrophic heart failure 
(Aaronson, 2013). Based on the “Heart Diseases and Stroke Statistics-2017” published by the 
American Heart Association (AHA), approximately 790,000 Americans annually will experience 
MI, with 580,000 new cases and 210,000 recurring attacks (Benjamin, 2017). The death toll of MI 
was reported to be 150,000 in 2014, and it is estimated that nearly 14% of cases will lead to 
patient death. Individuals who experienced MI are up to 15 times more vulnerable to disease and 
death than the general population (Benjamin, 2017). The life expectancy for male and female 
patients over, 45 years old after their first MI, is about 8.2 and 5.5 years, respectively (Benjamin, 
2017). In addition to the substantial morbidity and mortality, enormous amounts of hospitalization 
and medical costs are among the major healthcare and society burdens of MI. Specifically, the 
estimated healthcare cost of patient care with MI in 2011 was reported to be $11.5 billion, placing 
it among the top 10 most expensive illnesses within the U.S. (Benjamin, 2017; Pfuntner, 2006). 
Due to these facts, substantial concern has been granted for developing new effective therapies 
to reduce the incidence of MI and prevent heart failure and patient death.     
1.2. Myocardial Infarction Pathophysiology 
1.2.1. From onset to chronic stage  
MI is defined as the ischemic necrosis of the myocardium due to the lack of blood supply 
caused by the occlusion of coronary arteries (Frangogiannis, 2015). Thrombotic occlusion, which 
leads to MI, is the most prevalent cause of obstruction in coronary arteries  (Ridolfi, 1977). The 
thrombotic occlusion of coronary arteries is initiated with the rupture of a vulnerable 
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atherosclerotic plaque, which contains a lipid-rich core covered by a thin fibrous crust, due to the 
shear stress applied by circulating blood and/or the self-bursting of the accumulated lipid inside 
the plaque (Stefanadis, 2017). The rupture of this atherosclerotic plaque exposes the 
subendothelium and the lipid core to the blood, which triggers the aggregation of platelets, 
activation of the clotting cascades, and formation of the occlusive thrombus (Maseri, 1986). 
Immediately after the onset of ischemia, cardiomyocytes (CMs), within the affected area, lose 
their contractility (hypokinesis or stunned myocardium) (Frangogiannis, 2015). After 15 to 30 
minutes, myocardial necrosis and the formation of infarcted tissue begin and progress from the 
subendocardium outward towards the epicardium (Kumar, 2017). The duration and level of 
ischemia within the area at risk determine the amount of generated infarct, ranging from only 
partial (subendothelial) to a full (transmural) infarction of the ventricular wall (Chan, 2006).  
From onset to the chronic stage of MI, a series of micro- and macroscopic 
pathophysiological alterations occurs that substantially changes the appearance and function of 
the myocardium. At early time points (0-4 hours), aerobic glycolysis within the ischemic 
myocardium is stopped due to the lack of oxygen supply through the coronary arteries. This 
oxygen shortage results in a significant depletion of adenosine triphosphate (ATP), and a drop in 
intracellular pH caused by lactic acidosis (Neely, 1986; Vogt, 2002). ATP depletion induces the 
dysfunction of ATP-dependent calcium ion (Ca2+) pumps, which leads to high cytoplasmic 
concentration of Ca2+ and mitochondrial swelling (Linkermann, 2015). The swelling of the 
mitochondrial membrane has significant adverse effects on a wide range of cellular activities, 
most importantly ATP production, which ultimately induces apoptosis and necrosis in CMs 
(Webster, 2012). The substantial drop in intracellular pH of CMs, due to the accumulation of lactic 
acid, also increases the cytoplasmic Ca2+ concentration (Kubasiak, 2002; Sharma, 2015), and 
accordingly leads to mitochondrial swelling and cell death (Linkermann, 2015). These early stage 
microscopic alterations are considered to be potentially reversible if the ischemia duration is less 
than approximately 40 minutes, otherwise, irreversible myocardial necrosis will take place as a 
function of the induced ischemia duration (Frangogiannis, 2015; Kumar, 2017).  
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The earliest macroscopic pathophysiological event, known as dark mottling, develops 
within 3 days post-MI. Dark mottling appears because of coagulative necrosis of the ischemic 
myocardium along with tissue edema and hemorrhage (Frangogiannis, 2015). This process 
consists of CMs swelling as well as deterioration of intracellular organelles and proteins 
(Frangogiannis, 2015; Kumar, 2017). Additionally, the contractile force of the heart causes the 
excessive death of healthy CMs at the infarct border (Kumar, 2017). With the progression and 
accumulation of coagulative necrosis, excessive numbers of immune cells, mainly neutrophils, 
infiltrate within the infarct zone, initiating the inflammation phase of MI (Carbone, 2013; Prabhu, 
2016). The proteolytic enzymes secreted by neutrophils, during the inflammation phase, 
degrades the dead cells and damaged extracellular matrix (ECM) proteins. Afterwards, the infarct 
undergoes dissociation and softening, which subsequently initiates the removal process (i.e. 
phagocytosis) of dead tissue by macrophages (Horckmans, 2017; Lambert, 2008). The 
phagocytosis process continues progressively up to 10 days post-MI and is followed by the 
formation of granulation tissue at the infarct boundary, a process known as the proliferative phase 
of MI (Frangogiannis, 2015; Kumar, 2017; Prabhu, 2016). During the proliferative phase, the 
granulation tissue, mainly composed of neovascularized connective tissue develops and 
ultimately turns into a gray-white non-contractile fibrous scar tissue. Within 2-8 weeks, the 
generated scar tissue becomes a highly crosslinked thin matrix featuring dense collagen fibers 
and low cellular content, which replaces the infarct (i.e. the maturation phase of MI) (Prabhu, 
2016; Weber, 1996). The primary role of scar tissue is to maintain the structural integrity of the 
myocardium after infarction and prevent ventricular wall rupture (Talman, 2016). The production 
and architectural organization of scar tissue is mostly performed by a unique fibroblast-like cell 
type, known as myofibroblasts, with abundant smooth muscle actin microfilaments (Van Den 
Borne, 2009). Myofibroblasts are largely originated from resident interstitial fibroblasts, which 
have been activated by locally secreted factors including TGF-β (Sousa, 2007). Myofibroblasts 
secrete massive amounts of ECM proteins, especially collagen, which transform the infarct into a 
dense fibrous scar tissue.  
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After 2-3 months, the scar tissue further thins and expands to the remote non-infarcted 
myocardium, deteriorating the residual myocardium contractile capacity (Aikawa, 2001; Christia, 
2013; Prabhu, 2016). The thinning of scar tissue and additional negative morphological and 
functional changes is a phenomenon called ventricular remodeling which most often leads to 
heart failure (Konstam, 2011). Ventricular remodeling is a pathophysiological process in which the 
volume, shape and contractility of the left ventricle (LV) undergo massive adverse alterations 
(Sutton, 2000). Specifically, the LV volume increases due to the expansion and thinning of scar 
tissue, resulting in ventricular dilation (Cleutjens, 1995). In addition, the viable CMs undergo 
hypertrophy to compensate for the decreased contractile capacity of the LV, because of the CMs 
death following MI (Pfeffer, 1990). The CMs hypertrophy transforms the native elliptical shape of 
LV into a spherical one, which results in chamber enlargement (Mitchell, 1992). These alterations 
in shape and volume cause uneven stress distribution within the LV wall, resulting in further 
ventricular dilation and the deterioration of cardiac function (Sutton, 2000). Although LV remolding 
starts to compensate for the MI-induced loss of contractile capacity of the heart, its adverse 
pathophysiological effects, such as LV dilation, hypertrophy and uneven stress distribution, can 
lead to ventricular aneurysm and eventually heart failure. 
1.2.2. Standard therapeutic options for treatment of MI 
Emergency treatments for MI are mainly focused on reducing the heart’s workload, 
preventing further coronary occlusions, and delivering oxygen to the ischemic myocardium 
(Mercado, 2013). Next, restoring the occluded coronary blood flow and reperfusion of the 
ischemic myocardium is the most important action to undertake. The main purpose of these 
emergency treatments is to prevent or minimize further damage and necrosis to the ischemic 
myocardium (Mercado, 2013). To restore the blocked coronary blood flow and induce 
reperfusion, two major procedures are extensively practiced: the use of thrombolytic drugs and 
primary percutaneous coronary intervention (P-PCI). Thrombolytic drugs (e.g. Anistreplase and 
Tenecteplase) promote plasminogen activation, which consequently increases the degradation of 
thrombotic occlusions (Marder, 2013). P-PCI, also known as coronary angioplasty, is a catheter-
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based intervention to open the occluded coronary artery using either a stent or balloon, 
commonly inserted through the femoral artery to restore blood perfusion within the myocardium 
(Khera, 2016). In addition, there are other surgical procedures, including coronary bypass surgery 
to induce reperfusion of the infarcted myocardium, as well as ventricular assist devices and 
cardiomyoplasty to augment the heart pumping ability (Mercado, 2013). Heart transplantation is 
the final viable solution to prevent patient death due to MI-induced total heart failure (Tonsho, 
2014).  
1.3.  Regenerative Medicine as a Potential Strategy for MI Treatment 
The endogenous reparative capacity of human myocardium reduces significantly after the 
neonatal stage (Kikuchi, 2012). The low proliferation rate of adult CMs has been associated with 
their inability to enter the cell division cycle (Bergmann, 2009). Moreover, the massive loss of 
functioning CMs, due to the necrosis and apoptosis induced by MI (Frangogiannis, 2015; Kumar, 
2017), prevents the proper healing of the injured myocardium. Therefore, there have been 
extensive efforts to develop new effective therapies for treatment for MI. Despite the significant 
therapeutic outcomes of heart transplantation as the ultimate remedy for MI, it still encounters 
several critical limitations. In particular, organ donor shortage and risk of transplant rejection are 
two of the major issues that can negatively influence the efficacy of transplantation (JA 
Robertson, 1987; Tonsho, 2014). Furthermore, heart transplantation is extremely complicated 
and expensive, putting a financial burden and prolonged post-surgery recovery on patients (JA 
Robertson, 1987).  
Regenerative medicine has been introduced as one of the innovative strategies to induce 
efficient repair and restoration of the lost functionalities of infarcted myocardium obviating the 
need for heart transplantation (Hansson, 2013). In the next section, regenerative medicine as a 
potential strategy for treatment of MI will be discussed. This strategy is commonly categorized 
into two main branches: scaffold-based tissue engineering (Eschenhagen, 2012) and scaffold-
free cell-based therapy (Sanganalmath, 2013).  
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1.3.1. Cell-based therapies and scaffold-free cardiac tissue engineering 
Scaffold-free cell-based therapy (i.e. cell therapy) has been tremendously studied as a 
potential treatment to prevent or limit heart failure induced by MI over the past two decades 
(Sanganalmath, 2013). This approach aims to deliver cells within injured myocardium with 
minimal invasiveness in order to induce tissue regeneration and reestablish the loss of 
contractility upon MI (Sanganalmath, 2013). In addition, cell transplantation within the infarct can 
inhibit scar expansion and further deterioration of unaffected myocardial tissue (Farahmand, 
2008; Shintani, 2009). It is speculated that the growth factors released by the transplanted cells 
may trigger an endogenous regeneration within the infarcted myocardium. To date, several cell 
sources, including skeletal myoblasts, cardiac stem cells (CSCs), mesenchymal stem cells 
(MSCs), embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs), have been 
used for cardiac cell therapy (Masoudpour, 2017; P. K. Nguyen, 2016). The original cardiac cell 
therapy studies started with the use of skeletal myoblasts (Lavine, 1937; Taylor, 1998). Skeletal 
myoblasts can be acquired from autologous origin (Ince, 2004) and are proliferative and hypoxia-
resistant (Scaringi, 2013). The injection of skeletal myoblasts within myocardium resulted in 
reduced scar size, attenuated ventricular remodeling, and improved cardiac function (Farahmand, 
2008). However, the poor trans-differentiation of skeletal myoblasts into CMs and failure to create 
mature intercalated disks, composed of N-cadherins and connexins, lead to poor electro-
mechanical integration with the host myocardium and caused fatal arrhythmia (Reinecke, 2000; 
Reinecke, 2002b).  
Adult stem cells (e.g. MSCs and CSCs), ESCs and iPSCs are other cell sources that have 
been utilized in cardiac cell therapy (Jing, 2008). The capabilities of self-renewing and 
differentiation to multi-lineages are the two most important characteristics of stem cells which 
make them attractive for cardiac regeneration (Jing, 2008). MSCs are multipotent stem cells 
residing in various autologous tissues (Hass, 2011), which are to some extent capable of 
differentiating into CMs (Toma, 2002). Also, MSCs have shown significant potential to promote 
vascularization within myocardial scar tissue by secreting various paracrine signaling cues (e.g. 
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VEGF) (Singh, 2016). The vascularization of infarct reduces scar expansion as well as ventricular 
remodeling and enhances cardiac function (Silva, 2005). CSCs or cardiac progenitors are another 
type of adult stem cell capable of differentiating to CMs (Le, 2016). CSCs encompass a 
heterogeneous population of cardiac progenitor cells including c-kit+, islet-1+, Sca-1+, and 
cardiospheres, distributed throughout the heart (Le, 2016). Pre-clinical reported studies 
demonstrated that the injection of CSCs in a MI-induced rat model significantly decreased 
ventricular chamber dilation and wall stress, resulting in an improved ejection fraction and 
myocardium regeneration (Beltrami, 2003; Hong, 2014; Nadal-Ginard, 2014). In recent clinical 
trials using CSCs (Chugh, 2012; Malliaras, 2014) also similar therapeutic outcomes, including 
high level of biosafety, significant reduction of scar size, induced cardiac regeneration and 
improved regional ventricular function, were observed. Pluripotent stem cells, including ESCs and 
iPSCs, are other available candidates which have shown substantial promises for cell-based 
cardiac therapies (Masoudpour, 2017). These cells offer differentiation to a wide range of cell 
types specifically CMs. CMs derived from ESCs and iPSCs express cardiac transcription factors 
(e.g. GATA-4 and Nkx2.5) and have spontaneous beating and heterogeneity in cardiac 
population (e.g. nodal, atrial, and ventricular) (Eng, 2016; He, 2003). The in vivo studies of 
implanting ESC- and iPSC-derived CMs in rodent and primate MI-models have demonstrated the 
formation of intact cardiac muscles within infarct, attenuated adverse ventricular remodeling and 
improved cardiac function (Chong, 2014; Shiba, 2016; Ye, 2014). Despite the promising 
outcomes, the existing risk of teratoma formation and potential arrhythmogenesis are the major 
roadblocks that limit their clinical translation (Patricia K. Nguyen, 2015; Shiba, 2016; Y Zhang, 
2011).  
In general, the efficacy of cardiac cell therapy for regeneration of injured myocardium has 
been shown to be significantly reduced in vivo, primarily due to low viability, retention (less than 
2% (Hou, 2005)), and lack of long-term engraftment of injected cells (Jadczyk, 2013; L Li, 2016a). 
This failure has been attributed to the harsh microenvironment of the infarct, cell transplant 
leakage due to the vigorously contracting myocardium, and the imperfect routes of cell delivery 
(Bonios, 2011; Robey, 2008). The harsh microenvironment of the infarcted myocardium which 
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includes hypoxia, inflammation, and a high concentration of reactive oxygen species (ROS), does 
not provide a suitable substrate for adhesion and retaining of transplanted cells (Angelos, 2006; 
Song, 2010). For example, the presence of hypoxia and ROS within the infarct deteriorates 
expression and assembly of integrins, which induces cell apoptosis through anoikis (i.e. lack of 
cell-ECM interactions) (Song, 2010). In addition, cells delivered using intracoronary and 
intravenous infusions have shown lower retention in the site of injury compared to direct injection 
within the tissue (intramyocardial), clearly demonstrating the impact of delivery method (Kanelidis, 
2017). One of the advancements that have been introduced to improve viability and retention of 
cells after transplantation, is developing 3D scaffold-free multicellular cardiac microtissues 
instead of single cell delivery method. 3D structure of scaffold-free microtissues offers a 
physiologically relevant microenvironment with enhanced cell-cell (e.g. cadherins and connexins 
(Chang, 2009; EJ Lee, 2012)) and cell-ECM (e.g. production of endogenous ECM (W-Y Lee, 
2011)) interactions. Additionally, the endogenous secreted ECM within microtissue promotes 
expression of integrins and prevents anoikis of transplanted cells. Furthermore, the cell-cell 
mechanical and electrical interactions, through N-cadherins and connexins respectively, are 
virtually completely absent when single cells are injected. However, injection of cells in the format 
of microtissues with enhanced cell-cell interactions can induce their electro-mechanical 
integration with the host myocardium, leading to higher therapeutic outcomes (EJ Lee, 2012; S 
Zhang, 2015b). At last, the hypoxic core of tightly packed microtissues can passively act as 
proangiogenic factors, and induce vascularization within the damaged myocardium (Bhang, 
2011).  
1.3.2. Scaffold-based cardiac tissue engineering 
Tissue engineering is an approach, involving scaffold, cells and bioactive cues, to create 
and develop biomimetic tissue constructs for regeneration applications. Particularly, cardiac 
tissue engineering includes designing and fabricating artificial tissue surrogates in order to heal 
injured myocardium after MI, and to re-establish heart contractility (Eschenhagen, 2012). The 
implantation of tissue surrogates can also prevent or limit the adverse effects of post-MI 
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ventricular remodeling (Xiong, 2011). Engineered cardiac tissues (ECTs) are typically composed 
of a scaffolding biomaterial embedded with cells and bioactive signaling cues, such as growth 
factors (Eschenhagen, 2012). Scaffolds generally provide structural support and/or a suitable 
delivery vehicle for cells and signaling cues, until complete integration of the ECT with the host 
tissue occurs. Among a wide range of available scaffolds for cardiac tissue engineering (Locke 
Davenport, 2015), hydrogels have been at the center of attention as promising candidates for 
developing ECTs (Z Li, 2011). The aqueous macroporous structure (swollen) of hydrogels is 
similar to the native ECM (Fan, 2017). This unique and beneficiary characteristic allows adhesion, 
infiltration and growth of cells within hydrogel-based scaffolds (Fan, 2017). A wide range of 
different hydrogels with both natural and synthetic origins have been utilized for cardiac tissue 
engineering. For example, collagen (Zimmermann, 2006), fibrin (Xiong, 2011), gelatin (Saini, 
2015), alginate (Shachar, 2011) and chitosan (Pok, 2013) are the mostly used naturally-derived 
hydrogels. In addition, poly(N-isopropylacrylamide) or PNIPAAm (Navaei, 2016b), poly-2-
hydroxyethyl methacrylate or PHEMA (Zuwei Ma, 2010) and poly(ethylene glycol) or PEG (Habib, 
2011) are the frequently employed synthetic hydrogels. In addition, a combinatorial class of 
hybrid hydrogels has been developed to exploit advantages of both natural and synthetic 
biomaterials. For example, a hybrid of PNIPAAm-gelatin can be synthesized to incorporate the 
bioactivity and high cellular adhesion affinity of gelatin within a PNIPAAm hydrogel with well-
tuned mechanical and gelation properties (Navaei, 2016b). 
Hydrogel-based ECTs are usually administered to the injured myocardium as cardiac 
patches (J Zhang, 2015a) or injectable cell-laden biomaterials (Hasan, 2015). Cardiac patches 
are made by seeding on or encapsulating cells within a hydrogel construct, and subsequently are 
implanted onto the injured myocardium. Based on published studies, cardiac patches have been 
able to provide structural support for thinned myocardium, reduce ventricular dilation and wall 
stress, augment cell-host integration, and increase contractile capacity of the heart (Xiong, 2011; 
Zimmermann, 2006). For example, fibrin hydrogel patches encapsulated with human induced 
pluripotent stem cell (hiPSC)-derived CMs and hiPSC-endothelial cells (ECs) were implanted in 
MI-induced animal models (Bellamy, 2015; Weinberger, 2016). The fibrin patch significantly 
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enhanced cell engraftment, neovascularization, and ventricular contractility and attenuated the 
adverse ventricular remodeling in the MI-induced animals. In one step further to advance cardiac 
patches, hydrogel-based ECTs with micro- and nano-scale topographies have been introduced to 
mimic the native myocardium anisotropic cytoarchitecture (Annabi, 2013; D-H Kim, 2010; Navaei, 
2017; Weining, 2014). It has been widely accepted that the electrical and contractile 
functionalities of myocardium are strongly correlated with the anisotropic cytoarchitecture within 
the cardiac myofibers (Buckberg, 2008). Therefore, cardiac patches with anisotropic cellular 
alignments can exert electrical and mechanical functionalities in the same direction as the host 
myocardium to maximize their therapeutic contribution (Fleischer, 2017; Weining, 2014). For 
instance, tropoelastin methacrylate (MeTro) hydrogels with micron size groove-like topographies 
were fabricated using UV photolithography (Annabi, 2013). Cardiac cells seeded on the grooved 
MeTro hydrogels demonstrated highly aligned cardiac myofiber assemblies similar to the native 
myocardium with significant anisotropic contractions.  
Cell-laden hydrogel ECTs also can be injected within injured myocardium preferably 
through minimally invasive procedures, such as transendocardial catheterization (Hasan, 2015). 
The use of injectable ECTs offers clear advantages in comparison to the cardiac patches. First, 
the injection of cell-laden hydrogels inside the infarcted area increases the retention and 
engraftment of ECTs by providing maximized contact area thorough a 3D ECT-host interface 
(Traverse, 2012). Second, injectable ECTs can be delivered within the injured myocardium using 
minimally invasive procedures, including intracoronary, intramyocardial, transendocardial, and 
intravenous catheterizations (Johnson, 2013), which may be less complicated and intense 
compared to the open-chest operations for cardiac patch implantation (Montgomery, 2017; Seif-
Naraghi, 2013). The major considerations for developing injectable ECTs are the rheology 
properties (e.g. stiffness and gelation) and bioactivity (e.g. cell adhesion affinity) of hydrogels 
(Fitzpatrick, 2010; Ifkovits, 2010). For example, shear thinning hydrogels provide minimized shear 
stress on cells during their delivery through needles or catheters, which leads to high cellular 
viability post-injection (Rodell, 2016). In addition, incorporation of a bioactive natural polymer 
within an injectable synthetic hydrogel improves spreading, growth, and maturation of 
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encapsulated cells, leading to enhanced functionalities of ECT (Kraehenbuehl, 2008). Injectable 
cell-laden ECTs are in situ gelling scaffolds. Thus, specific biological conditions, such as pH or 
temperature, can be used to trigger gelation of injectable hydrogels. As an excellent example, 
temperature-responsive PNIPAAm-based hydrogels have been extensively utilized to synthesize 
injectable hydrogels for cardiac tissue engineering applications (Cai, 2015; Peña, 2016; Tang, 
2017). For instance, in a comprehensive in vivo study by (Tang, 2017), human cardiac stem cells 
were embedded within a PNIPAAm-based injectable hydrogels and transplanted in rat and pig 
MI-models. The injection of cell-laden hydrogels resulted in the reduction of scar size, promoted 
vasculature formation, and improvement of the cardiac function (e.g. ejection fraction) in both 
animal models. In another work by Li (XY Li, 2010) bone marrow stem cells were encapsulated 
within PNIPAAm-based hydrogels and injected in MI-induced animal models. The outcomes 
clearly demonstrated improved ejection fraction, ventricular fractional shortening, decreased 
infarct size, and promoted vascularization within the injured myocardium. 
1.4. The Use of Functional Nanomaterials in Cardiac Tissue Engineering 
In the previous section, a brief introduction about the conventional scaffold-based ECTs 
and scaffold-free cell-based therapies for heart regeneration was covered. The noteworthy 
outcomes of these approaches were discussed in terms of limiting scar expansion, reducing 
adverse effects of ventricular remodeling, and enhancing cardiac function (Hansson, 2013). 
However, despite the promising results, there are critical shortcomings associated with both 
scaffold-based and scaffold-free approaches that need to be further addressed (Kharaziha, 
2016). In this section, the recent advances in the use of conductive nanomaterials and their 
applications to address the limitations of scaffold-based and scaffold-free cardiac tissue 
engineering will be discussed (Figure 1.1.).  
1.4.1. Nanocomposite ECTs with enhanced material properties. 
The key characteristic of hydrogels for developing ECTs is their macroporous structure 
with similar architecture to the native ECM (Section 3.1.). Such macroporous structure enables 
cellular growth as well as the diffusion of nutrients and oxygen within hydrogel matrices (Fan, 
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2017). On the other hand, the native cytoarchitecture of myocardium consists of tightly connected 
CMs, forming uniaxially-aligned anisotropic myofibers (Coghlan, 2001). CMs within myofibers are 
electrically coupled by means of specific electrical gap junctions known as connexins (Oyamada, 
1994). This tight electrical connectivity through connexins allows the rapid conduction of ions 
between CMs, which results in synchronized contractions (Oyamada, 1994). Therefore, such 
specific cellular structure-function relationship should be considered for developing ECTs as 
potential therapeutics for MI (Engelmayr Jr, 2008; Liau, 2012). 
 
Figure 1.1. The utilization of conductive nanomaterials to develop engineered cardiac tissues 
(e.g. cardiac patches, injectable hydrogels and scaffold-free microtissues) with enhanced 
electrical, mechanical, topographical, and biological properties as potential treatments for MI. 
Hydrogel matrices typically do not offer electrically conductive microenvironments (Nenad 
Bursac, 2007; Dvir, 2011). CMs adhered within the pores of hydrogel matrix are electrically 
isolated by non-conductive polymeric scaffold, which can delay the conduction of action potential 
throughout the ECT (Dvir, 2011; Tian, 2012). Furthermore, low conduction velocity and 
subsequent unsynchronized contractions can lead to poor electro-mechanical integration of the 
13 
 
ECT with the native myocardium (Liau, 2012). These heterogeneous electrical and contractile 
patterns in the ECT-myocardium interface may result in arrhythmogenesis (Miura, 2010; Ter 
Keurs, 2011), leading to low efficacy or failure of the therapy (Liau, 2012). To develop electrically 
conductive ECTs, different organic and inorganic nanomaterials have been incorporated within 
the matrix of hydrogel scaffolds (Figure 1.1.) (Monteiro, 2017). The core rational behind this idea 
is to primarily facilitate the propagation of electrical signals, either action potential or external 
stimulation, among CMs throughout the ECT (Y Wu, 2018). The basic understanding of the 
interactions between conductive nanomaterials and cells was first explained in the context of 
ultra-sensitive nanosensors and nanoelectronics (Timko, 2010). Unlike macro-scale conductive 
materials, which only accumulate induced charges on their surfaces, one-dimensional (1D) 
nanomaterials (e.g. nanowires or nanorods) can transfer the surface charges into their bulk, 
leading the flow of electrical current (Timko, 2010). Therefore, the charges induced by CMs action 
potential can be conducted through the nanomaterials (Timko, 2010; Y Wu, 2018). This 
technology has been used to increase the electrical activity of neurons including excitability and 
signal transfer (Cellot, 2008; Lovat, 2005; Mazzatenta, 2007; Tian, 2012), therefore, could be 
used to improve the electrophysiology of CMs.  
The incorporation of conductive nanomaterials also increases the mechanical and surface 
topography of the hydrogels (Gaharwar, 2014). Nanomaterials act as reinforcing nanofillers, 
which reduce the motility of the polymeric backbone of the hydrogel matrix and enhance the 
stiffness (Tjong, 2006). Additionally, nanomaterials’ surface charge and functionalization can 
create physiochemical bonds (e.g. electrostatic, π-π stacking, and hydrophobic interactions) with 
the hydrogel backbone, which further improves matrix stiffness (Q Li, 2016b). Mechanical 
stiffness and surface topographies of the scaffolding hydrogels critically influence the cardiac 
maturation of ECTs (Bhana, 2010; Boothe, 2016; Carson, 2016; Deok-Ho, 2005). Cardiac 
maturation of ECTs can be simplistically defined as the ability of CMs to induce excitation-
contraction cycles via generating action potential resulting in mechanical contractions of the 
tissue (Kolanowski, 2017). In addition, conduction velocity of action potential as well as the 
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magnitude of contractile force in CMs are other important elements of cardiac maturation (C 
Robertson, 2013).  
One of the factors that has a significant impact on the maturation of CMs is their affinity for 
adhesion and expressing integrins within the surrounding matrix (Israeli-Rosenberg, 2014). CM-
matrix interactions are primarily modulated by the expression of integrins (Israeli-Rosenberg, 
2014). Accordingly, the expression level of integrins influences the maturation of CMs, regarding 
expressions of connexin43 (Cx43) gap junctions (Czyz, 2005), Ca2+ ion channels (YG Wang, 
2000b), and contractile proteins, such as sarcomeric α-actinin (SAC) and cardiac troponin I (cTnI) 
(X Wu, 2010). Specifically, the expression of integrins leads to the assembly of Costameres and 
thereafter activation (i.e. phosphorylation) of a wide range of signaling molecules including ILK, 
FAK, paxillin, vinculin, talin, and PINCH (Israeli-Rosenberg, 2014). The phosphorylation of these 
molecules results in the activation of AKT, ERK, MAPK, RhoA and WNT signaling pathways 
(Samarel, 2005), leading to the enhanced expression and maturation of intercalated disks (e.g. 
Cx43), contractile machinery (e.g. SAC and cTnI) and Ca2+ handling within CMs. Many studies 
have shown that stiff hydrogel scaffolds increase the adhesion and spreading of CMs (Bhana, 
2010). The same scenario has been reported about hydrogels incorporated with nano-scale 
topographies. Such topographies can act as anchoring points for CMs and improve their 
adhesion and spreading (Deok-Ho, 2005), ultimately leading to the intact formation of cell-cell 
junctions and tissue maturation. In the following sections, the frequently used conductive 
nanomaterials for engineering functional ECTs will be discussed (Table 1.1.).  
1.4.1.1. Gold nanomaterials 
Gold nanomaterials (GNMs), such as gold nanorods (GNRs) and gold nanowires (GNWs), 
with high electrical conductivity, biocompatibility (Connor, 2005; Khlebtsov, 2011), and facile 
synthesis and functionalization (Dykman, 2012; Lloret, 2013), have been employed for various 
biomedical applications including cardiac and neural tissue engineering (Baranes, 2016; Dvir, 
2011). In a pioneering study, Dvir (Dvir, 2011) incorporated GNWs within alginate hydrogels 
(Figure 1.2A.) and seeded with neonatal rat ventricular CMs (NRVCMs) to fabricate electrically 
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conductive ECTs. The length of GNWs was selected to be approximately 1 μm to increase the 
probability of electrically bridging cell clusters within the alginate pores with wall thickness of 
about 500 nm. The conductive atomic force microscopy (Figure 1.2A.) results confirmed the 
existence of many electrical connections within a 500 nm thick alginate-GNW hydrogel film. In 
addition, alginate-GNW hydrogels showed significantly higher bulk electrical conductivity 
compared to pristine alginate. Alginate-GNW ECTs were electrically stimulated to evaluate the 
ability of GNWs to electrically bridge the alginate porous scaffold. Their finding demonstrated that 
only CMs on alginate-GNW hydrogels received the propagated electrical stimuli resulting in the 
contractions of remote CMs (Figure 1.2B.). The maturation of cardiac specific markers including 
SAC, cTnI and Cx43 were also assessed using immunostaining and western blotting. The results 
revealed that CMs on alginate-GNW hydrogels produced higher amounts of cardiac proteins with 
mature phenotypic morphology (i.e. striated sarcomeres). In addition to induced electrical 
conductivity, incorporation of GNWs improved the mechanical properties (compressive modulus) 
of pristine alginate by acting as nanoscale reinforcements within the hydrogel backbone. 
However, the impacts of enhanced stiffness on CMs functionalities were not investigated. Overall, 
these findings demonstrated for the first time that conductive nanomaterials could electrically 
connect CMs within the porous scaffold of a hydrogel and induce maturation of contractile 
proteins and electrical gap junctions. In another study (Baei, 2016), gold nanoparticles (GNPs) 
were mixed with thermo-responsive chitosan hydrogels encapsulated with MSCs. Apart from 
extensive material characterizations, this study demonstrated that electrically conductive 
chitosan-GNP hydrogels enhanced cardiogenic differentiation of MSCs. However, no specific 
experiments were performed to evaluate the influence of electrical conductivity and enhanced 
mechanical stiffness on MSC-derived CMs electrophysiology and contractility.  
1.4.1.2. Carbon-based nanostructures 
Carbon-based nanostructures, such as carbon nanotubes (CNTs) (SR Shin, 2013; Zhou, 
2014) and reduced graphene oxide (rGO) (SR Shin, 2016), are among the other popular 
nanomaterials which have been widely utilized for developing conductive hydrogel-based ECTs 
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(Martinelli, 2013a). These nanostructures offer high electrical conductivity, and unique 
mechanical and topographical properties (Eatemadi, 2014). In a pioneering study (SR Shin, 
2013), CNTs were embedded within photocrosslinkable gelatin methacrylate (GelMA), to 
fabricate thin films (~50 μm) of GelMA-CNT hydrogels.  
 
Figure 1.2. A) The SEM micrograph of alginate-GNW hydrogel matrix showing the generated 
surface conductive nano-topographies by GNWs. B) Ca2+ spikes within CMs upon electrical point 
stimulation displaying synchronous propagation of the signal (Dvir, 2011). C) Electron microscopy 
images of GelMA-CNT hydrogel matrix. D) F-actin staining (green) images demonstrating the 
improved CMs retention and spreading on GelMA-CNT. E) The enhanced maturation of CMs 
mediated by the CNTs within the GelMA hydrogel matrix. F) The schematic illustrating the 
conductance of electrical signal via CNTs within CMs when the Cx43 gap junctions are blocked 
(SR Shin, 2013). 
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The embedded CNTs significantly increased electrical conductivity and mechanical 
stiffness of GelMA matrix. In addition, scanning electron microscopy (SEM) images depicted the 
localization of CNTs within macroporous matrix of GelMA as nano-scale topographies (Figure 
1.2C.). The enhanced stiffness and induced surface nano-topographies resulted in the significant 
increase in adhesion, retention, and viability of CMs on GelMA-CNT hydrogels (Figure 1.2D.). 
Their results also demonstrated that CMs cytoskeleton on GelMA-CNT hydrogels were more 
spread and aligned compared to pristine GelMA. This change can be associated with nano-
topographies created by the incorporation of CNTs within the GelMA matrix. Furthermore, CMs 
maturation in terms of the expressions of SAC, cTnI, and Cx43 was substantially enhanced on 
GelMA-CNT hydrogels, based on immunostaining and western blotting results (Figure 1.2E.). 
Two tests were performed to analyze the impact of scaffold conductivity on electrophysiology of 
CMs. First, ECTs were electrically paced by field stimulation; GelMA-CNT tissues showed 3- to 4-
fold lower excitation voltage thresholds. Second, cell-cell electrical coupling was disrupted using 
gap junction blocker (heptanol); where GelMA-CNT tissues maintained their synchronized 
spontaneous contractions upon heptanol treatment (Figure 1.2F.). These data showed that 
scaffold’s conductivity can enhance excitability and sustain signal propagation within the ECT. In 
another study (Pok, 2014), CNTs were chemically coated with chitosan to achieve more 
biocompatible nanomaterials with higher aqueous dispersity. Coated CNTs were then mixed with 
chitosan hydrogel to develop conductive and stiff scaffolds. Chitosan-CNT hydrogels increased 
SAC protein expression and electrical conduction velocity among CMs, which was consistent with 
other studies that developed conductive CNT-embedded ECTs for cardiac tissue engineering 
applications (Ahadian, 2016; SR Shin, 2013; H Sun, 2017). 
The promising in vitro studies (Martinelli, 2013a) led to implantation of CNT-embedded 
hydrogel ECTs in MI-induced rat models (X Li, 2014; Zhou, 2014). In a study by Zhou (Zhou, 
2014), gelatin-CNT hydrogels were fabricated and seeded with CMs. Then, ECTs were implanted 
onto the infarct region of MI-induced rats. The in vivo findings indicated that the exogenous CMs 
and CNTs were migrated from the ECT into the infarct. This was an indicative sign of ECT-
myocardium integration. In addition, vascularization was observed within the gelatin-CNT ECT as 
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well as in the interface of ECT-infarct. In terms of limiting adverse ventricular remodeling post-MI, 
both end-diastolic and end-systolic diameters of the left ventricle were maintained in animals 
implanted with gelatin-CNT ECTs, confirming minimized chamber dilation. Furthermore, 
implantation of gelatin-CNT ECTs in rats with infarcted myocardium resulted in significantly 
enhanced cardiac functions, in terms of ejection fraction and fractional shortening. In contrast no 
change or diminished myocardial functionalities were observed in implanted pristine gelatin 
group. These cellular- and organ-level functional improvements were associated with the 
enhanced cardiac maturation and adhesion of CMs on gelatin-CNT hydrogels. Specifically, 
expressions of Cx43, N-cadherin, and voltage-gated Na+ channels were upregulated. 
Furthermore, adhesion related proteins, including integrin-β1, integrin linked kinase (ILK), and β-
catenin, were highly expressed. Despite the comprehensive investigation on cardiac maturation 
of gelatin-CNT ECTs, the impact of induced electrical conductivity by CNTs on electrophysiology 
of CMs and infarcted myocardium were not assessed.  
Other scaffolding biomaterial s were also mixed with GNMs and carbon-based 
nanomaterials to enhance their electrical, mechanical and topographical properties. For instance, 
GNPs were sputter coated on poly(caprolactone)-based electrospun nanofibers to increase 
electrical conductivity and mechanical stiffness of the fibrous scaffolds (Fleischer, 2014; Michal 
Shevach, 2013). In another study (You, 2011), GNPs were chemically bonded to the HEMA-
based porous scaffolds for developing electrically conductive ECTs. CNTs similar to GNMs have 
been also incorporated within nanofibrous porous scaffolds, such as poly(glycerol sebacate) 
(Kharaziha, 2014), chitosan (Pok, 2014), and poly(lactic-co-glycolic acid) (Stout, 2014), to create 
electrically conductive and mechanically robust ECTs. In all these studies similar findings 
compared to the hydrogel-based nanocomposite ECTs were reported, including increased 
adhesion and retention of CMs as well as enhanced expressions of Cx43 gap junctions, SAC, 
and cTnI. In addition, lower excitation voltage threshold required to induce electrical stimulations 
within the ECTs, was reported.  
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Table 1.1. 
The scaffold-based tissue engineering approach for developing electrically conductive cardiac 
patches (ECTs). 
Conductive 
nanomaterial 
Scaffolding 
biomaterial  
Cell 
type 
Biological outcomes 
Gold nanomaterials  
GNWs 
(Dvir, 2011) 
Alginate  
hydrogel 
NRVCMs • Increased expressions of SAC, cTnI, and Cx43 
• Synchronized Ca2+ transients 
• Enhanced electrical signal propagation 
GNPs 
(Baei, 2016) 
Chitosan  
hydrogel 
MSCs • Enhanced cardiogenic differentiation 
GNPs 
(Fleischer, 
2014) 
PCL 
nanofibers 
NRVCMs • Uniaxially-aligned myofibers 
• High contraction amplitude and frequency 
• Low excitation voltage threshold 
GNPs 
(You, 2011) 
HEMA  
scaffold 
NRVCMs • Increased expression of Cx43 
Carbon-based nanostructures  
CNTs 
(SR Shin, 
2013) 
GelMA  
hydrogel 
NRVCMs • Increased cell retention and spreading 
• Increased expressions of SAC, cTnI, and Cx43 
• Low excitation voltage threshold 
• Synchronized beating in presence of heptanol 
CNTs 
(Pok, 2014) 
Chitosan  
hydrogel 
NRVCMs • Increased expressions of SAC  
• Enhanced formation of sarcomere structures 
• Faster conduction velocity 
CNTs 
(Zhou, 2014) 
Gelatin  
hydrogel 
NRVCMs • Integration with the native myocardium 
• Increased expressions of Cx43, N-cadherin, 
and Na+ channels  
• Enhanced cardiac output and reduced adverse 
ventricular remodeling in MI-model rats in vivo 
CNTs 
(Kharaziha, 
2014) 
PGS-Gelatin 
nanofibers 
NRVCMs • Improved cell retention and metabolic activity 
• Enhanced cellular anisotropic alignment  
• Low excitation voltage threshold 
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1.4.1.3. Gaps and challenges 
Incorporation of conductive nanomaterials within macroporous scaffolds leads to three 
major material modifications: 1) enhanced mechanical stiffness, 2) generation of nano-scale 
surface topographies, and 3) enhanced electrical conductivity. As discussed in previous sections, 
several studies have shown that each of these modifications alone or in combination exerts 
significant impacts on CMs functionalities and maturation (Bhana, 2010; Boothe, 2016; Carson, 
2016; Deok-Ho, 2005; Pok, 2014; Y Wu, 2018; You, 2011).  
Overall, there are two mechanisms which lead to enhanced functionalities of scaffold-
based ECT through incorporation of conductive nanomaterials. Enhancing mechanical stiffness of 
scaffolds increases integrin expression and CMs adhesion (Young, 2014). Upregulation of 
integrin expression in CMs results in an improvement in handling of cytoplasmic Ca2+ 
concentrations through the maturation of Ca2+ ion voltage-gated channels, SERCA pumps and 
ryanodine receptors (Boothe, 2016; X Wu, 2010). This improvement leads to complete excitation-
contraction cycles (Rodriguez, 2011). Expression of Cx43 gap junctions can be also upregulated 
by increasing CMs adhesion affinity (Czyz, 2005; Israeli-Rosenberg, 2014). Similar to the 
improved stiffness, nano-scale topographies and surface roughness of the scaffolds induce CMs 
adhesion and integrin expression as well (Carson, 2016; Deok-Ho, 2005). Therefore, the 
mechanical and topographical enhancements from addition of conductive nanomaterials within 
the scaffolds, regardless of nanomaterials’ electrical conductivity, lead to amplified signal 
propagation and synchronized contractility among CMs.  
Electrical conductivity of scaffolds also intensifies signal propagation within both skeletal 
and cardiac muscle cells, without altering their adhesion-dependent properties (Hsiao, 2013; 
Mawad, 2016; Mihic, 2015; You, 2011). For instance, in a study by Mihic (Mihic, 2015), two strips 
of rat leg skeletal muscle were separated (25 mm apart) using conductive poly(pyrrole)-chitosan 
hydrogels. When one of the strips was electrically stimulated, action potential signals were 
transmitted to the other strip through the conductive hydrogel substrate, an event that only 
occurred at significantly higher voltages for non-conductive chitosan hydrogel. Furthermore, 
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conductive poly(pyrrole)-chitosan hydrogel increased the calcium transient velocity among CMs in 
vitro and electrical excitability of healthy and infarcted myocardial tissue in vivo. In addition to 
existing experimental data, the enhancement of intercellular electrical coupling using conductive 
nanomaterials has been confirmed using theoretical models (Lovat, 2005; Y Wu, 2018). The 
simulations illustrated that CMs bridged by conductive nanomaterials can communicate 
electrically if the action potential amplitude is high enough, and cells are in tight contact with the 
nanomaterials (Y Wu, 2018).  
Overall, incorporation of conductive nanomaterials within scaffolds leads to a combinatorial 
enhancement of all electrical, mechanical, and topographical characteristics. However, to date, 
none of the studies focusing on the development of conductive nanomaterial-embedded ECTs 
have aimed to elucidate the individual impacts of these enhancements (stiffness, nano-
topography, conductivity) on CMs functionalities, such as CMs electro-mechanical coupling. In 
other words, could non-conductive nanomaterials, with similar morphology as the conductive 
ones, induce synchronized electrical and contractile functionalities among CMs by only enhancing 
the cardiac maturation rather than inducing the exogenous electrical conductivity?  
1.4.2. Nanomaterials-embedded scaffold-free cardiac microtissues   
In recent years, conductive nanomaterials have been at the center of attention to promote 
electrical and contractile maturation of CMs in scaffold-free tissues for cell-based therapies (Table 
1.2.). Early studies on cell-nanomaterial interactions revealed that CMs cultured on CNT-coated 
substrates were notably more metabolically active compared to those cultured on gelatin-coated 
substrates (Martinelli, 2012, 2013b). The CNTs also induced electrophysiological maturation by 
reducing resting membrane potential, enhancing their ability to fire action potential, and 
increasing the expression of Cx43 gap junctions. Genetically, CMs cultured on CNTs 
demonstrated upregulation of physiological (e.g. α-MHC and SERCA2a), and downregulation of 
pathophysiological (e.g. β-MHC, ANP and Sk-Actin) genes (Richards, 2016). Following these 
promising outcomes, other conductive nanomaterials, including rGO nanoflakes (rGONFs) (Park, 
2015) and silicon nanowires (SiNWs) (Richards, 2016; Y Tan, 2015), were used for developing 
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scaffold-free cardiac microtissues for minimally invasive cell-based therapies. Conductive cardiac 
microtissues are created by culturing cells and nanomaterials on ultra-low attachment substrates 
(Desroches, 2012). Cells are self-assembled as spherical microtissues usually known as cardiac 
spheroids. 
rGONFs are carbon-based nanostructures with high physiochemical surface reactivity and 
electrical conductivity (Dreyer, 2010; Gómez-Navarro, 2007). Due to the abundance of reactive 
functional groups (e.g. hydroxyl and carboxyl) on rGONFs, they can be used as surfaces for 
protein adsorption. Due to the fact that the ischemic myocardium is not suitable for cellular 
adhesion and retention (Gailit, 1993; Song, 2010), many of the transplanted cells undergo anoikis 
because of the lack of cell-ECM interactions and low integrin expression (Song, 2010). In this 
regard, Park (Park, 2015) demonstrated that incorporated rGO within scaffold-free MSC 
microtissues prevented anoikis of stem cells (Figure 1.3A.) by increasing interactions between 
cells and ECM proteins (e.g. fibronectin). The enhanced cell-ECM interactions also promoted 
secretion of angiogenic growth factors (e.g. VEGF), and subsequently higher expression of Cx43 
gap junctions (Figure 1.3B.). In addition, rGONFs offer electrical conductivity along with high 
physicochemical reactivity. The induced electrical conductivity within MSC microtissues by 
rGONFs elevated expression of Cx43 gap junctions, consistent to the results reported for 
scaffold-based conductive ECTs (You, 2011). The benefits of increased MSCs survivability, and 
upregulation of angiogenic factors and Cx43 were significantly translated to high vascularization 
and cardiac function upon implantation of MSC-rGO microtissues in MI-induced rat models (You, 
2011). In another sets of studies, cardiac microtissues have also been combined with electrically 
conductive SiNWs to promote maturation of iPSC-derived CMs (Richards, 2016; Y Tan, 2015). 
SiNWs are electrically conductive inorganic nanomaterials, which can be degraded in vivo 
(Anderson, 2003). The cardiac microtissues created using iPSC-derived CMs and SiNWs 
(Richards, 2016; Y Tan, 2017) demonstrated higher expressions of cell-cell junctions (e.g. N-
cadherins and Cx43) and contractile proteins (e.g. SAC and cTnI) compared to the pure CMs 
spheroids using western blotting (Figure 1.3C.). Faster release of cytoplasmic Ca2+ upon action 
potential was another indication of maturation of iPSC-derived CMs induced by SiNWs. When 
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utilized synergistically with chronic external electrical stimulations (Radisic, 2004), SiNWs 
significantly promoted iPSC-derived CMs ventricular specific maturation (i.e. less nodal-like CMs).  
 
Figure 1.3. A) The schematic drawing depicting the interaction of MSC with the embedded with 
rGONFs. B) Immunostained images showing the enhanced expressions of fibronectin (green) 
and Cx43 (red) within MSC-rGONF microtissues (Park, 2015). C) The schematic and 
immunostained images demonstrating the fabrication and the influence of SiNWs on the cardiac 
maturation of hiPSC-CMs (Richards, 2016). 
Iron oxide nanoparticles (IONPs), with magnetic and semi-conductive electrical properties, 
also have been used for engineering scaffold-free cell therapies for treatment of MI. In a study by 
Han (Han, 2015), IONPs were employed to indirectly enhance the expression of Cx43 in MSCs. 
Specifically, IONPs first were transferred inside rat myoblasts to induce Cx43 expression. The 
underlying mechanism was explained to be based on the release of Fe2+ from IONPs inside the 
cytoplasm of myoblasts (K Li, 2013). Then, over-expressed rat myoblasts were co-cultured with 
MSCs to enhance Cx43 expression within MSCs. The in vivo results of implanted engineered 
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tissue comprising co-culture of myoblast-MSC in MI-induced rat models demonstrated increased 
cardiac function along with reduced scar size. Despite the introduction of sophisticated 
techniques for engineering MSCs, no characterizations were performed to evaluate the impact of 
electrical conductivity of IONPs on electrophysiology of MSCs either in vivo or in vitro.  
Table 1.2. 
The scaffold-free tissue engineering approach for developing electrically conductive cardiac 
microtissues for cell therapies. 
Conductive 
nanomaterial 
Cell 
type 
Biological outcomes 
rGONFs 
(Park, 2015) 
MSCs • Enhanced cellular viability and reduced anoikis 
• Increased expressions of VEGF and Cx43 
• Improved vascularization and cardiac output in MI-
induced animal models in vivo 
SiNWs iPSC-CMs • Increased expressions of SAC, cTnI, Cx43, and N-
cadherin 
• Enhanced dynamic and handling of cytoplasmic Ca2+ 
• Increased ventricular-like population of CMs   
• Reduced spontaneous beating  
IONPs MSCs • Induced upregulation of Cx43 expression 
• Increased cardiac function and reduced scar size in 
MI-induced animal models in vivo 
 
1.4.2.1. Gaps and challenges 
Despite the promising outcomes demonstrating the potential of conductive nanomaterials 
to enhance the maturation of scaffold-free cardiac microtissues, the impact of nanomaterials’ 
electrical conductivity on signal propagation and electrophysiology of the cells/tissues have not 
been investigated. There is still a knowledge gap on whether the incorporated conductive 
nanomaterials (without the presence of any scaffolding biomaterial) could facilitate the action 
potential propagation (i.e. conduction velocity) among CMs. Furthermore, the localization and fate 
of these nanomaterials within the cells has not been fully identified. Transmission electron 
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microscopy images have spotted the nanomaterials in the extracellular microenvironment within 
the microtissues (Park, 2015; Y Tan, 2015). However, most of reported studies regarding cell-
nanomaterial interactions only have focused on the acute period (e.g. ~72 hours) (Huff, 2007; 
Linares, 2014). Therefore, comprehensive studies evaluating the localization of nanomaterials 
over long-term time periods are needed.  
1.5. Objectives and Specific Aims 
Over the past few decades, regenerative medicine has emerged as a new strategy to 
develop scaffold-based cardiac patches and scaffold-free cell therapies as potential approaches 
for MI treatment. Despite the progress, there are still critical shortcomings associated with these 
approaches regarding low cell adhesion-retention and lack of global CMs electrical coupling 
within the cardiac patch, as well as poor engraftment of transplanted cell therapies within the 
native myocardium. These issues have resulted in diminished functionalities of the therapies, 
such as unsynchronized contractility and lack of electromechanical integration with the native 
myocardium, leading to low efficacy or failure of the therapies. The overarching objective in this 
proposal is to develop two classes of ECTs with superior electrical, mechanical, topographical, 
and biological functionalities to address the limitations associated with previously developed 
tissue models as potential treatments for MI. The research design is founded upon a two-fold 
strategy; scaffold-based and scaffold-free tissue engineering, which are described below.  
Scaffold-based tissue engineering: Electrically conductive nanomaterials, including CNT 
and rGO, have been utilized to enhance electrical signal propagation as well as adhesion-
retention of CMs on the cardiac patches. Despite these advances, controversial debate on the 
cytotoxicity of CNT and rGO limits their clinical translation. Alternatively, GNMs, featuring high 
electrical conductivity, biocompatibility, and various nanostructures have shown promising results 
for fabricating cardiac patches with improved CMs electrical coupling and cellular adhesion-
retention. Thus, the first objective is to develop conductive gelatin-GNM hybrid cardiac patches 
with synchronized electrical and contractile functionalities as a potential treatment for MI. In 
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addition, grooved microtopographies are introduced on gelatin-GNM hydrogels to develop cardiac 
patches with native-like anisotropic cellular architecture. 
In addition, an injectable biohybrid cell-laden hydrogel was developed as a minimally 
invasive approach for treatment of MI. CMs alone and in co-culture with CFs were encapsulated 
within a PNIPAAm-gelatin hydrogel, and extensive in vitro characterizations were performed. This 
work was a collaborative effort with Dr. Vernon’s lab at Arizona State University.  
Scaffold-free tissue engineering: Multicellular cardiac microtissues embedded with 
conductive nanomaterials, such as rGO, have been developed to improve electrical and 
contractile functionalities as well as engraftment of cells within the native myocardium. However, 
these nanomaterials are dispersed randomly within cardiac microtissues with unspecific adhesion 
affinity to the cells, and minimal electrophysiological studies have been performed. Thus, our 
second objective is to develop electrically conductive scaffold-free injectable cardiac microtissues 
embedded with GNMs to address the limitations of cell-based therapeutics.  
We propose to complete this study through the following specific aims:  
1.5.1. Specific Aim1 
Development of gelatin-GNM cardiac patches (with and without grooved micropatterns) 
with enhanced contractile and electrical functionalities.  
1.5.2. Specific Aim2 
Engineering and characterization of electrically conductive scaffold-free injectable cardiac 
microtissues.  
1.5.3. Specific Aim3 
Fabrication and extensive material and in vitro biological characterizations of biohybrid 
injectable PNIPAAm-gelatin hydrogel tissues for cardiac regeneration. 
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CHAPTER 2 
GOLD NANOROD-INCORPORATED GELATIN-BASED CONDUCTIVE HYDROGELS FOR 
ENGINEERING CARDIAC TISSUE CONSTRUCTS 
2.1. Introduction 
MI is a major cause of mortality amongst cardiovascular diseases in the United States 
accounting for approximately one death per minute (Mozaffarian, 2015). Due to limited availability 
of donors and high complications associated with the heart transplantation, cell-based therapies 
(Orlic, 2001; Williams, 2013) and tissue engineering (Engelmayr Jr, 2008; Leor, 2000; 
Zimmermann, 2006) have been considered as promising strategies for treatment of MI. 
Particularly, tissue engineering approaches have enabled the development of biomimetic cardiac 
patches (Annabi, 2013; Dvir, 2009; Kharaziha, 2013), meshes (M Shin, 2004; Teplenin, 2015) 
and cell sheets (Masuda, 2008; Masumoto, 2014; Matsuura, 2011). In this regard, hydrogel-
based biomaterials have been proven to be suitable matrices for cardiac regeneration and repair 
(Camci-Unal, 2014; Kharaziha, 2016; Paul, 2014). To date, several synthetic and natural 
hydrogels, such as collagen (Pedron, 2011), gelatin (R-K Li, 1999; McCain, 2014; Saini, 2015), 
alginate (Khalil, 2009), Matrigel® (Radisic, 2004), and PNIPAAM (Navaei, 2016b) have been 
utilized to develop tissue substitutes to replace dysfunctional heart muscle. Although, these 
hydrogels have offered ECM-like microenvironment to support cardiac cell functions, the nano-
scale architectural and electrical properties of the previously developed hydrogels are inferior to 
the characteristics of the native myocardium (Dvir, 2011; Kharaziha, 2016; SR Shin, 2013; Tian, 
2012). Inadequate cell adhesion affinity along with electrically insulated structure of conventional 
hydrogels ultimately lead to poor cell-cell coupling between CMs and thereby diminished 
functionalities of the engineered tissue (Liau, 2012; Zhou, 2014). 
Many recent studies have demonstrated that employing electrically conductive 
nanomaterials enables addressing the current shortcomings of conventional hydrogel-based 
scaffolds for cardiac tissue engineering (Pok, 2014; SR Shin, 2012; SR Shin, 2013). In particular, 
CNTs have been amongst the prevalent conductive nanomaterials for engineering advanced 
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biomaterials to support cardiac cell functions (Martinelli, 2012). CNTs-embedded scaffolds 
(Kharaziha, 2014; SR Shin, 2013) have demonstrated enhanced electrical properties facilitating 
the signal propagation and consequently improved cell-cell coupling. While incorporation of CNTs 
results in superior tissue level properties, controversial cytotoxicity issues have raised numerous 
concerns for their use in clinical practice (H-F Cui, 2010; Dumortier, 2013; Firme, 2010; Jain, 
2012). In this regard, several strategies such as surface coating and/or functionalization 
(Vardharajula, 2012) have been considered to reduce the cytotoxicity of CNTs. However, these 
alterations are expected to compromise the electrical properties of the nanoengineered scaffolds 
(YY Huang, 2012b; Liu, 2010). Additionally, the low solubility of carbon nanotubes may require 
complex fabrication procedures (Vardharajula, 2012). Therefore, utilizing electrically conductive 
nanomaterials with minimized cytotoxicity and less intensive fabrication procedures provides an 
ideal solution to develop cardiac tissue constructs with enhanced functionalities. 
Gold nanostructures such as nanoparticles, nanorods, nanowires, etc. are amongst the 
most promising nanomaterial candidates for biomedical applications (Cobley, 2011; X Huang, 
2009; X-M Jiang, 2012). High electrical conductivity, facile fabrication and modification processes 
(Frens, 1973), diverse nano-scale  architecture (Dykman, 2012) and minimized cytotoxicity 
(Connor, 2005; Kharaziha, 2016; Khlebtsov, 2011; Shukla, 2005) are the key advantages of gold 
nanomaterials. Several studies, exploiting gold nanostructures incorporated scaffolds, including 
alginate (Dvir, 2011), poly(ε-caprolactone) (Fleischer, 2014; Michal Shevach, 2013), thiol-HEMA 
(You, 2011), and decellularized omentum matrix (Michal Shevach, 2014) have illustrated high 
potency of these nanomaterials for cardiac tissue engineering. Despite outstanding findings, 
several aspects of the previously developed scaffolds, including cell adhesion, spreading and the 
formation of a uniform tissue layer still need to be improved to enhance the functionalities of the 
engineered cardiac tissues. In the pioneer work of Dvir (Dvir, 2011), alginate hydrogel 
incorporated with GNWs, was used to form cardiac tissue constructs. Despite the significant 
outcome and outstanding findings, alginate may not provide a suitable microenvironment for cell 
binding and attachment. Therefore, it is required to explore hydrogel-based matrices with superior 
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cell adhesion characteristics along with enhanced electrical conductivity to support the 
functionalities of cardiac cells. 
In this chapter, we developed GNR-embedded GelMA hybrid hydrogels with enhanced 
material and biological characteristics, for cardiac tissue engineering applications. GelMA is a 
photocrosslinkable hydrogel, composed of dehydrated gelatin functionalized with methacrylate 
groups (Van Den Bulcke, 2000), suitable for a wide range of tissue engineering applications 
(Bertassoni, 2014; Nichol, 2010; Nikkhah, 2012). In particular, we fabricated GelMA-GNR hybrid 
hydrogels with variable GNR concentrations and performed extensive analyses to assess the 
material properties of the proposed hydrogel matrix. Furthermore, we conducted substantial 
biological studies to investigate cardiac cell retention, survival, cytoskeletal organization, 
expression of specific markers, as well as tissue-level beating and Ca2+ transient. The enhanced 
electrical properties of GelMA-GNR hybrid hydrogels and the nanoengineered architecture of the 
matrix resulted in improved cell-matrix interaction and cell-cell coupling, ultimately promoting the 
structural and functional properties of the engineered tissue. 
2.2. Experimental Methods 
2.2.1. Materials 
Gold (III) chloride trihydrate (HAuCl4) (>99.9%), sodium borohydride (NaBH4) (>99%), 
hexadecyltrimethylammonium bromide (CTAB) (>99%), silver nitrate (AgNO3) (>99%), and L-
ascorbic acid (>98%) were purchased from Sigma Aldrich and used without further purification. 
Gelatin (Type A, 300 bloom from porcine skin), methacrylic anhydride (MA), 3-(trimethoxysilyl) 
propyl methacrylate (TMSPMA), and 2-hydroxy-1-(4-(hydroxyethoxy) phenyl)-2-methyl-1-
propanone (the photoinitiator) all were obtained from Sigma Aldrich. Deionized water (DIW) (18 
MΩ) was used for GNR fabrication processes. 
2.2.2. GNR synthesis 
GNRs were synthesized using a previously established seed mediated growth method 
(Appendix Figure A.1.) (Nikoobakht, 2003). Briefly, first HAuCl4 (0.5 mM) was dissolved in DIW 
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and mixed with a 2 mL aqueous solution of CTAB (0.2 M), which turned the color of the solution 
to deep yellow. Next, 240 μL of ice-cold NaBH4 was added all at once to the solution under 
stirring and was kept agitated for 2 min. The color of the solution turned from deep yellow to 
brown-yellow immediately, indicating the formation of GNPs (seed solution). The seed solution 
contained GNPs with a mean diameter of less than 4 nm (Nikoobakht, 2003). Afterwards, the 
growth solution was prepared by adding 1.12 mL AgNO3 (4 mM in DIW) to 20 mL CTAB (0.2 M in 
DIW) followed by the addition of a 20 mL aqueous solution of HAuCl4 (1 mM), which created a 
deep yellow solution. Subsequently, 280 μL ascorbic acid (13.88 mg in 1 mL DIW) was added 
gently to this solution, immediately making the solution colorless. The temperature was kept at 25 
°C during all the processes. Finally, a 48 μL aliquot of seed solution was poured into the growth 
solution at 30 °C and the color of solution turned to brown-red over a period of half an hour, 
confirming the formation of GNRs. To obtain longer GNRs, the solution was kept overnight at 30 
°C. The solution contained GNRs with an average aspect ratio (length/width) of 3.15 (Table A.1.). 
Before further experimentation, the GNRs colloid was centrifuged at 12,000 rpm for 10 min and 
washed 2 times with DIW to remove the excess CTAB. 
2.2.3. Preparation of GelMA-GNR hybrid hydrogels 
First, photoinitiator (0.5% wt/v) was completely dissolved in Dulbecco's phosphate-buffered 
saline (DPBS), and then to this solution, lyophilized GelMA (5% wt/v), with high degree of 
methacrylation (96.41 ± 1.54%) (data not shown), was added and kept at 80 °C until a clear 
solution was achieved. Second, certain amounts of centrifuged GNRs (0.5, 1 & 1.5 mg/mL) were 
mixed with GelMA prepolymer solution followed by water bath sonication for 1 h to obtain a 
homogeneous mixture. To prepare hybrid constructs (Figure 2.1.), 15 μL of the GelMA-GNR 
mixture was located between two 150 μm tall spacers and covered by glass slides coated with 
TMSPMA. The constructs were formed via photopolymerization by UV light (800 mW, 360-480 
nm) for 6, 8, 25, and 35 s exposure time for 0, 0.5, 1, and 1.5 mg/mL GNR concentrations, 
respectively.  
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Figure 2.1. A) TEM micrographs of synthesized GNRs. B) UV-Vis absorption spectra of GNPs 
and GNRs, showing longitudinal and SPR peaks. C) UV-Vis absorption spectra of pure GelMA 
and GelMA-GNR hybrid prepolymer solutions with 0.5, 1, and 1.5 mg/mL GNRs concentrations. 
D) Schematic illustration of the fabrication procedure of GelMA-GNR hybrid hydrogel construct. 
2.2.4. Characterization of GNRs and GelMA-GNR hybrid hydrogels 
GNRs micrographs were obtained by using TEM (Philips CM200-FEG, USA) operating at 
an accelerating voltage of 200 kV. In addition, the energy dispersive X-ray spectroscopy (TEM-
EDX, Philips CM200-FEG, USA) was utilized to further confirm the presence of GNRs within 
GelMA hydrogel. The porous micro-structure of hydrogel constructs was evaluated by means of 
SEM (XL30 ESEM-FEG, USA). To prepare samples for SEM, fabricated hydrogels located in 
DPBS inside an incubator (37 °C) for 24 h. The swollen hydrogels were then submerged in liquid 
nitrogen followed by freeze-drying, and coating with Au/Pd (4 nm). However, the hydrogel 
constructs, which were used for localizing GNRs within GelMA hydrogel matrix, were coated with 
carbon followed by utilizing backscattered electron microscopy (SEM-BSE). Five SEM images 
were acquired to analyze the porosity and average pore size of the hydrogel constructs using NIH 
ImageJ software. To measure the mechanical stiffness (Young’s modulus) of the hydrogel 
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constructs, 150 μm thick swollen hydrogels in DPBS were tested by an AFM (MFP-3D AFM, 
Asylum Research) with silicon nitride tips (MSNL, Bruker). Three samples were used for each 
GNR concentration and the contact model for a cone indenter was used (Peela, 2016; Sneddon, 
1965). For impedance analysis, hydrogel constructs were located between two indium tin oxide 
(ITO) coated glass slides (Sigma Aldrich) with an AC bias sweeping (Agilent 4284A LCR meter) 
from 20 Hz to 1 MHz. Four samples were analyzed per each GNR concentration. To evaluate 
swelling behavior of pure and hybrid hydrogel constructs, 10 mm radius disc-shape (150 μm 
height) hydrogel constructs were prepared and immediately soaked in the DPBS and stored 
inside 37 °C for 24 h. Constructs were blotted gently with Kim Wipe to remove the residual DPBS, 
and the weight values were subsequently recorded. The swollen hydrogels were immersed in 
liquid nitrogen, followed by lyophilization. The swelling ratio defined as below (Equation 2.1.): 
𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 𝑟𝑟𝑟𝑟𝑟𝑟𝑆𝑆𝑟𝑟 = M𝑤𝑤𝑤𝑤𝑤𝑤−M𝑑𝑑𝑑𝑑𝑑𝑑
M𝑤𝑤𝑤𝑤𝑤𝑤
      (1) 
where Mwet is the mass of swollen and Mdry is the mass of lyophilized hydrogels. Three identical 
samples were selected for each hybrid and pure hydrogels. 
2.2.5. CMs isolation and culture 
NRVCMs were harvested from the ventricular region of 2-day old neonatal rats based on 
previously developed protocol (Saini, 2015) accepted by the Institution of Animal Care (IACUC) at 
Arizona State University. After isolation, the CMs were separated from cardiac fibroblasts by pre-
plating the isolated cell suspension for 1 h. Before seeding CMs, the hydrogel constructs were 
washed 2 times, 10 min intervals, in 1% (v/v) penicillin-streptomycin (Gibco, USA) in DPBS and 
then washed 2 times in 10 min periods in the cardiac culture medium containing Dulbecco’s 
modified eagle medium (DMEM) (Gibco, USA), fetal bovine serum (FBS) (10%) (Gibco, USA), L-
Glutamine (1%) (Gibco, USA), and penicillin-streptomycin (100 units/mL). Harvested CMs were 
seeded on top of disk-shape constructs (diameter × height, 10 mm × 150 μm; 7.5 × 105 cells/well) 
and were cultured in the cardiac specific culture media for 7 days under static condition. 
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2.2.6. Characterization of survival, retention, metabolic activity, and cytoskeleton 
organization 
CMs viability was determined using standard Live/Dead assay kit (Life technologies, USA) 
based on manufacturer’s instruction. Triplicate samples were used for each hydrogel construct 
and three individual areas were selected within each replicate (n = 9). Fluorescent images were 
acquired using a fluorescent microscope (Zeiss Observer Z1) and the subsequent quantifications 
were performed utilizing NIH ImageJ software. The viability was quantified as number of live cells 
divided by total number of cells. Cell retention was measured by quantifying area fraction, using 
ImageJ software, one day upon seeding the cells. Five phase contrast images were taken within 
each sample (three samples for each hydrogel construct, (n = 15)). To examine metabolic activity 
of cells on the constructs, Alamar Blue assay kit (Invitrogen, USA) was used according to 
manufacturer’s protocol at day 3, 5, and 7 of the culture. Three samples were specified for each 
hydrogel construct and results were normalized with respect to day 1. 
To assess the cytoskeleton organization, hydrogel constructs were stained for F-actin 
fibers. Cells were fixed in paraformaldehyde (PF) and soaked in Triton X-100 for 45 min at room 
temperature to permeabilize the plasma membrane, and then blocked in 1% (v/v) bovine serum 
albumin (BSA) for 1 h. Finally, CMs were stained (1:40 dilution in 1% BSA) with Alexa Fluor-488 
phalloidin (Life technologies, USA) for 40 min, and counter-stained with 40,6-diamidino-2-phenyl 
indole dihydrochloride (DAPI, 1:1000 dilution) for ≈18 min. Z-stack fluorescent images were taken 
by a fluorescent microscope equipped with ApoTome2 (Zeiss, Germany) and analyzed by ImageJ 
(FFT built-in plugin). Cells’ nuclei alignment was quantified similar to previously established 
procedures (Bertassoni, 2014; Saini, 2015). Briefly, an ellipse (built-in plugin, ImageJ) was fitted 
to the nuclei (DAPI) and deviation angle from the main axis of ellipse with respect to the x-axis 
was determined. All alignment angles were normalized by subtracting from average angle of each 
image and presented in 10° increment spans. 
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2.2.7. Immunostaining for CMs specific markers and cell-matrix interaction 
Immunocytochemistry technique was used to visualize cardiac specific markers including 
SAC, Cx43 and cTnI. CMs were fixed in 4% PF for 40 min, followed by treatment with 0.1% Triton 
X-100 for 45 min at room temperature to permeabilize the plasma membrane. Then, cells were 
blocked in 10% goat serum for 2 h at 4 °C. Afterwards, CMs were stained with primary antibodies 
(1:100 dilution in 10% goat serum for SAC and Cx43, and 2 µg/mL in DPBS for cTnI) and placed 
in cold room (4 °C) for 24 h. After primary staining (Abcam, USA), samples were washed three 
time in DPBS and stained with secondary antibodies (Life Technologies, USA) comprised of 
Alexa Fluor-594 (pseudo-colored with green) for SAC, Alexa Fluor-488 for cTnI, and Cx43 
(pseudo-colored with red) at 1:200 dilution in 10% goat serum for 6 h. Eventually, cells were 
stained with DAPI (1:1000 dilution in DPBS) for ≈18 min to label the nucleus. For adhesion 
specific marker, integrin-β1, all staining steps were similar to cardiac specific markers except that 
the cells’ membranes were not permeabilized and Alexa Fluor-594 secondary antibody was used 
to stain integrin-β1. High magnification (100x) images of SAC and Cx43 were obtained using 
confocal microscopy (Leica TCS SP5 AOBS Spectral Confocal System). cTnI images were 
obtained using a fluorescent microscope equipped with ApoTome2. 
2.2.8. Analysis of beating behavior of the cells 
The spontaneous beating of CMs was measured and monitored from day 1 to day 7 of the 
culture. For each data point, 3 videos (30 s long) were captured per sample (12 replicates for 
each group of hydrogel constructs). Representative beating signals were acquired using a custom 
written MATLAB code (SR Shin, 2013). 
2.2.9. Intracellular Ca2+ transient assay 
To assess intracellular Ca2+ transient within cultured CMs on pure and hybrid hydrogels, 
calcium indicator assay kit (Life Technologies, USA) including Fluo-4 AM and Pluronic F127 (20% 
in DMSO) was utilized. All samples (pure and hybrids) on day 7 of the culture were washed one 
time with pre-warmed DPBS, followed by loading (10 µL/mL in DPBS) the calcium indicator 
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solution (a mixture of 50 μg of Fluo-4 Am in 50 μL of Pluronic F127) for 45 min. Next, the indicator 
was discarded, and the hydrogel constructs were soaked in pre-warmed Tyrode solution (Sigma-
Aldrich, pH ∼7.4) to allow de-esterification for 40 min. Afterwards, spontaneous increase in 
intracellular Ca2+ concentration were imaged using a fluorescent microscope (at 50 frame/s) at 
488 nm wavelength. To analyze the change in Ca2+ concentration, the fluorescent dye intensity 
(F) during cells’ contractions was normalized by dividing to the background intensity (F0) and 
plotted over the time. 
2.2.10. External electrical stimulation 
The response of the cultured CMs on top of pure and hybrid hydrogels to the external 
electrical stimulation was investigated according to previously established protocol (Tandon, 
2009). Primarily, a chamber was assembled using 2 carbon electrodes (5 mm) with 1 cm spacing 
attached to a plastic petri dish (6 mm diameter) by silicone adhesive (Figure 2.10A.). Platinum 
wires were connected to the carbon electrodes (at the opposite ends of each electrode) and all 
connections were sealed using silicone adhesive. The assembled chamber was sterilized before 
use by placing under UV light for 1 h. Pulsatile electrical signals produced by a pulse generator 
(BK PRECISION 4052) were applied on the pure GelMA and hybrid GelMA-GNR hydrogels. 
Electrical pulses with 2 ms durations at three different frequencies (1, 2, and 3 Hz) were 
considered for the experiment. The minimum required voltage to observe contraction of CMs was 
defined as the excitation threshold.  
2.2.11. Statistical analysis 
All the data collected in this chapter were analyzed using one-way and two-way ANOVA 
analyses and reported as mean ± standard deviation (SD). To determine a statistically significant 
difference between groups, we used a Tukey’s multiple comparison test with a p-value <0.05 
considered to be significant. All the statistical analyses were performed by GraphPad Prism (v.6, 
GraphPad San Diego). 
 
36 
 
2.3. Results and Discussion 
2.3.1. Fabrication and characterization of GelMA-GNR hybrid hydrogels 
The GNRs were synthesized via a seed-mediated growth technique (Nikoobakht, 2003) 
(Appendix Figure A.1.). TEM micrographs (Figure 2.1A.) confirmed the rod-like shape of the 
GNRs. Figure 2.1B. shows the UV-Vis absorption spectrum with the longitudinal (∼810 nm) and 
transverse (∼530 nm) surface plasmon resonance (SPR) (X Huang, 2009) wavelength peaks of 
the GNRs, demonstrating the successful fabrication of GNRs consistent with the previously 
published studies (Gole, 2004; Nikoobakht, 2003). The average aspect ratio of the synthesized 
GNRs was calculated using TEM micrographs, approximately 3.15. The GelMA-GNR prepolymer 
solution was sonicated to prepare a homogeneous hydrogel solution. All prepared prepolymer 
solutions (0.5, 1, and 1.5 mg/mL of GNRs) exhibited similar transverse and longitudinal 
wavelength peaks (Figure 2.1C.), confirming that the GNRs did not break into smaller sizes 
during the sonication process. The final GelMA-GNR hybrid hydrogel constructs (150 μm thick) 
were formed through UV photopolymerization, as shown schematically in Figure 2.1D. 
The TEM images (Figure 2.2A. and Appendix Figure A.2A) of a thin layer (1-5 μm) of the 
GelMA-GNR constructs showed that GNRs were successfully embedded within the hydrogel 
matrix (white dashed area). The EDX microscopy (Appendix Figure A.2B.) of the selected area 
(dashed line) further confirmed the presence of gold (Au) within the hydrogel layer. Additionally, 
SEM-BSE images (Figure 2.2B.) of GelMA-GNR hydrogel (1.5 mg/mL) demonstrated that GNRs 
located within the hydrogel matrix, specifically on the walls of pores. Furthermore, Figure 2.2C. 
shows similar micro-architecture within GelMA and GelMA-GNR hydrogel constructs. The SEM 
images demonstrated analogous micro-architecture of pure and hybrid hydrogels as well as no 
micro-agglomerations of GNRs within the hybrid hydrogel with 1.5 mg/mL GNR concentration. 
The SEM results clearly demonstrated that the incorporation of GNRs did not cause any 
considerable alteration within the GelMA micro-structure. 
Next, impedance analysis was performed to evaluate the electrical conductivity of the 
hybrid and pure hydrogel constructs. Figure 2.3A. indicates that GelMA-GNR hybrid hydrogels, 
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with high concentrations of GNRs (1 and 1.5 mg/mL), exhibited relatively lower electrical 
impedance as compared to pure GelMA hydrogel at physiologically relevant frequencies (You, 
2011). The low electrical impedance of the hybrid hydrogels can be attributed to the resistive 
current passing through the bridging GNRs, suggesting that high concentration of GNRs 
improved the overall electrical conductivity of the hydrogel matrix. Such properties have been 
shown to facilitate signal propagation and coupling between cardiomyocytes (Dvir, 2011; 
Martinelli, 2012). 
 
Figure 2.2. A) TEM micrographs showing GNRs embedded within a thin layer (white dashed line) 
of GelMA-GNR hybrid hydrogel (1.5 mg/mL) (black region is the TEM sample holder). B) SEM-
BSE of GelMA-GNR (1.5 mg/mL) hybrid hydrogels displaying the presence of GNRs (yellow 
arrow heads) within the GelMA matrix located on the pores. C) SE-SEM images illustrating cross-
section of GelMA-GNR and pure GelMA hydrogels (insets are photographs of the related 
hydrogels). Scale bars represent 20 μm. 
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Swelling and porosity are amongst other important properties of hydrogel-based scaffolds 
which directly influence nutrients and gas exchanges, specifically in case of cell encapsulation 
(Dolatshahi-Pirouz, 2014; Nikkhah, 2012) and cell ingrowth within the constructs (Annabi, 2010). 
As illustrated in Figure 2.3B., incorporation of high concentrations of GNRs (1 and 1.5 mg/mL) 
within the hydrogel matrices led to a statistically significant decrease in the swelling ratio, from 51 
± 4% for pure GelMA to 23 ± 2% for 1.5 mg/mL GelMA-GNR hybrid hydrogel. This decrease can 
be associated to the smaller average pore size (Figure 2.3C.) of the hybrid hydrogels (8 ± 2 μm 
for 1 and 1.5 mg/mL GNRs) as compared to the pure GelMA (12 ± 2 μm), ultimately leading to a 
decrease in the overall water content. Although incorporation of GNRs resulted in a decrease in 
pore size, nano-scale porous structures were still available for nutrient and gas exchanges within 
the hydrogel constructs (Annabi, 2010; YH Lee, 2005). In addition, incorporation of GNRs did not 
notably influence the porosity percentage of the hydrogel constructs (Figure 2.3D.). 
The Young’s modulus, as a representative of mechanical stiffness of hydrogels, was 
measured using AFM, based on nano-indentation, to investigate the constructs’ capability for 
enduring generated compressive forces by CMs. The samples were indented in 4 × 4 grids up to 
a maximum depth of 4 μm and analyzed in 1 μm sections similar to previous studies (Fuhrmann, 
2011). Figure 2.3Ea. and 2.3Eb. show the distribution of local Young’s moduli of the hydrogels. 
The heterogeneity of stiffness increased as a function of GNR concentration. The average 
Young’s moduli for indentation depths of 3-4 μm (Figure 2.3F. and Appendix Figure A.3.) 
confirmed a significant increase in elastic moduli of GelMA-GNR hybrid constructs up to ≈1.3 kPa 
with 1 mg/mL GNRs in comparison to ≈450 Pa for pure GelMA. The Young’s modulus for pure 
GelMA construct (150 μm thickness, 6 s UV exposure), quantified herein, relatively correlated to 
similar studies for a 1 mm thick hydrogel with 60 s UV exposure (Nichol, 2010; Xavier, 2015). The 
improved mechanical stiffness of hybrid hydrogels can be attributed to the increased structural 
integrity of the matrix caused by electrostatic interaction between positively charged GNRs (Gole, 
2004; X Huang, 2009) and the negatively charged carboxyl groups (Nichol, 2010) of GelMA 
backbone. Also, GNRs are envisioned to act as reinforcing fillers and thus inducing enhanced 
mechanical properties (Tjong, 2006). Despite the fact that incorporation of GNRs improved 
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mechanical stiffness of pure GelMA hydrogel up to 1.3 kPa, this value was still considerably lower 
than the stiffness of the native human myocardium during contraction cycle (Hassaballah, 2013). 
However, cardiac patches (Dvir, 2009; Dvir, 2011; SR Shin, 2013) with similar Young’s moduli 
have demonstrated the suitability of these scaffolds, in terms of mechanical robustness, to 
accommodate cultured CMs contractile forces. 
 
Figure 2.3. A) Impedance of whole hydrogel construct (150 μm thick). B) Swelling ratio 
percentage as a function of GNRs concentration (*p < 0.05); C) Mean pore diameter and D) 
porosity percentage of GelMA and GelMA-GNR hydrogel constructs (n = 5; *p < 0.05). Ea) Maps 
of Young’s moduli for different indentation depths. The force indentation curves were fitted in 1 
μm segments (0-1 μm, 1-2 μm, and 3-4 μm indentation depths). Eb) Cross section of depth 
dependent fit for different GNR concentrations. F) Average Young’s moduli for all hydrogels (*p < 
0.05). (Scale bars: vertical 1 μm; horizontal 20 μm). 
Previous studies have shown that due to the presence of MMP-sensitive moieties, GelMA 
hydrogel degrades in biological environment mainly because of the action of collagenase enzyme 
(Nichol, 2010). Consistently, many studies in the literature have investigated the fate of other 
conductive nanomaterials (e.g. CNTs) embedded within hydrogel constructs in vivo (Zhou, 2014). 
The findings of these works have clearly confirmed that the CNTs remained within the proximity 
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of the cells and further facilitated cell-cell coupling (Martinelli, 2012; Zhou, 2014). Therefore, 
GelMA-GNR hybrid hydrogels are envisioned to degrade upon implantation. However, extended 
in vivo study is required to assess the fate of GNRs upon degradation of the matrix. In vivo 
studies will be the subject of our future work. 
2.3.2. CMs retention, survival, and metabolic activity 
To evaluate the capability of the nanoengineered hydrogel constructs to support cell 
adhesion and spreading, the fraction area of the construct covered by seeded CMs (day 1), was 
quantified as an indicator for cell retention. The phase-contrast images on day 1 (Figure 2.4A.) 
demonstrated higher number, more packed and homogeneous distribution of adhered CMs on 
GelMA-GNR hybrid hydrogels contrary to the discrete and agglomerated cell adhesion patterns 
on pure GelMA hydrogel. Furthermore, a significant increase in cell retention (Figure 2.4B.) was 
observed as a function of GNR concentration; from 11 ± 3% for pure GelMA to 26 ± 11%, 49 ± 
11%, and 58 ± 6% for 0.5, 1, and 1.5 mg/mL GelMA-GNR hybrid hydrogels, respectively. This 
major dissimilarity between cell adhesion affinity of GelMA and GelMA-GNR hydrogels can be 
attributed to the increased stiffness and the presence of GNRs providing cell anchoring points 
within the hydrogel constructs. To further confirm that the presence of GNRs was the main driver 
for higher cellular adhesion and retention, we prepared control hydrogel substrates using 20% 
GelMA with comparable stiffness to GelMA-GNR (1 and 1.5 mg/ml) hybrid constructs (Appendix 
Figure A.4A. and A.4B.). As expected, cellular retention was significantly lower on 20% GelMA 
hydrogel as compared to GelMA-GNR hybrid constructs with 1 and 1.5 mg/ml concentrations of 
GNRs (Appendix Figure A.4C. and A.4D.). These findings clearly demonstrate that GNRs 
embedded within GelMA hydrogel not only improved the stiffness of the constructs, but also 
presented higher cell adhesion moieties thereby promoting overall cellular retention, specifically 
at the initial points of culture.  
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Figure 2.4. A) Phase-contrast images and B) fraction area of hydrogels covered by CMs on day 1 
(cell retention). (*p < 0.05). C) Representative fluorescent images of live (green) and dead (red) 
cells and D) quantified cellular viability at day 1 and 7 of culture (*p < 0.05). E) Normalized 
Alamar Blue fluorescent signal at day 3, 5, and 7 of culture. All scale bars represent 250 μm. 
Such properties make GelMA-GNR hybrid hydrogels as superior matrices due to suitable 
cellular adhesion sites (Aubin, 2010; H-B Wang, 2000a), stiffness as well as electrical 
conductivity in comparison to previously reported gold-impregnated scaffolds for cardiac tissue 
engineering. For instance, Dvir (Dvir, 2011) incorporated gold nanowires within alginate hydrogel, 
which may not provide sufficient adhesion points to promote cell retention. In the study by You et 
al. (You, 2011), gold nanoparticles were embedded within thiol-HEMA/HEMA scaffolds. However, 
due to the cell-repellant nature of HEMA (Nikkhah, 2012), the developed constructs had to be 
treated with fibronectin (Mosher, 1981) to increase cell adhesion prior to cell seeding. Next, cell 
viability studies were performed at day 1 and 7 of the culture to provide a comprehensive (from 
seeding to the end culture period) investigation on survival of CMs seeded on the fabricated 
hybrid hydrogels (Figure 2.4C. and 2.4D.). Figure 2.4D. illustrates that cardiomyocytes viability 
increased significantly from 78 ± 3% in pure GelMA hydrogel to 87 ± 3% in 1 mg/mL and 88 ± 1% 
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in 1.5 mg/mL GelMA-GNR hybrid hydrogels at day 1. Similarly, viability values at day 7 within 
pure GelMA and hybrid hydrogels confirmed that the seeded cardiomyocytes maintained a 
considerably high level of survival. In addition, the statistically significant lower cellular viability 
within 20% GelMA control hydrogel (Appendix Figure A.4E. and A.4F.) as compared to hybrid 
GelMA-GNR constructs, further strengthens the argument that the presence of GNRs along with 
enhanced stiffness, enhanced cell retention and eventually led to higher viability of seeded cells. 
We further determined the metabolic activity of the cultured cells using Alamar Blue assay at day 
3, 5, and 7 of the culture (Figure 2.4E.) (normalized to day 1). Across all pure and GelMA-GNR 
hybrid hydrogels, no statistically significant cellular metabolic activity was observed. However, 
cultured cells exhibited a gradual increase in metabolic activity within each construct at day 5 and 
7 as compared to day 3 of culture which can be due to presence of small population of cardiac 
fibroblasts during isolation of cardiomyocytes (SR Shin, 2013). 
Overall, GelMA-GNR hybrid hydrogels supported CMs culture and exhibited no major risk 
of cytotoxicity. Our findings are consistent with previous studies by Connor et al. [46] which 
demonstrated that CTAB-capped gold nanoparticle, washed 2 times with DIW before use, did not 
result in acute toxicity on the leukemia cells. Consistently, Shukla et al. [48] reported similar 
findings for exposing gold nanoparticles to the macrophages. In future studies, our group will 
further perform experiments to investigate the fate of GNRs using in vivo MI model. 
2.3.3. Actin cytoskeleton organization and formation of cardiac tissue layer 
To investigate the F-actin cytoskeleton organization of the CMs and the formation of 
interconnected cell network (tissue layer), the cells were stained for F-actin fibers at day 7 of the 
culture. The expression of F-actin fibers enhanced on GelMA-GNR hydrogels with 1 and 1.5 
mg/mL of GNR concentrations, in contrast to pure GelMA and hybrid hydrogel with 0.5 mg/mL of 
GNR concentration (Figure 2.5A.). The improved expression of F-actin fibers can be directly 
correlated to the enhanced cell retention (Figure 2.4B.) on hybrid hydrogels as also shown by 
phase contrast images (Figure 2.4A.). Furthermore, at high concentration of GNRs, specifically at 
1.0 mg/mL and 1.5 mg/mL, improved local alignment of F-actin fibers (Figure 2.5A., white arrows) 
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was observed. This can also be observed from Fast Fourier Transform (FFT) analysis of F-actin 
images which depicted enhanced local alignment of fibers within GelMA-GNR hybrid at high 
concentrations of GNRs as compared to pure GelMA hydrogel (Figure 2.5A. insets).  
 
Figure 2.5. A) Z-stack (top-view) fluorescent images of F-actin stained (green) at day 7 of the 
culture for pure GelMA and hybrid GelMA-GNR hydrogels. Local fiber alignment is shown with 
white arrows. DAPI (blue) represents stained nuclei. FFT images (top right insets) demonstrating 
local alignment of F-actin fibers. (top-row scale bars represent 50 μm; bottom-row scale bars 
represent 20 μm). B) CMs’ nuclei alignment distribution from 0 to 90 degrees. C) A 3D Z-stack 
fluorescent image of the GelMA-GNR (1.5 mg/mL) tissue construct.  
Such induced local alignment at high concentration of GNRs is significant, since no global 
alignment (Figure 2.5B.) was observed due to absence of any micropatterned feature on the 
hydrogel constructs (Saini, 2015). The elongated and highly packed cells within the hybrid 
GelMA-GNR hydrogels led to the formation of a uniform and interconnected tissue layer. 
Particularly, the Z-stack fluorescent (Figure 2.5C.) and phase contrast images (Figure A.5.) 
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confirmed the formation of an intact tissue layer on top of hybrid hydrogel constructs over 7 days 
of the culture. Overall, the improved cellular spreading, induced by the bioactivity of gelatin 
structure and mediated cell adhesion by incorporation of GNRs, led to the formation of an 
integrated cardiac tissue layer. 
2.3.4. Cardiac-specific markers and cell-matrix interaction 
Cardiac-specific markers including SAC, Cx43, and cTnI were immunostained to assess 
the phenotype of the cultured CMs over the culture period. While SAC and cTnI are the two 
specific proteins, involved in the actin-myosin contraction complex, Cx43 is a well-known gap 
junction protein responsible for synchronous contraction of the cells (Guerrero, 1997; Oyamada, 
1994; Saini, 2015; You, 2011). As shown in Figure 2.6. and Appendix Figure A.6., at day 1 of 
culture, the cells mainly adopted a round morphology without intact formation of sarcomeres and 
cTnI within all the hydrogel constructs. However, the immunostained images on day 3 displayed 
the formation of a few sarcomere structures specifically in case of GelMA-GNR hydrogels with 1 
and 1.5 mg/mL GNRs (white arrows). Eventually on day 7, uniform and highly organized SAC 
structures were evident across hybrid hydrogels (e.g. 1.0 and 1.5 mg/mL) in contrast to pure 
GelMA constructs. Similar observations were made in cTnI immunostained images, 
demonstrating extended architecture as a marker of contractile machinery within hybrid hydrogels 
with high concentrations of GNRs. Thus, the assembled tissue on GelMA-GNR hybrids, with high 
concentration of impregnated GNRs, exhibited more organized myofilament assembly, consistent 
to previously reported studies (Dvir, 2011; Kharaziha, 2014; SR Shin, 2013; Zhou, 2014). Our 
immunostaining results for Cx43 gap junction proteins also demonstrated a similar trend. While 
on day 1, Cx43 expression was agglomerated and undispersed across all the groups, by day 7, a 
more homogenous distribution of Cx43 was observed, specifically on GelMA-GNR hybrid 
hydrogels (1 and 1.5 mg/mL). Therefore, GelMA-GNR hybrid hydrogels with high concentrations 
of GNRs demonstrated improved cell-cell coupling with mature contractile machinery as 
compared to pure GelMA hydrogel. 
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Figure 2.6. A) Representative immunostained images showing the expression of SAC (green) 
and Cx43 (red) on day 1, 3 (arrows showing sarcomeres formation), and 7 of the culture. B) 
Immunostained images of cTnI (green) on day 1 and 7 of culture for GelMA and 1.5 mg/mL 
GelMA-GNR hybrid hydrogels. 
Further, to analyze the cell-matrix interaction on the synthesized hydrogel, samples were 
stained with Integrin-β1 which is a transmembrane protein and plays a significant role in 
mechano-transduction (Zhou, 2014). Figure 2.7. shows immunostained images of the cells at 
different magnifications (20x and 40x) on day 7 of the culture, confirming the abundance of 
integrin-β1 and consequently cell adhesion sites with higher concentrations of GNRs. The 
expression of integrin-β1 further confirmed our observations on improved cellular retention 
(Figure 2.4B.) and the abundance and organization of F-actin fibers (Figure 2.5A.) on hybrid 
constructs with higher concentrations of GNRs (1 and 1.5 mg/mL). 
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Figure 2.7. Immunostained Z-tack images (20× and 40×) of integrin-β1 for pure GelMA and 
GelMA-GNR hybrid hydrogels (0.5, 1, and 1.5 mg/mL) on day 7, showing the presence and 
distribution of cell adhesion affinities. Scale bars represent 50 μm for 20× and 20 μm for 40× 
figure panel. 
Overall, seeded CMs on GelMA-GNR hybrids, specifically with 1 and 1.5 mg/mL 
concentrations of GNRs, demonstrated improved tissue structure as compared to pure GelMA 
hydrogel. To further investigate the influence of conductive GelMA-GNR hydrogels on tissue-level 
functionalities, we analyzed the spontaneous beating and intracellular Ca2+ transient of the CMs 
as a function of time. 
2.3.5. Beating behavior of CMs 
To assess tissue-level functionalities, beating behavior (represented as an average 
number of synchronous beats per minute (BPM)) of CMs seeded on hydrogel constructs was 
further analyzed through real-time video microcopy from day 1 to day 7 of the culture. CMs 
started beating in a spontaneous and synchronous manner, as they created interconnected cell 
networks as a function of GNRs concentration on day 3. Figure 2.8A. displays average number of 
BPM for pure and hybrid hydrogel constructs. As can be observed, hybrid tissue constructs with 1 
and 1.5 mg/mL of GNRs exhibited a significantly higher beating frequency (BPM) as compared to 
pure GelMA hydrogel at day 3. By day 7, CMs within 1.5 mg/mL GelMA-GNR hybrid hydrogels 
demonstrated notably increased beating frequency (102 ± 72 BPM), as compared to 1 mg/mL (56 
47 
 
± 24 BPM), 0.5 mg/mL (38 ± 11 BPM) GelMA-GNR hybrids, and pure GelMA (33 ± 9 BPM) 
hydrogel.  
 
Figure 2.8. A) Synchronous beating frequency (BPM) of CMs from day 3 to day 7 of culture. (*p < 
0.05). B) Representative beating signal graphs. C) Photographs of a detached centimeter scale 
hybrid hydrogel tissue constructs (1.5 mg/mL GelMA-GNR) displaying contraction (white arrows) 
of the whole hydrogel construct by seeded CM. 
Furthermore, representative beating signals (Figure 2.8B.) and real time movies (Appendix 
C.1., C.2., C.3. and C.4.) illustrated more synchronous, stable, and robust beating behavior within 
GelMA-GNR hybrids (1 and 1.5 mg/mL) in comparison to pure GelMA and hybrid hydrogel with 
0.5 mg/mL GNR concentration. Such beating behavior can be attributed to the enhanced 
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electrophysiological characteristics and improved cell-cell coupling of the formed tissues on 
nanoengineered hydrogels. Additionally, to examine the capability of the formed cardiac tissue 
layer to contract the hydrogel construct, we detached 2 samples of hybrid hydrogels (1 and 1.5 
mg/mL GelMA-GNR) at day 5 of culture from the TMSPMA glass slide and suspended the tissue 
in the culture media (Figure 2.8C.). We were able to successfully create a suspended beating 
tissue sheet (centimeter scale) (Appendix C.5. and C.6.). These observations further confirmed 
that the formed cardiac tissue layers, on top of GelMA-GNR hydrogels, were highly functional to 
bend the 150 μm thick construct. 
Although similar observations for highly stiff CNT-embedded GelMA hydrogels were 
reported by Shin et al. (SR Shin, 2013), cytotoxicity (H-F Cui, 2010; Dumortier, 2013; Firme, 
2010) and high UV absorption of CNTs (SR Shin, 2012) remain as major concerns for cardiac 
tissue engineering applications. Specifically, high UV absorbance of CNTs interferes with 
photoinitiator excitation, and consequently influences hydrogel crosslinking process (SR Shin, 
2012; SR Shin, 2013) and the subsequent formation of 3D tissue constructs (beyond 150 μm 
thickness). This is particularly crucial in case of 3D cellular encapsulation within hydrogel 
constructs, where the cells have to be exposed to extended duration of UV. On the other hand, 
GNRs with low UV absorption (Figure 2.1B. and 2.1C.) and minimized cytotoxicity (Connor, 2005; 
Khlebtsov, 2011) enabled us to fabricate relatively thicker cardiac patches (e.g. 150 μm). 
2.3.6. Intracellular Ca2+ transient 
To investigate calcium signaling (puffs) within seeded CMs, calcium ions transient (Ca2+) 
analysis was performed. First, tissue constructs were loaded with the dye, followed by capturing 
videos from different region of 1 mm2 of GelMA and GelMA-GNR hybrid hydrogels. Five different 
sites within each region were selected and the increase in concentration of Ca2+ ions was 
represented as fluorescent intensity of dye (F) divided by the background intensity (F0). As 
represented in the Figure 2.9. and Appendix C.7., intracellular Ca2+ puffs occurred at different 
frequencies across 5 considered spots on pure GelMA and GelMA-GNR (0.5 mg/mL) hydrogels. 
However, cardiomyocytes cultured on GelMA-GNR hydrogels with 1 and 1.5 mg/mL of GNRs 
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exhibited synchronized calcium spikes within all considered spots. Such calcium transient profile 
further confirmed enhanced cell-cell communication between CMs cultured on electrically 
conductive hydrogels. Specifically, GNRs embedded in GelMA hydrogel at high concentration 
bridged the electrically insulated structure of the matrix and further played a role to facilitated 
signal propagation between the cells. 
 
Figure 2.9. Calcium transient and extracted related frequency signals of intracellular change in 
concentration of Ca2+ within cultured CMs for A) pure GelMA (5%), B) GelMA-GNR (0.5 mg/mL), 
C) GelMA-GNR (1 mg/mL), and D) GelMA-GNR (1.5 mg/mL). R1 to R5 represent regions 1-5 and 
scale bars depict 100 μm. 
2.3.7. Impact of external electrical stimulation 
A custom-made electrical stimulation set up, according to the previous protocol (Tandon, 
2009) (Figure 2.10A.), was utilized to evaluate the capability of the hydrogel constructs for 
accommodation of external electrical stimuli. Excitation threshold, which is defined as the 
minimum required voltage to induce synchronous contractions of CMs, was measured for three 
different frequencies (1, 2, and 3 Hz). Notably a lower excitation threshold (Figure 2.10B.) for 1 
and 1.5 mg/mL GelMA-GNR hydrogels was observed as compared to 0 and 0.5 mg/mL GelMA-
GNR hydrogel constructs at 1 and 2 Hz. In addition, at high frequency (3 Hz), only hybrid 
hydrogels with the highest amount of GNR concentration (1.5 mg/mL) exhibited significant 
difference in terms of excitation threshold. This decrease in excitation threshold can be attributed 
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to the relatively lower impedance of GelMA-GNR hydrogels in comparison to pure GelMA 
hydrogel. Despite significant decrease in excitation threshold, all pure and hybrid hydrogels were 
enabled to generate similar beating pattern related to the applied frequencies (Figure 2.10C. and 
Appendix C.8.–C.11.). Thus, it can be envisioned that GNRs incorporated within the tissue 
constructs could promote integration (electrically) with native myocardium as compared to pure 
GelMA hydrogel. Investigation of the integration of the nanoengineered constructs with the host 
myocardium in vivo, is the subject of our future studies. 
 
Figure 2.10. A) Fabricated chamber for external electrical stimulation photograph. B) Excitation 
thresholds at different frequencies (1, 2, and 3 Hz) for pure and GNR-embedded hydrogels. (*, #p 
< 0.05). C) Beating frequency signals for all types of hydrogels at different applied frequencies. 
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2.4. Conclusion 
In this study, we developed GNR-embedded GelMA hybrid hydrogels as an advanced 
biomaterial to develop functional cardiac tissue constructs for myocardial regeneration and repair. 
GNRs with the average aspect ratio of 3.15 (16 ± 2 nm width and 53 ± 4 nm length) were 
synthesized and homogeneously incorporated with GelMA prepolymer solution, followed by UV 
crosslinking to fabricate hybrid GelMA-GNR hydrogel constructs (150 μm thick). The GelMA-GNR 
hybrids exhibited electrically and mechanically enhanced material characteristics as compared to 
pure GelMA hydrogel. Primarily, the GelMA-GNR hybrid hydrogels induced high cell retention and 
improved cytoskeleton organization. The highly mediated cell-matrix interactions, through 
integrin-β1, along with enhanced expression of cardiac specific markers (cTnI, SAC) resulted in 
the formation of interconnected cardiac tissue layers. Further studies confirmed that the stiffness 
of the matrix is not the only factor, and in fact GNRs are the major driver for higher cell adhesion 
and retention on the matrix. Due to the high affinity of the cells on the hybrid hydrogels, the 
formed tissues represented an organized, packed, and uniform architecture while maintained a 
high level of cellular viability and metabolic activity. Secondly, the conductive constructs facilitated 
cell-cell signaling and electrical signal propagation, as confirmed through the expression of Cx43 
gap junctions and synchronized calcium signaling amongst CMs exposed to high concentration of 
GNRs (1.5 mg/mL). These enhancements eventually gave rise to higher functionalities of cardiac 
tissue constructs and specifically improved tissue contractility with lower excitation threshold. 
Notably, GelMA-GNR hybrids (1 and 1.5 mg/mL) illustrated more robust and synchronous beating 
behavior as compared to the pure GelMA hydrogel. In conclusion, these findings confirmed that 
the nanoengineered GelMA-GNR hybrid hydrogels, with excellent characteristics, provide a 
suitable matrix for specific applications in cardiac tissue engineering. 
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CHAPTER 3 
ELECTRICALLY CONDUCTIVE HYDROGEL-BASED MICRO-TOPOGRAPHIES FOR THE 
DEVELOPMENT OF ORGANIZED CARDIAC TISSUES 
3.1. Introduction 
The native myocardium is a structurally orchestrated and adaptive tissue consisting of 
tightly packed uniaxial cytoarchitecture and electrically conductive Purkinje fibers, which provides 
electrical conduction through the heart (Dvir, 2011; Engelmayr Jr, 2008; Ling, 2011; Zhou, 2014). 
Such a unique cellular microenvironment contributes critical cues involved with initiation and 
development of the structure-function relationship. In particular, electrical and geometrical cues 
are two of the most impactful stimuli, influencing proper functionalities of the heart (D-H Kim, 
2010) and efficient pumping of blood throughout the body (Pijnappels, 2010). In vitro investigation 
of these signaling cues and their subsequent effects on cytoarchitecture can lead to better 
understanding of the tissue function and optimization of regenerative-based therapies for 
treatment of heart diseases (e.g. MI). 
In the past two decades, tissue engineering has emerged as a powerful strategy to develop 
cardiac constructs with geometrical and electrical cues that mimic the native cardiac 
microenvironment. Numerous hydrogel-based scaffolds along with microscale techniques (i.e. 
micropatterning) have been integrated (Annabi, 2013; N. Bursac, 2002; Radisic, 2004) to develop 
biomimetic cardiac tissue substitutes that can be used in disease modeling and regeneration 
studies following injury. Micropatterned constructs fabricated by GelMA (Cha, 2014; Kharaziha, 
2013; Saini, 2015), MeTro (Annabi, 2013), PEG (Zhen Ma, 2015; Yeo, 2007), collagen (Camelliti, 
2006; Chiu, 2012), PGS (Engelmayr Jr, 2008), and chitosan (Chiu, 2012) are among the 
biomaterials that have been widely used for cardiac tissue engineering due to their excellent 
material and biological characteristics. For instance, in a pioneering study by Engelmayr 
(Engelmayr Jr, 2008) PGS accordion-like honeycombs with native-like anisotropic architecture 
were micro-fabricated to develop organized cardiac tissue constructs. Their findings indicated 
enhanced formation of aligned cardiac tissue constructs with anisotropic mechanical properties 
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similar to native heart muscle. Photocrosslinkable hydrogels such as GelMA and MeTro have 
also shown promising results for cell-based studies and cardiac tissue engineering applications 
mainly due to their bioactivity and ease of precise fabrication (Annabi, 2013; Klotz, 2016; Nichol, 
2010). The integrin-based cell adhesion moieties in GelMA hydrogel provided a desirable 
microenvironment for cell growth and spreading, while methacrylated polymer chains enabled 
formation of micro-topographies (Klotz, 2016; Nichol, 2010). For example, Saini et al. (Saini, 
2015) fabricated cell-laden GelMA hydrogel constructs to develop 3D rectangular cardiac 
microtissues with variable geometrical features encapsulated with CMs alone and with a co-
culture with cardiac fibroblasts (CFs). Their results showed the necessity and critical impacts of 
CFs and construct geometry on cell spreading, cytoskeleton alignment, tissue formation, and 
overall functionalities of the cardiac microtissues. 
Despite these significant progresses, there remains critical shortcoming related to the 
electrical properties of the previously developed micropatterned hydrogel constructs that can be 
further improved for cardiac tissue engineering applications (Kharaziha, 2013; Navaei, 2016a; 
Paul, 2014; SR Shin, 2013; SR Shin, 2016). Specifically, the electrically insulated macroporous 
matrix of hydrogel can interfere with cell-cell electrical coupling and signal propagation within the 
tissue (Dvir, 2011; Navaei, 2016a). This phenomenon can impede full electrical integration of the 
tissue constructs with the native myocardium, which could potentially lead to undesired 
arrhythmias (Furuta, 2006; Rubart, 2003; Zhou, 2014; Zimmermann, 2006). To address this, 
incorporation of biocompatible nanomaterials with high electrical conductivity was demonstrated 
to significantly reduce the hydrogel matrix's resistivity and facilitate electrical signal propagation 
among the cardiac cells (Dvir, 2011; Ling, 2011; SR Shin, 2013; SR Shin, 2016; Zhou, 2014). For 
instance, in a recent work, Ramon-Azcon and Ahadian (Ahadian, 2014) fabricated micropatterned 
GelMA hydrogel constructs incorporated with aligned carbon nanotubes via dielectrophoresis for 
skeletal muscle tissue engineering. The microgrooved hydrogel constructs demonstrated robust 
anisotropic electrical conductivity, leading to pronounced expression of skeletal muscle specific 
genes and proteins. However, there are numerous concerns regarding the utilization of carbon 
nanotubes for biomedical applications (Annabi, 2013) specifically with respect to biological toxicity 
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(Firme, 2010; Simon, 2014; Zhu, 2008), low solubility (YY Huang, 2012b; Vardharajula, 2012) as 
well as high UV light absorption which limits development of 3D thick (i.e. millimeter scale) tissue 
constructs using photolithography (SR Shin, 2012). Alternatively, previous work of ours (Navaei, 
2016a) and others (Baei, 2016; Dvir, 2011; Fleischer, 2014; Jung, 2012; T-J Lee, 2014; 
Ravichandran, 2014; Michal Shevach, 2014) have exhibited the tremendous potential of GNMs 
for myocardial tissue engineering. Particularly, cardiac tissue constructs incorporated with GNMs 
showed excellent viability and metabolic activity (Baei, 2016; Navaei, 2016a) enhanced 
cardiogenic differentiation (T-J Lee, 2014; Ravichandran, 2014; Sridhar, 2015) upregulated 
expressions of cardiac proteins and genes (Dvir, 2011; You, 2011) and facilitated cell-cell 
electrical coupling (Dvir, 2011; Navaei, 2016a; Michal Shevach, 2014; Michal Shevach, 2013). In 
addition, high biocompatibility (Connor, 2005; Shukla, 2005) wide range of nanostructures 
(Cobley, 2011; Hu, 2006) as well as ease of fabrication and biofunctionalization (X Huang, 2009; 
Lloret, 2013) are among the other reported characteristics of GNMs. 
We previously developed gold nanorod-incorporated GelMA hybrid hydrogels (GelMA-
GNR) to assess the applicability of the conductive material in prompting cardiac cell functions 
(Navaei, 2016a). Specifically, 5% (wt/v) GelMA hydrogels with different concentrations of GNRs 
(0, 0.5, 1, and 1.5 mg mL−1) were formed using photolithography technique. NRVCMs were 
seeded on the GelMA-GNR hydrogel constructs and subsequently cardiac cell phenotype (i.e. 
sarcomere organization, Cx43) as well as tissue-level functionalities were assessed. Specifically, 
our results confirmed the formation of highly contractile tissues on the synthesized conductive 
hydrogels with 1 and 1.5 mg mL−1 GNRs, demonstrating synchronous cell-cell coupling and Ca2+ 
transients compared to pure GelMA hydrogel. However, the developed GelMA-GNR constructs 
did not exhibit biomimetic geometrical (i.e. topographical) cues to induce native-like anisotropic 
cellular organization. Therefore, in this chapter, we utilized an integrated micro- and nano-scale 
strategy by simultaneous incorporation of biomimetic geometrical (i.e. anisotropic microgrooved 
architecture) and electrical cues (i.e. GNRs) to develop highly oriented and contractile cardiac 
tissue constructs. We additionally optimized the concentration of GelMA hydrogel to 10% (wt/v) 
incorporated with GNRs (1 mg mL−1) to maintain robust pattern fidelity. We performed material 
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characterization to assess the electrical and mechanical properties of the new matrix. NRVCMs 
were seeded on pristine GelMA and GelMA hydrogel incorporated with GNRs for 7 days, and 
cellular organization, cardiac specific markers expression as well as tissue contractility were 
further assessed. The findings confirmed the formation of dense and highly organized cellular 
networks within GelMA-GNR microgrooved constructs. The electrically conductive and highly 
organized cardiac tissues exhibited continuous and synchronized contractions induced by 
external electrical stimuli, mimicking physiologic synchronous cardiac cell beatings. The proposed 
strategy demonstrates a unique approach, which can be used to develop biomimetic cardiac 
patches that could better integrate with native myocardium (Zhou, 2014; Zimmermann, 2006). 
3.2. Experimental Methods 
3.2.1. Materials 
Gelatin (type A), TMSPMA, the photoinitiator, HAuCl4, NaBH4, AgNO3, CTAB, and L-
ascorbic acid were purchased from Sigma Aldrich and utilized with no further purifications. DIW 
(18 MΩ) was used for the all syntheses. 
3.2.2. Fabrication of PDMS micromolds 
The micromolds were fabricated using standardized photo- and soft-lithography methods 
(Betancourt, 2006; Qin, 2010; Truong, 2016). First, the groove design (50 μm width and spacing) 
was created using a CAD (computer aided design) software. Next, a transparent mask was 
created and utilized in the SU-8 photolithography. SU8-2075 (Micro Chem) was spun onto a 
silicon wafer until it reached a final height of 50 to 70 μm. The wafer was placed underneath the 
transparent mask with the microgrooved patterns and exposed to UV light. Subsequently, the 
wafer was transferred to a conventional oven for final crosslinking at 50 °C for 24 h. Finally, the 
wafers, containing of microgrooves, were developed at room temperature using SU-8 developer 
(Micro Chem) and hard baked at 150 °C for 30 min. Wafers were salinized using 
trichloro(methyl)silane (TCMS, Sigma Aldrich) for 20 min in a vacuum chamber. Next, 
polydimethylsiloxane (PDMS, Sylgard 184 Silicon Elastomer kit, Dow Corning) was casted over 
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the SU-8 wafer and baked for 1 h at 80 °C. Afterwards, the PDMS micromolds (Figure 3.1A.) was 
peeled off and individual micromolds were cut and sterilized using 70% ethanol and UV.  
3.2.3. Fabrication of cell-seeded GelMA and GelMA-GNR microgrooved hydrogels 
GNRs and GelMA prepolymer were synthesized based on previously reported protocols 
(Navaei, 2016a; Saini, 2015). TEM (Philips CM200-FEG, USA) operating at 200 kV accelerating 
voltage was used to view and confirm the formation of synthesized GNRs (Figure 3.1B.). Mean 
length, width, and aspect ratio of GNRs were calculated based on the TEM images (n = 10) using 
NIH ImageJ software. GelMA-GNR microgrooved hydrogels were fabricated using the soft 
lithography technique (Figure 3.1C.). A clear prepolymer solution of GelMA (10% wt/v) in 
photoinitiator (0.5% wt/v in DPBS) was prepared, and subsequently mixed with purified GNRs (1 
mg mL−1 of GelMA prepolymer solution). GelMA-GNR solution was sonicated in water bath for 1 
h to obtain a homogenous mixture. In the next step, PDMS micromolds (50 μm width, spacing, 
and depth) were treated by oxygen plasma (Harrick Plasma, USA) for 30 s to render the surface 
of the micromold more hydrophilic resulting in uniform penetration of hydrogel prepolymer 
solution within the microgrooves. The mold was placed on a droplet (15 μL) of GelMA-GNR 
hydrogel and the whole assembly was exposed to UV light (800 mW, 360-480 nm) for 25 
seconds. To avoid any disruption in the structure, microgrooved hydrogels were soaked in the 
sterile DPBS for 10-15 min and then the PDMS mold was peeled off. GelMA microgrooved 
hydrogels (the control group) were fabricated also using the same procedure with 10 s UV light 
exposure. All microgrooved hydrogels were washed in an antibiotic solution (1% v/v 
penicillin/streptomycin in DPBS) twice with 10 min intervals, followed by a washing using cardiac 
culture media (containing DMEM, L-glutamine (1%), FBS (10%), and penicillin-streptomycin (100 
units per mL)) in the same fashion. Afterwards, isolated 2-day old NRVCMs were seeded (1 × 106 
cells/constructs) on GelMA-GNR microgrooved hydrogels (1 × 1 cm2 construct size) for 24 h, 
which were placed in 24 multiwell plates and incubated at 37 °C with 5% CO2. Unattached cells 
were washed off on the next day and 500 μL of fresh cardiac culture media were added to the 
samples. The media were exchanged every other day. 
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3.2.4. Electrical, rheology, and morphological characterizations of GelMA and 
GelMA-GNR hydrogels 
To evaluate the electrical conductivity of the GelMA and GelMA-GNR hydrogels, the 
constructs were placed between two conductive glass slides (ITO coated, 30-60 Ω sq−1, Sigma 
Aldrich) and AC bias (Agilent 4284A LCR meter) was swept from 10 Hz to 1 MHz. Real portions 
of the impedance complex values were averaged (n = 4) and plotted versus the frequency. A 
rheometer (parallel plate rheometer, Anton Paar MCR-101) was utilized to measure the storage 
moduli (elasticity) of crosslinked GelMA and GelMA-GNR hydrogels. In this regard, hydrogels 
were placed between the parallel plates of the rheometer and storage moduli were measured as 
a function of strain sweep (0-100%). The values at 5% strain (n = 3) were considered the ultimate 
storage moduli of the hydrogels. Macroporous structure of GelMA and GelMA-GNR hydrogels 
were investigated using SEM. Hydrogels were fabricated and mounted onto the SEM sample 
holders, and sputter coated by Au/Pd. Matrix porosity of both hydrogels were calculated based on 
SEM images (n = 6) using ImageJ software. 
3.2.5. Viability, cellular alignment, and cardiac cells phenotype 
Viability of cultured cardiac cells on GelMA and GelMA-GNR hydrogels were investigated 
using a standard Live/Dead assay kit (Thermo Fisher, USA). The samples were treated by the 
assay on day 1 and 7 of culture and fluorescent images were taken using an inverted microscope 
(Zeiss Observer Z1, USA). Cytoskeleton organization of microgrooved cardiac tissues was 
assessed based on F-actin fibers staining images. The hydrogel constructs were stained on day 1 
and 7 of culture using Alexa Fluor® 488 Phalloidin (Thermos Fisher, USA) according to 
previously published protocols (Navaei, 2016b). Sequentially, samples were fixed in PF (4% v/v) 
for 30 min, permeabilized in Triton X-100 (0.1% v/v) for 45 min and blocked in BSA (1% v/v) for 1 
h. Next, a mixture of Alexa Fluor® 488 Phalloidin (1 to 40 dilution) and DAPI (1 to 1000 dilution) 
in BSA was added to the samples for 1 h, and Z-stacked images were captured by a fluorescent 
microscope equipped with Apotome.2 (Zeiss, USA). The averaged area coverage and index of F-
actin fibers were calculated (n > 15). The area coverage index specifically was defined as the 
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area covered by cardiac cells delineated by the F-actin fibers inside the microgrooves. In addition, 
fiber alignment index (n > 10) was defined as the ratio of long axis to short axis of FFT (built-in 
tool in ImageJ software) analysis images (Nichol, 2010; Saini, 2015). To evaluate the maturation 
of the created cardiac tissues on the hydrogel microgrooves, cardiac-specific markers, SAC and 
Cx43 gap junctions were immunostained using primary antibodies (Abcam, USA) (Navaei, 
2016a). In brief, samples were fixed in PF (4% v/v) for 30 min, permeabilized in Triton X-100 
(0.1% v/v) for 45 min and blocked in goat serum (10% v/v) for 1 h. Afterwards, primary antibodies 
(1 to 100 dilution in 10% goat serum) were loaded on the samples for 24 h at 4 °C, followed by 
staining using secondary antibodies (1 to 200 dilution in goat serum) (Thermo Fisher, USA) for 6 
h. Finally, DAPI was added to stain the cells' nuclei. The area coverage of stained cardiac 
markers was averaged (n > 5) on day 7 of culture. 
3.2.6. Spontaneous and stimulated beating behavior of microgrooved cardiac 
tissues 
The spontaneous contractile behavior of GelMA and GelMA-GNR microgrooved cardiac 
constructs was monitored using an inverted microscope (Zeiss, USA) over 7 days, and presented 
as averaged BPM (n > 11). Also, a custom-made stimulation chamber was fabricated (Tandon, 
2009) and utilized to induce electrical stimuli on the cardiac tissues on day 7. The cardiac 
microgrooved tissues were stimulated at 0.5, 1, 2 Hz and excitation thresholds (the minimum 
required voltage to induce synchronous cells' contraction) were recorded. To extract the beating 
signal from the videos, a custom-written Matlab (MathWorks, USA) code was used (SB Kim, 
2011; Navaei, 2016a). 
3.2.7. Statistical analysis 
All results were statistically analyzed with a Student's t-test (two-tailed) method using 
GraphPad Prism software. A p-value less than 0.05 (two-sided) was considered statistically 
significant difference within the samples. 
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3.3. Results and Discussion 
3.3.1. Development and characterization of the electrically conductive hydrogel 
microgrooves 
Fabricated PDMS micromolds (Figure 3.1A.) with microgrooved topographies were casted 
and used for creating GelMA and GelMA-GNR hydrogel constructs. Similar to our previously 
published work (Navaei, 2016a) the synthesized GNRs (Figure 3.1B.) exhibited nanorod-like 
structure with average length and width of ∼53 and ∼16 nm respectively (aspect ratio of ∼3.15). 
Purified GNRs were mixed and sonicated with GelMA prepolymer solution (10% wt/v). A drop of 
GelMA-GNR mixture was then located on TMSPMA-coated glass slides, and PDMS mold was 
placed on top. Finally, the microgrooved hydrogel constructs were fabricated through UV photo-
crosslinking and submerged in sterile DPBS prior to biological studies (Figure 3.1C.). The 
microarchitecture of fabricated GelMA-GNR microgrooved hydrogels is demonstrated in Figure 
3.1D. As can be seen, the microgrooves with 60 μm depth (Figure 3.1D., middle image) and 50 
μm width were formed on the surface of hydrogel slab with 65 μm thickness. This result showed 
successful formation of surface microgrooves on GelMA-GNR hydrogel constructs. 
In our recent work (Navaei, 2016a) we performed extensive studies on the synthesis and 
characterization of GelMA (5% wt/v) hydrogel embedded with variable concentrations of GNRs 
(0-1.5 mg mL−1) for the development of cardiac tissue constructs. However, the aim was to 
assess the role of matrix properties on behavior and function of cardiac cells. Our previously 
developed GelMA-GNR hydrogels did not exhibit biomimetic oriented topographical features to 
induce cardiac cells uniaxial alignment. In these studies, we optimized hydrogel concentration 
using 10% wt/v GelMA incorporated with 1 mg mL−1 GNRs for fabrication of microgrooved 
features due to its superior material and biological properties to conduct biological studies 
(Navaei, 2016a). In other words, the control condition in this chapter was the microgrooved 
GelMA hydrogel constructs without the presence of GNRs (GelMA vs. GelMA-GNR). 
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Figure 3.1. A) SEM images of casted PDMS micromolds. Inset image demonstrates higher 
magnification. B) TEM micrograph of synthesized GNRS. C) A schematic illustrating the 
fabrication procedure of GelMA-GNR microgrooved tissues. D) Z-Stack images of fluorescently 
fabricated GelMA-GNR hydrogel showing the 3D structure of the microgrooved patterns. Dash 
white lines at x-z and y-z axes indicate the relative z position of the top-view (y-x) image. 
Numbers at the top-right box represent the distance of dotted white line from the bottom of the 
construct (0 μm is the bottom, 65 μm is the height of the hydrogel slab, and 125 μm shows the 
whole thickness of the construct). Scale bars are 50 μm. 
SEM micrographs (Figure 3.2A.) displayed the porous structure of GelMA and GelMA-GNR 
hydrogel matrices after 24 h hydration. As evident, both hydrogels showed similar porous 
architectures with no obvious aggregations of GNRs within the hydrogels' matrices. In addition, 
the architecture of GelMA and GelMA-GNR matrix were compared based on the measured 
porosity percentage (Figure 3.2B.) using SEM images. Both hydrogels demonstrated similar 
porosity with no statistically significant differences (GelMA 69 ± 6% and GelMA-GNR 67 ± 6%). 
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The results showed that incorporation of GNRs within GelMA hydrogel did not disturb the 
macroporous architecture of the GelMA hydrogel matrix, consistent with our previously published 
work (Navaei, 2016a). Matrix porosity plays a critical role in cellular viability, spreading, and 
function especially in the case of cell encapsulation (cell-laden constructs) within hydrogel-based 
tissue constructs (Annabi, 2010; Loh, 2013). 
 
Figure 3.2. A) SEM micrographs of GelMA and GelMA-GNR hydrogels matrices at different 
magnifications. B) Porosity percentage of both hydrogels calculated based on the SEM images. 
C) The electrical impedance measurements of GelMA and GelMA-GNR at different swept 
frequencies. D) Comparison of matrix impedance at 10 Hz frequency. (E) Rheology analysis of 
GelMA and GelMA-GNR hydrogels showing the storage modulus variations as a function of the 
strain, and (F) ultimate storage moduli at 5% strain (*p-value < 0.05). 
Electrical conductivity of GelMA and GelMA-GNR hydrogels measured as the impedance 
of hydrogel matrix are shown in Figure 3.2C. The results showed lower electrical impedance of 
GelMA-GNR hydrogel compared to pure GelMA within the frequency variations. Specifically, 
GNR-embedded hydrogels exhibited significantly less impedance (1.35 ± 0.36 kΩ) at the lowest 
tested frequency (10 Hz), which is relatively closer to the physiological range (You, 2011) 
compared to pure GelMA hydrogel (15.58 ± 9.18 kΩ) (Figure 3.2D.). Such characteristic can be 
correlated to the presence of GNRs within the GelMA matrix due to bridging of the electrically 
insulated hydrogel's pores. It has been shown that the electrically conductive hydrogel matrices 
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provide an excellent microenvironment for the growth and functioning of cardiac cells (Martinelli, 
2012; You, 2011).  
Mechanical properties of the hydrogels in terms of rheology (storage moduli) are shown in 
Figure 3.2E. The storage moduli of GelMA and GelMA-GNRs hydrogels decreased as a function 
of strain. At 5% strain, both hydrogels exhibited their ultimate storage moduli, where it was 
statistically higher for GelMA-GNR hydrogel as shown in Figure 3.2F. Improved mechanical 
characteristics have been consistently reported elsewhere for similar nanomaterial-incorporated 
hydrogels (Navaei, 2016a; SR Shin, 2013; Xavier, 2015). Specifically, electrostatic interactions 
between GNRs (positively charged) (Nikoobakht, 2003) and GelMA chemical structure 
(negatively charged carboxyl groups) (Nichol, 2010) along with the filler effect (Tjong, 2006) of 
incorporated GNRs are speculated to lead to higher mechanical stiffness (storage modulus) of 
GelMA-GNR hydrogel. However, such mechanical enhancements did not result in a several folds 
increase in GelMA-GNR (10% wt/v) hydrogel storage modulus. It is speculated that as hydrogel 
prepolymer solution (GelMA) concentration increases (e.g. 10%), the influences in the 
mechanical properties caused by embedding of nanomaterials (GNRs) may be compromised. For 
example, it was shown in chapter 2 that the incorporation of 1 or 1.5 mg mL−1 GNRs within 
GelMA hydrogels with 5% wt/v prepolymer concentration significantly increased the mechanical 
stiffness (Young's modulus) of the material (∼2 folds) (Navaei, 2016a), measured by AFM. 
However, it is important to note that although increasing GelMA prepolymer concentration 
enhances the mechanical properties of the hydrogel, it can have adverse influence by decreasing 
the electrical conductivity of the hydrogel (Tarus, 2016; Veleirinho, 2008). Nevertheless, 
nanoengineered hydrogels with enhanced mechanical properties have exhibited superior cell 
adhesion, spreading and tissue formation (Grover, 2012; H-B Wang, 2000a; Zhou, 2014). 
3.3.2. Cellular viability and formation of organized cardiac tissues 
Figure 3.3A. illustrates phase contrast images of CMs on the GelMA and GelMA-GNR 
hydrogel microgrooves on day 1 and day 7 of culture. Seeded CMs formed discrete aggregated 
clusters inside the microgrooves on both substrates (GelMA vs. GelMA-GNR), on day 1. 
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However, the cell adhesion pattern inside GelMA-GNR microgrooves was more homogenous. 
Over 7 days of culture, CMs were spread and formed cellular networks within the microgrooves 
(Figure 3.3B.). Specifically, GelMA-GNR microgrooved cardiac tissues exhibited mostly concrete 
uniaxial cellular networks.  
 
Figure 3.3. Phase-contrast images of cardiac cells seeded on GelMA and GelMA-GNR 
microgrooved hydrogel on A) day 1 B) and day 7 of culture. White arrows represent the 
disconnect between cellular clusters. Fluorescent viability images of GelMA and GelMA-GNR 
microgrooved cardiac tissues on C) day 1 and D) day 7. Live cells are stained in green and dead 
cells are stained in red. All scale bars represent 100 μm. 
In contrast, cell clusters exhibited discrete spreading within microgrooves on GelMA 
constructs. In some locations complete disconnections (Figure 3.3B., white arrows) between the 
cellular clusters were evident. Cell retention comparing GelMA and GelMA-GNR on day 1 was 
not significantly different (data not shown). However, CMs spreading, and formation of organized 
tissues were profoundly improved on GelMA-GNR as compared to GelMA constructs (Figure 
3.3B., day 7). The dissimilarity in the cell adhesion and spreading patterns can be associated with 
the difference in elasticity (storage modulus) and surface characteristics between GelMA and 
GelMA-GNR hydrogels. As it has been demonstrated, the hydrogels with higher stiffness 
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improved cell adhesion and spreading compared to the softer hydrogels, specifically in the case 
of 2D cell seeding on the constructs (Navaei, 2016a; SR Shin, 2013). Consistently, in our 
previous work, we confirmed the localization of GNRs within the micro-pores of the hydrogel 
constructs, which may subsequently lead to the formation of nano-scale local topographies, 
providing more anchoring points for cell adhesion and spreading. Higher surface roughness and 
nano-scale topographies were also observed in previous studies on the incorporation of CNTs 
within PNIPAAm hydrogels (H Sun, 2017). Regardless of hydrogel type (GelMA and GelMA-
GNR), fluorescent Live/Dead images showed only few dead cells (red) on day 1 (Figure 3.3C.) 
and day 7 (Figure 3.3D.) of culture. In other words, purified GNRs (twice washed) (Connor, 2005) 
incorporated within GelMA-GNR hydrogel did not induce major cytotoxicity over 7 days. Due to 
formation of dense cell clusters (day 1) and 3D topographical features of microgrooves (day 7), 
we were not able to quantify the percentage of viability.  
3.3.3. Cytoskeleton organization and cardiac cells phenotype 
Cytoskeleton architecture of organized cardiac tissues on microgrooved GelMA and 
GelMA-GNR hydrogels were investigated through staining of F-actin fibers on day 1 (upon 
seeding) and day 7 of culture. As shown in Figure 3.4A., CMs were confined mostly within the 
microgrooves, and acquired round morphology on day 1 of culture within both hydrogel 
constructs. Quantified F-actin area coverage and index (Figure 3.4B. and 3.4C., day 1) also 
confirmed the same scenario as illustrated by immunostained images of round cells. After 7 days 
of culture, cardiac cells created compact and extended tissues (Figure 3.4A., day 7) with 
significantly higher area coverage (Figure 3.4B., day 7) on GelMA-GNR hydrogels as compared 
to disconnected cellular clusters on pure GelMA. Area coverage index (Figure 3.4C.) also 
confirmed considerable formation of organized tissues inside the GelMA-GNR microgrooves. 
Therefore, the major differences between GelMA and GelMA-GNR constructs were in terms of 
cellular connectivity, area coverage as well as formation of highly organized and compact tissues. 
Cytoskeleton alignment was further assessed using FFT analysis (inset images in Figure 3.4A.) 
on day 1 and 7.  
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Figure 3.4. A) Staining images of F-actin fibers of cardiac tissues on day 1 and 7 of culture. Insets 
demonstrate FFT analyses. All scale bars represent 100 μm. B) Area coverage and C) area 
coverage index of F-actin fibers within GelMA and GelMA-GNR microgrooved tissues on day 1 
and 7. D) F-Actin fiber alignment index on day 1 and 7 of culture (*p-value < 0.05). 
The outcomes indicated notably higher F-actin fiber alignment for cardiac tissues formed 
on GelMA-GNR microgrooves in comparison to GelMA constructs on day 7 (Figure 3.4D.). 
Despite the fact that GelMA-GNR hydrogels (∼3.5 kPa) provided stiffer matrices compared to 
GelMA (∼2.5 kPa), on day 1, cell adhesion coverage data (Figure 3.4A. and 3.4B.) did not show a 
meaningful difference between both constructs. We speculate that GelMA hydrogel with 10% 
(wt/v) prepolymer concentration provided a microenvironment with sufficient stiffness for early cell 
adhesion but was not able to maintain cell spreading over time in comparison with GelMA-GNR 
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hydrogel. Such behavior may be attributed to the excess cell anchoring points provided by 
embedded GNRs on the hydrogel matrix, as also demonstrated in our previous work (Navaei, 
2016a) improving cellular spreading and tissue formation. Overall, the data in Figure 3.4. were in 
agreement with our phase contrast images, confirming substantial formation of uniaxially aligned 
cardiac tissues directed within the microgrooves on GNR-incorporated GelMA hydrogels.  
 
Figure 3.5. A) Immunostained images of SAC (green) and Cx43 gap junctions (red) within GelMA 
and GelMA-GNR microgrooved cardiac tissues on day 7 of culture. White arrows demonstrate 
uniaxially aligned sarcomeric structures. Scale bars represent 50 μm for low magnification 
images and 20 μm for merged images. B) Quantified area coverage of cardiac specific markers 
on day 7 (*p-value < 0.05). 
The phenotype of cardiac cells on GelMA and GelMA-GNR microgrooved constructs was 
assessed using SAC and Cx43 gap junctions on day 7 of culture. As represented by 
immunostained images in Figure 3.5A. (separated channels), aligned SAC structures (white 
arrows) and well distributed Cx43 gap junctions are evident on both GelMA and GelMA-GNR 
hydrogels. However, similar to the cytoskeleton organization data (Figure 3.4A.) cellular 
disconnectivity and lack of tissue compactness were present on pure GelMA microgrooved 
constructs as compared to concrete and highly organized tissues on GelMA-GNR hydrogels. 
Fluorescent area coverage of SAC and Cx43 (Figure 3.5B.) further demonstrated significant 
differences in the formation of intact cardiac tissues comparing GelMA-GNR to GelMA (control) 
microgrooved constructs. These findings emphasize the critical role of hydrogel properties (e.g. 
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stiffness) and the nano-scale cues provided by GNRs for the development of dense cardiac 
patches with native like organization and architecture. In addition, the electrically conductive 
matrix provided by GelMA-GNR hydrogel was involved in promoting cell-cell coupling (Dvir, 2011; 
Fleischer, 2014; Navaei, 2016a; You, 2011). 
3.3.4. Spontaneous and stimulated contractile behavior of cardiac tissue 
microgrooves 
The functionality of aligned cardiac tissues in static culture condition and under external 
electrical stimulation on day 7 was further investigated using real time cellular contraction 
analysis (Figure 3.6.). As can be seen, cardiac tissues formed on GelMA and GelMA-GNR 
microgrooved constructs started beating at day 4 and continued until day 7 (Appendix C.12. and 
C.13.). The results (Figure 3.6A.) exhibited no statistically significant differences in terms of 
spontaneous synchronous BPM between GelMA and GelMA-GNR tissues. However, our 
previously published work (Navaei, 2016a) on 1.5 mg mL−1 GNRs-incorporated 5% (wt/v) GelMA 
hydrogel, without surface topographies (i.e. microgrooves), demonstrated significantly enhanced 
contractility (higher BPM) as compared to pure GelMA hydrogel. Despite the statistically higher 
mechanical stiffness of GelMA-GNR hydrogel (∼3.5 kPa) as compared to GelMA (∼2.5 kPa), we 
speculate that 10% (wt/v) GelMA with high degree of methacrylation provided sufficient 
mechanical cues to initiate and maintain spontaneous contractility. Therefore, it is conjectured 
that incorporation of GNRs within GelMA hydrogel (10% wt/v) and enhanced “electrical 
conductivity” (Figure 3.2A. and 3.2B.) of the matrix would provide added benefits in terms of 
induced (controlled) electrical stimulation and contractility. Therefore, cardiac tissues were 
stimulated externally at 0.5, 1, and 2 Hz frequencies using an external pulse generator and 
custom-made bioreactor setup (Navaei, 2016a; Navaei, 2016b). As the data shows (Figure 
3.6B.), interestingly, it was not possible to induce stimulated contractions on tissues formed on 
pure GelMA constructs by electrical pulses up to 10 V amplitude. Conversely, highly organized 
tissues formed on GelMA-GNR hydrogel were successfully stimulated at all tested frequencies 
with relatively low excitation voltage thresholds (Figure 3.6B.). In addition, extracted beating 
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signals (Fig3. 6C. and Appendix C.14.) demonstrated that CMs were constantly contracted (no 
major peak-to-peak variation of amplitudes, dash black lines) with the same frequency provided 
by external stimulator.  
 
Figure 3.6. A) Synchronous spontaneous beating behavior (beats per minute; BPM) of cardiac 
tissues on GelMA and GelMA-GNR constructs. B) Voltage excitation thresholds and (C) extracted 
beating signals of GelMA-GNR cardiac tissue at different frequencies. Dash lines indicate similar 
peak amplitudes with no variations (*p-value < 0.05). 
Therefore, addition of GNRs within the microgrooved GelMA hydrogel constructs not only 
induced higher cellular alignment, better connectivity and sarcomere organization but also 
provided a conductive matrix where the formed tissues could precisely follow external pulsed 
electrical stimulation regime. Therefore, it is envisioned that highly organized cardiac tissue 
formed on electrically conductive matrix would better integrate with the native myocardium 
following implantation (Zhou, 2014). This is a critically important component of a viable cardiac 
patch for implantation as electrical signals in native cardiac tissue are often initiated and 
propagated by specialized cardiac cells (e.g. sinoatrial node and His-Purkinje cells) and then 
rapidly propagated throughout contractile cardiomyocyte tissue to effect synchronous contraction 
for optimum cardiac output. A highly organized tissue construct formed on microgrooved GelMA-
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GNR hydrogel that can be stimulated with low excitation threshold voltage would advance the 
ability to fully integrate with the synchronous contraction of native myocardium. Investigation of 
the functionalities of the proposed microengineered tissues in vivo, is the subject of our future 
work.  
3.4. Conclusion 
In this study we developed and tested novel GNR-incorporated GelMA hydrogel 
microgrooved constructs (GelMA-GNR) for development of uniaxially aligned cardiac tissues. As 
a continuation of our previous work (Navaei, 2016a) we incorporated anisotropic topographical 
cues on electrically conductive GelMA-GNR hybrid hydrogels to provide simultaneous 
topographical and electrical signals to support cardiac cells functionalities in a biomimetic fashion. 
Our results showed improved mechanical elasticity (storage modulus) and electrical conductivity 
of GelMA-GNR hydrogels (lower impedance) compared to pure GelMA constructs. Phase-
contrast images exhibited more uniform cell seeding fashion (day 1) on GelMA-GNR 
microgrooves compared to pure GelMA. Despite the resemblance in the cell coverage on day 1 
for both constructs (with and without GNRs), cardiac tissues formed on GelMA-GNR hydrogels 
demonstrated highly dense and uniaxially aligned architectures, mainly inside the microgrooves. 
A similar scenario was observed for cardiac-markers demonstrating aligned cytoarchitecture. 
Specifically, cardiac cells on GelMA-GNR microgrooves revealed compact sarcomeric structures, 
while discrete pattern with considerably lower area coverage were detected on GelMA constructs 
without the presence of GNRs. Although both GelMA and GelMA-GNR microgrooved tissues 
demonstrated spontaneous contractility from day 4 to 7 of culture, only cardiac tissues formed on 
the electrically conductive GelMA-GNR microgrooves were able to be externally stimulated at 
different frequencies (0.5, 1, and 1 Hz) at low voltages. Overall, the data presented here 
demonstrate that the utility of integration of micro- and nano-scale strategy to developed highly 
organized and native-like cardiac tissues with superior functionalities for potential applications in 
regenerative medicine, disease modeling and drug screening. Finally, the use of hiPSCs in 
regenerative medicine has dramatically increased in the past few years, due to their unique 
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potential to model human myocardial pathophysiology and understand the mechanism of disease 
progression. In this regard, our future work will be focused on the use of hiPSC-derived CMs to 
develop functional human cardiac patches for treatment of myocardial infarction.  
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CHAPTER 4 
INFLUENCE OF ELECTRICALLY CONDUCTIVE AND NON-CONDUCTIVE NANOMATERIALS 
ON MATURATION AND EXCITABILITY OF ENGINEERED CARDIAC TISSUES 
4.1. Introduction 
Over the past decade, electrically conductive nanocomposite scaffolds have been at the 
center of attention for developing engineered cardiac tissues with enhanced contractility and 
biological function for regeneration of injured myocardium upon MI (Zhi Cui, 2016; Kharaziha, 
2016; Monteiro, 2017). As we discussed in chapter 2 and 3, conductive tissue constructs 
exhibited significantly improved cell adhesion and cardiac maturation along with the enhanced 
electrical excitability and signal propagation (Dvir, 2011; Navaei, 2017; Navaei, 2016a; Pok, 2014; 
SR Shin, 2013). Conductive nanocomposite scaffolds are typically fabricated by incorporating 
electrically conductive nanomaterials within the matrix of scaffolding biomaterials (e.g. hydrogels). 
In previous studies, it has been argued that the embedded conductive nanomaterials facilitate the 
propagation of electrical signals within the macroporous matrix of scaffold by bridging the 
isolating pore walls (Dvir, 2011; Pok, 2014; SR Shin, 2013). To that end, GNMs and carbon-
based nanostructures are among the mostly utilized nanomaterials for fabricating electrically 
conductive cardiac tissues (Martinelli, 2013a; Shapira, 2016). In an original study by Dvir (Dvir, 
2011), electrically conductive cardiac tissues were formed by seeding CMs on GNW-embedded 
alginate hydrogels. The conductive alginate-GNW hydrogels enhanced the maturation of cardiac 
cells thorough upregulation of contractile proteins such as SAC and cTnI as well as Cx43 gap 
junctions. In addition, the external electrical stimuli were propagated globally only within the 
conductive alginate-GNW hydrogels, while pure alginate did not facilitate similar signal 
transmittance. In another pioneering study by Shin (SR Shin, 2013), gelatin-CNT nanocomposite 
hydrogels were synthesized for engineering conductive cardiac tissues. Engineering of 
conductive gelatin-CNT tissues led to mature cardiac phenotype (i.e. striated sarcomeres) and 
enhanced protein expression as compared to pure gelatin hydrogel. Furthermore, the electrical 
excitability (i.e. voltage threshold) and synchronized spontaneous contractility of CMs were 
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significantly promoted within the conductive gelatin-CNT hydrogels. Similar outcomes including 
improved cardiac maturation and electrical excitability have been reported for other conductive 
cardiac tissue constructs (Kharaziha, 2014; Navaei, 2017; Pok, 2014; Michal Shevach, 2014; SR 
Shin, 2016).  
Although the primary motive for developing conductive cardiac tissues has been on 
enhancing the electrical signal propagation within the insulating matrix of scaffold (i.e. 
synchronicity) (Dvir, 2011; SR Shin, 2013), however, inclusion of conductive nanomaterials also 
results in enhanced mechanical and surface topographical features within the scaffold’s matrix. 
Specifically, the incorporated nanomaterials increase matrix rigidity and stiffness by acting as 
reinforcing nanofillers (Q Li, 2016b; Tjong, 2006) and lead to the formation of nano-scale surface 
topographies (Gaharwar, 2014; H Sun, 2015). Each of these matrix characteristics, regardless of 
electrical conductivity, has been shown to significantly promote maturation as well as contractility 
of primary and stem cell-derived CMs (Bhana, 2010; Boothe, 2016; Carson, 2016; Deok-Ho, 
2005; Jacot, 2008; AJS Ribeiro, 2015a). For example, in a study by Bhana (Bhana, 2010), CMs 
phenotypic maturation (e.g. cTnI expression) and contractile force generation were significantly 
enhanced by increasing the matrix stiffness. Therefore, it is speculated that the mechanical 
properties and surface topography play more prominent roles in maturation and synchronicity of 
engineered cardiac tissues compared to the matrix electrical conductivity (Dvir, 2011; Navaei, 
2016a; SR Shin, 2013).  
In this chapter, our aim is to dissect the role of mechanical stiffness and nano-scale 
surface topography from electrical conductivity of the scaffold on maturation and excitability of 
cardiac tissues. In chapter 2, we reported the development of characterization of electrically 
conductive GelMA-GNR hydrogels for engineering of functional cardiac tissues (Navaei, 2017; 
Navaei, 2016a). Incorporation of GNRs within GelMA significantly increased the electrical 
conductivity and mechanical stiffness of the hydrogel matrix (Chapter 2, Figure 2.3.). Notably, the 
BSE-SEM micrographs of GelMA-GNR hydrogel demonstrated localization of GNRs on the 
surface of macroporous GelMA matrix (Chapter 2, Figure 2.2B.), which led to generation of nano-
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scale topographies. The obtained in vitro results demonstrated that GelMA-GNR hydrogels, 
specifically with 1 or 1.5 mg/mL GNRs concentrations, significantly increased cellular retention 
and spreading, cardiac maturation (e.g. protein expression and sarcomere formation), 
synchronized contractility and electrical excitability (Chapter 2, Figures 2.4-10.) of the cardiac 
tissues. In this chapter, for the first time, we developed conductive and non-conductive 
engineered cardiac tissues to investigate side-by-side the impact of matrix electrical, mechanical 
and topographical characteristics on the cellular retention, cardiac maturation and excitation 
threshold of CMs. The excitability of the engineered cardiac tissues was also evaluated in the 
presence of a gap junction uncoupler (heptanol) to further examine the potential compensatory 
influence of matrix conductivity on the excitation voltage threshold. Overall, our goal was to shed 
light upon the impact of scaffold’s matrix conductivity on the maturation and excitability of the 
engineered cardiac tissue constructs. 
4.2. Experimental Methods 
4.2.1. Materials 
HAuCl4, NaBH4, CTAB, AgNO3, L-ascorbic acid, gelatin, methacrylic anhydride, TMSPMA, 
and the photoinitiator were purchased from Sigma Aldrich and used without any modifications. 
The 80 nm silica nanoparticles (SNPs) with the specific surface area of 30-40 m2/g and skeletal 
density of 2.1-2.2 g/cm3 were purchased form General Engineering and Research (San Diego, 
USA). DIW (18 MΩ) was used for all the synthesis and fabrication processes.  
4.2.2. Fabrication and characterization of pure, SNP- and GNR-embedded gelatin 
hydrogel constructs 
GelMA hydrogel and GNRs were synthesized based on the protocols explained in chapter 
2, section 2.2. (Navaei, 2016a; Saini, 2015). To fabricate the hydrogel constructs, first, a clear 
solution of GelMA (5% and 20% wt/v) in 0.5% (wt/v) photoinitiator in DPBS was prepared. Next, 
GNRs (1.5 mg/mL) and SNPs (9.69 mg/mL) were mixed with GelMA prepolymer solution (5% 
wt/v) and sonicated (bath) for 1 hr to create homogenous colloid solutions. The selected 
concentration of SNPs provided approximately similar number of nanoparticles (1.36 × 1013 
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particles/mL) as 1.5 mg/mL GNRs concentration. SNPs were ultrasonicated (on ice) in DIW for 2 
hr prior to mixing with GelMA prepolymer solution to obtain a homogenously dispersed colloid. 
Afterwards, 150 μm thick GelMA (5%), GelMA-SNP and GelMA-GNR hydrogel constructs were 
fabricated by UV photo-crosslinking for approximately 6, 10, and 30 sec exposure time, 
respectively. GelMA (20%) samples were prepared using similar method with 10 sec UV 
exposure time. Electrical conductivity and mechanical stiffness of the fabricated hydrogel 
constructs were measured using AFM and LCR meter based on the established protocols 
described in chapter 2, section 2.2. (Navaei, 2016a).  
4.2.3. CMs isolation and culture of the cardiac tissue constructs 
All the hydrogel constructs were sterilized by washing two times (10 min intervals) in 
antibiotic solution (1% penicillin/streptomycin in DPBS). Samples were then washed twice using 
culture media prior to cell seeding. CMs were isolated from ventricular region of 2-day old 
neonatal rats based on the previously established protocols (Saini, 2015). Briefly, hearts were 
extracted from neonatal rats and cut in small (1-2 mm3) pieces. The cut tissues were then treated 
by Trypsin overnight and followed by serial collagen digestions. The isolated cardiac cells were 
incubated for 1 hr at 37 oC to allow the separation of CMs and CFs. Cardiac tissue constructs 
were fabricated by seeding CMs (7.5 × 105/construct) for 1 day and cultured for 7 days in an 
incubator at 37 oC and 5% CO2. The culture media, containing DMEM supplemented with 10% 
FBS, 1% glutamine, and 1% penicillin/streptomycin, were exchanged every other day. 
4.2.4. Characterization of CMs retention and expression of cardiac markers 
The retention (n=6) of seeded CMs was evaluated thorough measuring the area 
percentage of hydrogel constructs covered by cells on day 1. Samples were washed two times 
with pre-warmed culture media to eliminate the loosely adhered cells prior to the phase-contrast 
imaging. To evaluate cardiac maturation, hydrogel tissue constructs were immunostained on day 
7 of culture for Cx43 electrical gap junctions as well as contractile proteins including SAC and 
cTnI. Specifically, tissue constructs were first fixed using 4% PFA (20 min), then permeabilized 
with 0.1% Triton X-100 (10 min) and finally blocked by 10% goat serum (1 hr) at room 
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temperature. Afterwards, tissue constructs were incubated with primary antibodies for SAC 
(Sigma Aldrich, USA), cTnI and Cx43 (Abcam, USA) overnight followed by fluorescence staining 
using secondary antibodies for 1-2 hr at room temperature (Life Technologies, USA). The 
captured immunostained images (Zeiss ObzerverZ1, USA) were analyzed using NIH ImageJ for 
measuring the level of protein expression (n>3). Specifically, the area of fluorescence signal 
(μm2) were calculated for each protein of interest and normalized by dividing to the total number 
of nuclei.  
4.2.5. External electrical simulation and excitability testing 
A custom-made field stimulation chamber was used to apply external electrical stimuli to 
the hydrogel tissue constructs as previously described (Navaei, 2016a; Tandon, 2009). Tissue 
constructs on day 7 of culture were characterized for the excitation voltage threshold, defined as 
the minimum voltage potential to induce synchronous contractions, at different frequencies (0.5, 
1, 2, 3, 4 and 5 Hz). Specifically, samples were placed in the stimulation chamber and the voltage 
potential was increased step-wise by 0.2 V until synchronous contractions of CMs were evident. 
For the heptanol treatment experiment, tissue constructs were incubated (37 oC) with 2 and 3 mM 
heptanol, as a gap junction uncoupler, for 20 min and the excitation voltage threshold was 
measured at 0.5, 1, 2 and 3 Hz. In addition, the beating stopping time, defined as the total time of 
spontaneous contractions (sporadic and synchronous) of CMs after addition of heptanol (2 and 3 
mM), was determined by constant monitoring of tissue constructs. All the measurements were 
performed at 37 oC and pH was maintained at approximately 7 by adding 10 mM HEPES buffer to 
the cell culture medium. A custom-written Matlab code (SB Kim, 2011) was used for extracting 
the beating signals form the recorded videos. 
4.2.6. Statistical Analysis 
All the collected data were graphed using GraphPad Prism software. The statistical 
analysis was performed based on student t-test, one-way and two-way ANOVA methods. The p 
value less than 0.05 was considered as the statistical significance. 
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4.3. Results and Discussions 
4.3.1. Development of hydrogels with specific matrix characteristics  
As it was shown in chapter 2 (Section 2.3.1.), incorporation of GNRs within GelMA 
hydrogel resulted in the enhancement of mechanical stiffness (higher Young’s modulus, Figure 
2.3F.), electrical conductivity (lower impedance, Figure 2.3A.) and generation of nano-scale 
surface topographies (Figure 2.2B.).  
In this study, pure GelMA (5%) hydrogel was selected as the control group with relatively 
low mechanical stiffness (i.e. soft matrix), low electrical conductivity and without nano-scale 
surface topographies. GelMA (5%) hydrogel embedded with 1.5 mg/mL GNRs was used as the 
hydrogel candidate (GelMA-GNR) featuring high mechanical stiffness, enhanced electrical 
conductivity and with nano-scale surface topographies. In addition, SNPs (Figure 4.1A.) 
embedded within GelMA (5%) matrix provided non-conductive (Figure 4.1C.) and relatively soft 
(Figure 4.1D.) hydrogels, however with presence of nano-scale surface topographies (Chen, 
2003; Gaharwar Akhilesh, 2012; Khelifa, 2013). The 80 nm (diameter) SNPs were used to nearly 
recapitulate the morphology and size of the synthesized GNRs (Figure 4.1B.) with ~60 nm length 
and ~20 nm width. Furthermore, the concentration of SNPs was selected as 9.69 mg/mL to 
provide approximately similar number of nanoparticles (1.36 × 1013 particles per mL) within the 
hydrogel matrix in comparison with GelMA-GNR (1.5 mg/mL). Lastly, pure GelMA with 20% (v/v) 
prepolymer concentration was prepared as the hydrogel group with similar mechanical stiffness 
(Figure 4.1D.) to GelMA-GNR matrix, while non-conductive (Figure 4.1C.) and without the 
presence of nano-scale surface features. 
Therefore, with the selection of proposed hydrogel candidates, we were able to modulate 
three different matrix properties, namely stiffness, electrical conductivity and nano-scale 
topography. All the hydrogel groups including GelMA (5%), GelMA (20%), GelMA-SNP and 
GelMA-GNR were fabricated through UV photocrosslinking on TMSPMA-coated glass slides and 
were further used for developing cardiac tissue constructs. 
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Figure 4.1. A) SEM images of SNPs (GEANDR-Co., 2018) and B) TEM images of GNRs. C) 
Impedance and D) Young’s moduli values of all fabricated hydrogel constructs. (*p-value < 0.05). 
4.3.2. Impact of matrix characteristics on CMs retention and cardiac maturation 
Figure 4.2. displays the phase-contrast images and measured retention of CMs on the 
hydrogel constructs on day 1. The seeded CMs demonstrated a sparse and agglomerated 
adhesion patterns on GelMA (5%), while, more compact and uniform adhesion patterns were 
observed for CMs on GelMA (20%), GelMA-SNP and GelMA-GNR hydrogels. Quantification of 
cell retention (Figure 4.2B.) demonstrated that CMs covered approximately 30.9% of GelMA 
(20%), 68.8% of GelMA-SNP and 73.6% of GelMA-GNR hydrogels, which all were significantly 
higher than 14.2% cell retention on GelMA (5%). Overall, an increasing trend of cell retention was 
seen by enhancing the stiffness and nano-scale surface topographies within the GelMA matrix. 
However, GelMA-SNP and GelMA-GNR hydrogels promoted significantly higher cell adhesion 
affinity as compared to GelMA (20%). These findings indicated that stiffness and nano-scale 
surface topographies, via the incorporation of nanomaterials (SNPs or GNRs), has synergistic 
influence on higher cell adhesion affinity. Consistent with previous studies, hydrogels matrices 
with high stiffness and/or incorporated with nanomaterials, such as SNPs (Gaharwar, 2013; 
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Gaharwar Akhilesh, 2012), have also shown to promote cellular adhesion and retention (Bhana, 
2010; Deok-Ho, 2005; Ren, 2017). The induced cell adhesion affinity is attributed to the 
enhanced integrin expression and mechanosensitive kinases including FAK, MAPK, ERK, and 
AKT (Young, 2014). Furthermore, nano-scale topographies formed by incorporation of 
nanomaterials within the macroporous matrix of hydrogel, increase surface area and protein 
adsorption and induce focal adhesion points, leading to overall improved cell adhesion affinity 
(Dalby, 2007; Gaharwar Akhilesh, 2012). In this regard, CMs retention on electrically conductive 
GelMA-GNR hydrogel was similar to non-conductive GelMA-SNP, demonstrating the negligible 
impact of matrix electrical conductivity on the cell adhesion affinity within cell-seeded nano-
engineered matrices.  
 
Figure 4.2. A) Phase-contrast images of CMs on the hydrogel constructs on day 1 showing the 
influence of the incorporated SNPs and GNRs on B) the CMs retention. (*p-value < 0.05). 
Figure 4.3A. demonstrates the immunostained images of cardiac-specific proteins 
including SAC, cTnI as well as Cx43 gap junctions. A clear formation of striated sarcomere 
structures (SAC staining) were evident on GelMA (20%), GelMA-SNP and GelMA-GNR tissue 
constructs compared to the disoriented SAC expression on pure GelMA (5%) hydrogel. In 
addition, SAC stained images exhibited more elongated and uniaxially aligned striated 
sarcomeres on GelMA (20%), SNP- and GNR-embedded tissue constructs in contrast with the 
random and round morphology (white arrows) on GelMA (5%). The expression of cTnI also 
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followed similar pattern as SAC. GelMA (20%), GelMA-SNP and GelMA-GNR cardiac tissues 
illustrated extended and abundant expression of cTnI, while, scattered patterns were observed 
within GelMA (5%) matrix. Cx43 gap junctions (red punctuated stains) were present among CMs 
on all hydrogel constructs. However, less homogeneous distribution was observed on GelMA 
(5%) as compared to the other hydrogel groups.  
 
Figure 4.3. A) The immunostained images and B) measured fluorescence area of SAC, Cx43 and 
cTnI expressions on day 7 illustrating the enhanced cardiac maturation by the improving the 
hydrogel matrix mechanical, topographical and electrical characteristics. White arrow heads are 
pointing to the round CMs. (*p-value < 0.05). 
In addition to representative immunostained images, the quantified fluorescent area 
(Figure 4.3B-D.) also confirmed significantly higher expressions of cardiac specific markers (SAC, 
cTnI and Cx43) on GelMA (20%), GelMA-SNP and GelMA-GNR hydrogels in comparison to 
GelMA (5%). In addition, we did not find significant differences, in terms of protein expression, 
between electrically conductivity GelMA-GNR and non-conductive GelMA-SNP hydrogels. These 
80 
 
findings demonstrate that enhanced cardiac maturation of the electrically conductive GelMA-GNR 
tissue constructs (Figure 4.3.) is mainly associated with improved mechanical and topographical 
characteristics of hydrogel matrix (Boothe, 2016; Forte, 2012; Jacot, 2008; Rodriguez, 2011), 
while electrical conductivity of the matrix may not solely play a role in maturity of the engineered 
cardiac tissues. 
4.3.3. Influence of matrix characteristics on contractility and electrical excitability of 
cardiac tissue constructs  
Figure 4.4. shows the excitation voltage thresholds and representative extracted beating 
signals for GelMA (5%), GelMA (20%), GelMA-SNP and GelMA-GNR tissue constructs under 
external electrical field stimulation, respectively. As can be seen, all the hydrogel groups were 
able to fully accommodate electrical stimulation frequencies up to 2 Hz. In this range, 5% GelMA 
cardiac tissues exhibited highest excitation voltage threshold (~8.4 V) as compared to 20% 
GelMA (~4.3 V), GelMA-SNP (~3.8 V) and GelMA-GNR (~3.7 V). In addition, our results did not 
show any significant differences for excitation thresholds across GelMA (20%), GelMA-SNP and 
GelMA-GNR groups. By increasing the frequency to 3 and 4 Hz, 5% GelMA and 20% GelMA 
cardiac tissues were no longer able to follow the stimulation regime and the tissue contractions 
became chaotic (Figure 4.4A-B.). On the other hand, GelMA-SNP and GelMA-GNR hydrogel 
tissue constructs still demonstrated contractile behavior consistent with the induced stimulation 
frequencies at 3 and 4 Hz (Figure 4.4C-D.). Lastly, none of the hydrogel groups could fully 
accommodate electrical stimulations with frequencies larger than 4 Hz (data not shown).  
Figure 4.5. illustrates the excitation thresholds at 0.5, 1 and 2 Hz frequencies in presence 
of heptanol (gap junction uncoupler). Heptanol has been widely used to impair electrical gap 
junctions, such as Cx43, leading to reduced conduction velocity and unsynchronized (sporadic) 
contractions in CMs (Gizurarson, 2012; Takens-Kwak, 1992; G. Tse, 2016). We utilized heptanol 
to diminish the intrinsic electrical coupling within CMs through Cx43 gap junctions, to further 
elucidate the potential compensatory impact of matrix conductivity on excitability of engineered 
cardiac tissue constructs. 
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Figure 4.4. A-D) The extracted CMs beating signals in response to electrical stimulation at 0.5-4 
Hz frequencies on day 7. E) The excitation voltage thresholds of pure GelMA and nanomaterial-
embedded tissue constructs following the applied electrical stimuli. (*p-value < 0.05). 
After 20 min exposure to 2 mM heptanol, GelMA (5%) tissue constructs did not follow the 
electrical stimulation at any of the applied frequencies (Figure 4.5A. and 4.5E.). Cardiac tissues 
cultured on GelMA (20%) hydrogels only responded to stimuli with 0.5 and 1 Hz upon heptanol 
treatment and were not able to follow 2 Hz stimuli. On the other hand, both GelMA-SNP and 
GelMA-GNR tissue constructs fully accommodated up to 2 Hz electrical stimuli even in the 
presence of heptanol. None of the engineered cardiac tissues were able to generate contractions 
upon electrical stimulation with frequencies higher than 2 Hz (data not shown). When higher 
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concentration of heptanol (3 mM) was tested, we were not able to induce contractions on any of 
the tissue contracts at any frequencies with voltage up to 10 V.  
 
Figure 4.5. A-D) The extracted beating signals and E) excitation voltage thresholds of the 
electrically stimulated cardiac tissues upon 20 min treatment with heptanol (2 mM) on day 7, 
showing the impact of embedded SNPs and GNRs on the enhanced excitability of engineered 
cardiac tissue constructs. 
Our findings (Figure 4.4. and 4.5.) indicated that nanomaterials (SNPs and GNRs)-
embedded GelMA hydrogels induced enhanced tissue maturity, electrical excitability (lower 
excitation threshold) and contractility (higher stimulation frequency) of engineered cardiac tissues. 
Enhanced tissue maturation can be attributed to the impact of increased matrix stiffness and 
nano-scale topographies due to the presence of SNPs or GNRs. Finally, both conductive (GelMA-
GNR) and non-conductive (GelMA-SNP) nanocomposite tissue constructs exhibited similar 
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excitation thresholds at all applied frequencies in both coupled and uncoupled gap junctions 
(Figure 4.4E. and 4.5E.). Our findings demonstrate that the stiffness and nano-scale topography 
of GelMA hydrogel matrix significantly improved excitability and contractility of the engineered 
cardiac tissues, and impact of matrix electrical conductivity was negligible.  
In our study, we developed conductive (GelMA-GNR) and non-conductive (GelMA-SNP) 
hydrogels to investigate the impact of enhanced matrix conductivity, stiffness and nano-scale 
topography, due to the incorporation of GNRs and SNPs, on excitation threshold of cardiac 
tissues. We also evaluated excitation threshold, while Cx43 gap junctions were uncoupled using 
heptanol, to further investigate the compensatory influence of scaffold conductivity for maintaining 
the electrical excitability of cardiac tissues. Despite the significance and promising outcomes, our 
study was focused only on the tissue-level electrical excitability of engineered cardiac constructs 
via utilizing an electric field stimulation chamber to measure excitation threshold. However, there 
are other important factors which may induce substantial impact on excitability and electrical 
coupling of CMs, including membrane depolarization threshold and action potential propagation 
velocity, which can be the subjects of further studies. In addition, utilization of other 
electrophysiology techniques, such as voltage sensitive fluorescent dyes and point electrical 
stimulation using bipolar microelectrodes, can further provide more insight on the influence of 
scaffold conductivity on the electrophysiological properties (e.g. conduction velocity) of 
engineered cardiac tissues. In addition, we have utilized NRVCMs isolated form 2-day old rats for 
our studies, which are able to transit from neonatal stage to mature adult phenotype 
(Belostotskaya, 2014). Therefore, it is speculated that the use of other cell types, such as iPSC- 
and ESC-derived CMs, with typically insufficient cardiac maturation capability (Veerman, 2015) 
could give rise to different outcomes regarding the electrical excitability and electrophysiological 
properties of the engineered tissues. 
4.4. Conclusion 
In this study, our goal was to dissect the role of mechanical stiffness and nano-scale 
topography of scaffolding hydrogels on the maturation and electrical excitability of engineered 
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cardiac tissues, regardless of electrical conductivity. We designed and fabricated four different 
hydrogel groups including 5% GelMA, 20% GelMA (mechanically stiffness), GelMA-SNP (non-
conductive with nano-topographies) and GelMA-GNR (conductive with nano-topographies). Our 
results demonstrated that GelMA-SNP and GelMA-GNR hydrogels significantly improved CMs 
adhesion affinity as compared to pure GelMA (5% and 20%), highlighting the influence of nano-
scale topography on cellular adhesion and retention. Furthermore, cardiac specific protein 
expressions revealed that the increased stiffness alone promote maturation of engineered cardiac 
tissues, however, such increase was significantly higher in the presence of nano-scale 
topographies within the hydrogel matrix. In terms of electrical excitability with and without 
heptanol (gap junction uncoupler), the impact of increased stiffness and nano-scale topography, 
induced by incorporation of SNPs and GNRs, significantly lowered the required excitation voltage 
threshold (i.e. higher excitability). GelMA-SNP and GelMA-GNR cardiac tissues were able to 
accommodate external electrical stimuli at higher frequencies in both coupled and uncoupled gap 
junction conditions. Most importantly, no significant differences regarding cell retention, cardiac 
maturation and electrical excitability were observed between conductive GelMA-GNR and non-
conductive GelMA-SNP tissue constructs. These findings indicate the prominent impact of 
hydrogel matrix mechanical stiffness and nano-scale surface topography on the overall tissue 
function, regardless of electrical conductivity. Further electrophysiology studies using patch 
clamping is required to shed more light on the influence of scaffold conductivity on CMs electrical 
coupling and conduction velocity.  
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CHAPTER 5 
ENGINEERING OF SCAFFOLD-FREE CARDIAC MICROTISSUES EMBEDDED WITH 
FUNCTIONALIZED GOLD NANOWIRES 
5.1. Introduction 
Transplantation of autologous cells (e.g. MSC and skeletal myoblasts) within the infarcted 
myocardium has offered promising outcomes to diminish the adverse pathophysiological events 
post-MI and to prevent heart failure (Fisher, 2015; Passier, 2008; Sanganalmath, 2013). Cell-
based therapies (i.e. cellular cardiomyoplasty), traditionally consisting of a single cell suspension, 
are delivered within the ischemic myocardium often based on using a minimally invasive 
procedures, such as intracoronary catheterization (Campbell, 2012; Suzuki, 2014). To date, 
numerous studies have demonstrated that cardiac cell-based therapies result in activating 
endogenous reparative mechanisms (Avolio, 2015; Loffredo, 2011), neovascularization (S-W 
Kim, 2014), reduced scar size (Amado, 2005), limited ventricular remodeling (Chung, 2015), and 
enhanced cardiac output (Amado, 2005). Despite promising outcomes, the regenerative efficacy 
of cell-based therapies has shown to be significantly limited (Gyöngyösi, 2015), primarily due to 
the poor survival, retention and engraftment with the host as well as cardiogenic differentiation 
and maturation of injected cells within the injured myocardium (Bartolucci, 2017; L Li, 2016a; 
Yang, 2014). These drawbacks are mainly associated with low cell adhesion affinity of ischemic 
myocardium due to innate hypoxia and inflammation, as well as high concentrations of ROS 
(Angelos, 2006; Song, 2010). To address these limitations, numerous attempts have utilized 3D 
scaffold-free cardiac microtissues or cellular aggregates instead of single cells injection strategy 
(Doan C Nguyen, 2014). The 3D structure of scaffold-free microtissues induces a physiologically 
relevant microenvironment (Atmanli, 2016; Kofron Celinda, 2017) and leads to enhanced cell-cell 
electrical (e.g. Cx43) and mechanical (e.g. N-cadherin) coupling (Chang, 2009; EJ Lee, 2012). In 
addition, cells in the 3D scaffold-free microtissue secrete endogenous ECM proteins, promoting 
the expression of integrins and minimizing anoikis (W-Y Lee, 2011).  
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In recent years, the use of electrically conductive nanomaterials, including CNTs, rGONFs 
and SiNWs, in conjunction with scaffold-free microtissues has led to substantial improvements in 
viability, proliferation, maturation and differentiation of primary and stem cell-derived CMs 
(Martinelli, 2013a; Park, 2015; Richards, 2016). The specific physicochemical characteristics and 
electrical conductivity of these nanomaterials enable promoting specific cellular functionalities. 
For example, rGONFs are a type of carbon-based nanomaterials featuring high physicochemical 
reactivity, provided by the abundance of surface functional groups (e.g. hydroxyl and carboxyl) 
(Dreyer, 2010). This unique physicochemical property was utilized by Park (Park, 2015) to 
promote cell-ECM interactions in MSC-rGONF microtissues via adsorption of ECM proteins on 
rGONF’s surface. Incorporation of rGONFs led to the formation and maturation of MSC-based 
microtissues, which were resistant to the deleterious impact of hypoxia and ROS on retention and 
viability of injected cells. In addition, electrical conductivity of rGONFs (Dreyer, 2010; Gómez-
Navarro, 2007) increased the expression of Cx43 gap junctions in MSCs through activation of 
FAK pathway and upregulation of VEGF expression (Pimentel, 2002), leading to enhanced 
coupling of injected microtissues with the host myocardium (Sarah Fernandes, 2009; You, 2011). 
SiNWs belong to another class of electrically conductive nanomaterials that have been 
recently employed for engineering scaffold-free microtissues made of iPSC-derived CMs. In a 
series of studies by Ying Mei’s group (Richards, 2016; Y Tan, 2017; Y Tan, 2015), it was shown 
that SiNWs were able to induce significant cardiogenic maturation of hiPSC-derived CMs. 
Specifically, upregulated expressions of cardiac-specific markers, including SAC, cTnI, Cx43, and 
N-cadherin, as well as enhanced assembly and organization of striated sarcomeres were notably 
evident in the presence of SiNWs. Furthermore, the CM-SiNW microtissues exhibited higher 
contraction amplitude (i.e. fractional shortening) as well as faster cytoplasmic release of Ca2+ 
ions, indicating the mature phenotype and electrophysiology of microtissues (Pointon, 2015; MC 
Ribeiro, 2015b). To elucidate the impact of electrical conductivity of SiNWs (doped) on the 
cardiac phenotype and physiology of iPSC-derived microtissues, non-conductive (undoped) 
SiNWs were used (Y Tan, 2017). Interestingly, enhanced expressions of SAC and Cx43, and 
mature handling of cytoplasmic Ca2+ transients (i.e. rapid release with high amplitude) of 
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microtissues were only observed in the presence of electrically conductive (doped) SiNWs. These 
findings indicated that the electrical conductivity of SiNWs played a key role in maturation of 
hiPSC-derived CMs. 
Despite the significance of previously mentioned studies, the detailed impact of conductive 
nanomaterials on the electrophysiology of CMs were mostly neglected. Specifically, none one of 
these studies investigated the influence of electrically conductive nanomaterials on action 
potential propagation (i.e. conduction velocity) within CM microtissues. Based on our foundational 
work in the use of GNMs for cardiac tissue engineering (Navaei, 2017; Navaei, 2016a), in this 
study we aimed to specifically assess the role of conductive nanomaterials on electrophysiology 
of CMs using microelectrode array. Our further goal was to evaluate cardiac phenotypic and 
functional maturation in sole presence of GNMs and in absence of scaffolding biomaterials (i.e. 
scaffold-free microtissues). We synthesized GNWs and conjugated them with RGD peptide to 
increase the adhesion affinity of nanomaterials to the cells (Choi, 2011). Our working hypothesis 
was centered on that scaffold-free cardiac microtissues incorporated with biocompatible GNWs, 
conjugated with RGD, would exhibit enhanced physiological response, including electrical signal 
propagation and contraction amplitude. We further investigated the influence of conductive GNWs 
on phenotypic maturation (expression level of SAC, cTnI, and Cx43 proteins) of the cells. 
5.2. Experimental Methods 
5.2.1. Materials 
Carboxymethyl-PEG-thiol (COOH-PEG-SH, MW 3500) was purchased from Laysan Bio 
(USA). Cyclo (Arg-Gly-Asp-D-Phe-Lys) (cRGD) was purchased from Peptides International 
(USA). N-hydroxysulfosuccinimide (Sulfo-NHS) was purchased from ThermoFisher. HAuCl4 
(>99.9%), NaBH4 (>99%), L-Ascorbic acid (>98%), nitric acid (HNO3) (70%), N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC), and CTAB (>99%) were 
purchased from Sigma Aldrich (USA). DIW (18 MΩ) was used for all synthesis processes.  
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5.2.2. Synthesis of CTAB-capped GNWs  
GNWs were synthesized based on the seed-mediated growth method (Y-N Wang, 2013). 
Seed solution containing GNPs is prepared by mixing 2 mL of HAuCl4 (0.5 mM in DIW) and 2 mL 
of CTAB (0.2 M in DIW) solutions. The GNPs were then synthesized by addition of 180 μL of ice-
cold freshly-made NaBH4 (20 mM in DIW) and mixing vigorously for 2-5 min. To allow complete 
decomposition of NaBH4, the seed solution was kept at 29 oC for at least 2 hours before further 
use. Next, a 30 mL growth solution was prepared by mixing 29.475 μL CTAB (0.1 M in DIW) and 
525 μL HAuCl4 (10 mM in DIW).  
 
Figure 5.1. Schematic drawing illustrating the seed-mediated growth procedure of GNW-CTAB 
synthesis. The depicted colors represent actual color change of the solutions during the 
synthesis. 
The growth solution was divided into three separate tubes (A, B, and C) containing 2.5 mL 
(tube A), 2.5 mL (tube B), and 25 mL (tube C) of the growth solution (Figure 5.1.). 5 mL of HNO3 
(0.5 M in DIW) was introduced to the tube C only and mixed gently. Then, 10, 10, and 100 µL 
aliquots of ascorbic acid solution (0.1 M in DIW) were added into the tube A, B, and C, 
respectively. All tubes were gently mixed to which made the solutions colorless. To initiate the 
sequential growth process, 200 µL of the seed solution was transferred to the tube A and mixed 
gently for 10 s. Afterwards, 200 µL of the “tube A-seed mixture” was added to the tube B and 
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gently mixed for 10 s. Finally, 200 µL of the “tube B-tube A mixture” was introduced to tube C and 
gently swirled for 5 s. The tube C was kept undisturbed at 30 oC for 4-5 days to allow completion 
of the growth synthesis. The formed pellet at the bottom of the tube C, which contained mostly 
GNWs, was harvested by carefully discarding the supernatant and dispersing the pellet in DIW for 
storage.  
5.2.3. PEGylation, RGD conjugation and material characterization of GNWs 
PEGylation of CTAB-capped GNWs was performed using a custom-designed 2-step 
ethanol-assisted exchange process (Kinnear, 2013; Z Zhang, 2014). The exchange procedure is 
schematically illustrated in Figure 5.2. First, CTAB-capped GNWs (~300 μg) were centrifuged 
(2000 rpm, 20 min) two times and re-dispersed in a 1 mM CTAB solution to reduce concentration 
of CTAB to near critical micelle formation concentration (CMC in water for CTAB is ~1 mM) 
(Moulik, 1996). After second centrifugation step, supernatant was discarded and 400 µL of Tris 
buffer (50 mM, pH ~3) was added drop-wise to the GNWs pellet. To initiate PEGylation process, 
30 µL of COOH-PEG-SH (1 mM in Tris buffer) was added to GNW-Tris mixture while vortexing 
and kept agitated for 1 min. Final mixture remained undisturbed for 24 hr at room temperature. 
The mixture was then centrifuged once (4000 rpm, 30-35 min) to remove unreacted COOH-PEG-
SH and free CTAB molecules.  
To further improve CTAB-PEG exchange, an additional PEGylation step was performed 
using 20% (v/v) ethanol solution. Then, partially PEGylated GNWs were re-dispersed in 20% 
ethanol followed by addition of 30 µL of COOH-PEG-SH (1 mM in 20% ethanol) to the mixture 
under gentle vortexing. Mixture was kept undisturbed at room temperature for 24 hours. Two-step 
PEGylated GNWs (pGNW-COOH) were harvested by centrifugation at 4500 rpm for 30-35 min, 
and then dispersion in 300 µL DPBS. In order to conjugate RGD peptides on PEGylated GNWs 
with free COOH groups (pGNW-COOH), EDC/NHS reaction chemistry was employed (Choi, 
2011). Briefly, pGNW-COOH were activated by adding 2.5 mg of EDC and 5.5 mg of Sulfo-NHS 
consecutively and thoroughly mixed for 5 min at ambient temperature. Afterwards, 200 µL of 
RGD peptide (1 mg/mL in DPBS) was added to activated pGNW-COOH and the mixture was kept 
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in 4 oC for 6-8 hours. GNWs with conjugated RGD peptide (pGNW-RGD) were purified by 
centrifugations in DPBS (4000 rpm, 30-35 min) at 4 oC, and were used immediately for the 
experiments. 
 
Figure 5.2. Schematic drawing depicting the 2-step ethanol-assisted PEGylation and RGD 
conjugation of GNWs. 
Nano-scale morphology and size measurement of the synthesized GNWs were assessed 
using TEM (Philips CM200-FEG, USA) operating at an accelerating voltage of 200 kV. In 
addition, dynamic light scattering (DLS) measurements were carried out using DelsaNano 
Zetasizer (Beckman Coulter, USA) at 25 oC to evaluate surface charge of nanowires before and 
after PEGylation process. Furthermore, a Micro-Raman Spectrometer (Goldwater Materials 
Science Facility, AZ, USA) was utilized to investigate the RGD conjugation on GNWs. The 
spectroscopy characterization was performed using a 785 nm laser operating at 4-5 mW power 3 
times for 10-second-long acquisitions.   
5.2.4. Cell isolation and 2D in vitro cytotoxicity assays 
CMs from 2-day old rats were isolated and purified using previously established protocol 
(Navaei, 2017; Navaei, 2016a; Saini, 2015). Cells were cultured in a humidified incubator with 5% 
CO2 at 37 oC. The culture medium was composed of DMEM (Gibco, USA), 10% (v/v) FBS (Gibco, 
USA), L-Glutamine (1%) (Gibco, USA), and 100 units/mL of penicillin-streptomycin. To evaluate 
the impact of CTAB removal and RGD conjugation on viability and metabolic activity of CMs, 
Live/Dead and Alamar Blue assays were used. CMs were cultured (45-52 × 103 per well) with 
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GNW-CTAB, pGNW-COOH and pGNW-RGD (1, 10 and 50 μg/mL) for 48 hr. Live/Dead 
fluorescent images (n=4) were taken using an inverted microscope (Zeiss Observer Z1, 
Germany) and Alamar Blue (Invitrogen, USA) signals (n=3) were recorded by a plate reader.  
5.2.5. Engineering of scaffold-free cardiac microtissues 
Scaffold-free cardiac microtissues were developed by culturing CMs and GNWs (pGNW-
COOH and pGNW-RGD) within agarose concave microwell arrays (Desroches, 2012). First, high 
purity agarose (VWR Life Science, USA) was dissolved completely (2% wt/v) in NaCl solution 
(0.9% wt/v in DIW) using a microwave. Next, 330 μL of agarose solution was injected into a 
master mold (Microtissue Inc., USA) containing 35 concave recesses (800 μm in diameter and 
800 μm depth) and was placed on a cold block until agarose hydrogel was solidified. Fabricated 
agarose microwell arrays were then detached gently from the master mold and washed twice (10 
min intervals) using culture medium prior to cell loading. In the next step, a 75 μL aliquot of CMs 
(~0.7 × 106 cells/mL) and GNWs (0, 5, and 10 μg/mL) mixture was loaded into the microwells and 
kept in incubator for 10 min to allow the precipitation of cells. The experimental groups were 
defined as CM only, CMs with 5 and 10 μg/mL of either pGNW-COOH (CM-COOH5 and CM-
COOH10) or pGNW-RGD (CM-RGD5 and CM-RGD10). Afterwards, 600 μL of fresh culture 
medium was added gently to the surrounding of the microwell array mold and exchanged every 
other day. The microtissues were cultured for 7 days. 
5.2.6. Immunocytochemistry (ICC) and western blot (WB) of the microtissues 
The microtissues were harvested after 6 days of culture to evaluate the phenotypic 
characteristics and expression levels of cardiac-specific markers (SAC, Cx43, and cTnI). ICC 
technique was utilized to analyze the phenotype of the cardiac markers. Specifically, harvested 
cardiac microtissues were fixed in PF (4%) for 30 min and then treated with 30% (wt/v) sucrose 
solution as cryoprotecting agent for 48 hr. Afterwards, microtissues were embedded in optimal 
cutting temperature compound (OCT) and placed on a pre-cooled aluminum block with liquid 
nitrogen. Frozen OCT-embedded microtissues were sectioned into 7 μm thick slices using 
cryotome (Leica). The ICC process of freshly cut microtissue slices started with washes 3 times 
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of DPBS (5 min intervals) and permeabilization with 0.1% Triton X-100 (5 min). Samples were 
then blocked in 10% goat serum (Gibco, USA) for 1 hour and exposed to the primary antibodies 
for SAC (Sigma Aldrich, USA) and Cx43 (Abcam, USA) overnight at 4 oC. Next, samples were 
washed 5 times using DPBS (5 min intervals) and stained with secondary antibodies (Life 
Technologies, USA) for 1-3 hr. Lastly, immunostained microtissue slices were stained for nuclei 
with DAPI and preserved in antifade solution (VECTASHIELD, USA) prior to imaging. A Zeiss 
Observer Z1 microscope equipped with Apotome2 (Zeiss, Germany) was used for acquiring 
fluorescent images.  
The WB technique was used for quantification of the expression level of cardiac-specific 
markers. Cardiac microtissues were collected and digested in lysis buffer (150 mM NaCl, 1% 
Triton X-100 and 50 mM Tris) for 30-40 min at 4 oC. The cell lysate was centrifuged at 16,000 × g 
for 20 min (4 oC) and the supernatant containing extracted proteins was collected. The extracted 
proteins ran through a Novex Wedge Well 10-20% Tris-Glycine Gel (Invitrogen, USA) for 2 hr to 
separate the proteins. After the completion of gel electrophoresis, the proteins were transferred to 
a cellulose membrane (100 V for 50 min). The transferred blots were then washed two times with 
PBS, blocked by 5% (v/v) BSA for 2 hr, and incubated with primary antibodies for SAC (Sigma 
Aldrich, USA) and Cx43 (Abcam, USA) overnight at 4 oC. Afterwards, the blots were stained with 
secondary antibodies (Life Technologies, USA) fro 1 hr and then scanned and analyzed using a 
LI-COR Odyssey Imaging System. GAPDH and β-actin primary antibodies were used as the 
housekeeping proteins for normalization and calculation of the relative expression results.  
5.2.7. External electrical field stimulation and contraction amplitude of the 
microtissues 
Cardiac microtissues were externally stimulated by an electric field using a custom-made 
chamber (Tandon, 2009). Excitation voltage threshold was defined as minimum required voltage 
to induce contractions in microtissues in suspension. Electrical pulses with 5 ms durations at 1 
and 2 Hz frequencies were generated (BK PRECISION 4052) and the voltage was ramped until 
the suspended microtissues started contracting (n=3). To measure the contraction amplitude (i.e. 
93 
 
fractional shortening), the suspended microtissues were electrically stimulated (10 V, 1 Hz and 5 
ms pulse duration) and simultaneously videos of contractions were recorded. The captured 
videos were analyzed using NIH ImageJ software and the contraction amplitude (n=3) was 
extracted based on the edge-detection method (Bazan, 2009). Contraction amplitudes were 
reported as the percentage of fractional shortening (diameter) of the microtissue in contracted 
and relaxed states.  
5.2.8. Microelectrode array (MEA) electrophysiology of CMs  
A 28-microelectrode array system (BMSEED LLC, USA) was utilized to analyze the impact 
of electrically conductive GNWs on the electrophysiology (Graudejus, 2011; Kang, 2014; Yu, 
2009), specifically the conduction velocity (CV) of CMs. MEAs were consisted of 28 
microelectrodes (90 μm electrode size) with approximately 200 μm spacing (Figure 5.3A. and 
5.3B.), embedded within a PDMS membrane. The MEA was connected to a head-stage board 
(Plexon, USA) equipped with two amplifiers (Intan Technologies, USA). The whole assembly was 
connected to a stimulation/reading controller (Intan Technologies USA). The data acquisition was 
performed using Intan Stimulation/Recording System Software. The recorded data (*.rhs file 
format) was processed and analyzed using Matlab (MathWork, USA) and OriginPro (OriginLab, 
USA).  
Prior to loading cells, MEAs were washed thoroughly with autoclaved DIW and then 
sterilized overnight under UV inside a biological safety cabinet. Next, MEAs were treated with 
oxygen plasma (Harrick Plasma, USA) for 3 min to create a hydrophilic surface and then coated 
with 0.1% (wt/v) gelatin solution for at least 2 hr. The gelatin coating is vital to promote the tight 
adhesion and spreading of CMs on the microelectrodes and enhance the signal to noise ratio. 
After sterilization and gelatin coating of MEAs, a 2 mL CM (0.7 × 106 per mL) suspension 
containing either pGNW-COOH or pGNW-RGD (5 and 10 μg/mL) was seeded on each MEA, and 
extracellular voltage potentials were captured (i.e. field potential or FP). The spontaneous FP 
(Figure 5.3C.) changes are correlated with the action potential triggering and propagation on CMs 
membrane (Halbach, 2003). The conduction velocity among CMs was measured on days 4 and 6 
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of culture. Specifically, the activation times for FP signals were extracted for all the working 
electrodes (impedance less than 1-2 MΩ) and sorted (earliest to latest) using OriginPro software. 
Afterwards, the direction of FP signal (i.e. propagation directions) was determined based on the 
order of the activation times.  
 
Figure 5.3. A) Photograph of MEA well and B) microelectrodes layout. C) A representative FP 
signal reading showing the different components of extracellular field potential induced by cardiac 
action potential.  
The conduction velocity (cm/s) among CMs was calculated by dividing the distance 
between the electrodes to their respective time difference. One minute of electrical activities were 
processed and analyzed for determining the conduction velocity for each condition. To maintain 
pH 7 during the experiment, the culture media were exchanged with the one supplemented with 
HEPES buffer (10 mM) and cells were incubated (37 oC) for at least 30 min prior to recording 
FPs. In the gap junction blocking experiment, several concentrations of heptanol including 0.5, 1, 
2, and 4 mM were tested. Cells were exposed to heptanol (1 and 2 mM in culture medium + 
HEPES) and FP signals were immediately recorded for 20 min. Cells were washed 3 times and 
incubated for at least 1 hr with fresh culture medium plus HEPES to be rescued from heptanol, 
before measuring FP signals for the second heptanol concentration. The CVs for each 
concertation of heptanol were measured upon 10 and 20 min exposure. The percentage of 
reduction in CVs was calculated with respect to the CV of each sample before addition of 
heptanol. For cleaning and reusing purposes, MEAs were washed with sterile DIW 3-5 times, 
then incubated (37 oC) with trypsin (1x) for at least 1 hr. Afterwards, MEAs were washed 3-5 
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times with sterile DIW and treated with 1mg/mL collagenase (type 1) for at least 1 hr in 37 oC. 
MEAs were washed with sterile DIW 3-5 times again and stored in closed containers. 
5.2.9. Statistical analysis  
All data obtained from the experiments was analyzed based on Student’s t-test, one- and 
two-way ANOVA with Tukey post analysis by GraphPad Prism 6. A p-value less than 0.05 was 
measured as statistically significant difference within the groups.  
5.3. Results and Discussion  
5.3.1. Characterization of GNWs PEGylation and RGD conjugation 
GNWs were synthesized using serial consecutive anisotropic growths of the seeds (Figure 
5.1.) (Y-N Wang, 2013). TEM micrographs (Figure 5.4A.) of freshly synthesized GNWs revealed 
the wire-like morphology of the synthesized nanomaterials with ultralong aspect ratio of 
approximately 46. The measured average size of GNWs, based on the TEM images, was 4 ± 1.4 
μm in length and 87 ± 32 μm in diameter. CTAB was used as stabilizer-surfactant agent for 
synthesizing GNWs and preventing agglomeration (Y-N Wang, 2013). However, its cytotoxic 
effect (Alkilany, 2009) requires elimination before direct exposure to CMs. It has been shown that 
GNMs biocompatibility can be significantly improved just by removing the free CTAB molecules 
from the colloid solution through several centrifugations (Alkilany, 2009; Connor, 2005). However, 
there is still a CTAB coating bilayer on the GNWs that can be toxic to the cells at high 
concentrations of the nanomaterials (Kinnear, 2013). In this regard, it is critical to exchange 
CTAB with a biocompatible coating layer, such as thiolated PEG, to complete the removal 
process of CTAB molecules.  
In our work, the concentration of free CTAB in the GNWs colloid solution was reduced by 
two centrifugations. However, the CTAB concentration was kept at near its CMC (~1 mM in 
water) to prevent aggregation of GNWs (Moulik, 1996). This step was substantially important to 
perform a successful PEGylation process with virtually no aggregation of GNWs. In the next step 
(Figure 5.2.), the CTAB coating bilayer on the GNWs was exchanged with SH-PEG-COOH in Tris 
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buffer. Typically, one-step (24 hr) PEGylation processes lead to the removal of a significant 
amount of CTAB coating bilayer (Alkilany, 2009). However, due to the strong interactions 
between CTAB molecules and Au atoms, as well as the packed bilayer structure of CTAB 
coating, the PEGylation process is not complete and CTAB residue may remain on the surface of 
GNWs (Kinnear, 2013). Therefore, a second PEGylation of GNWs was carried out using 20% 
ethanol (Figure 5.2.) to disrupt the formation of the CTAB bilayer and also facilitate the interaction 
of SH-PEG-COOH with the surface of GNWs (Kinnear, 2013). As the DLS measurements 
revealed, zeta potential was +61.5 ± 1.0 mV for GNW-CTAB and -32.9 ± 2.4 mV for pGNW-
COOH. The GNW-CTAB was positively charged due to the CTAB coating (Gole, 2004; X Huang, 
2009). However, after the exchange of CTAB with SH-PEG-COOH, the zeta potential of pGNW-
COOH alternated to a negative value due to the presence of carboxyl groups (-COOH) (Su, 
2017).  
In addition, Raman spectroscopy (Figure 5.4B.) further confirmed substitution of CTAB with 
SH-PEG-COOH via removal of Au-Br band at 189 cm-1 and appearance of Au-S bands at 273 & 
295 cm-1. Furthermore, the vibration of C-O-C band at 845 cm-1 demonstrated the coating of PEG 
on GNWs (Liao, 2005; Schulz, 2016; S Sun, 2014; Z Zhang, 2014). Conjugation of RGD peptides 
on the surface of pGNW-COOH nanomaterials was performed using typical EDC/NHS protocol 
(Choi, 2011). The Raman spectrum of pGNW-RGD (Figure 5.4B.) demonstrated the appearance 
of two amide bands, including amide II at 1555 cm-1 and amide III at 1275 cm-1, consistent with 
previously reported studies (Choi, 2011). The amide bands are the result of covalent interactions 
between carboxyl groups on pGNW-COOH and amine (NH2) groups in cRGD-Phe-Lys peptide 
sequence. In addition, the peak near 1015 cm-1, associated with the benzyl ring of the extra 
Phenylalanine (Phe) in the cRGD peptide sequence, further confirming the successful 
conjugation of RGD on the surface of GNWs (S Sun, 2014).  
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Figure 5.4. A) TEM micro-graph of synthesized GNW-CTAB. B) Raman spectra of GNW-CTAB 
and pGNW-RGD showing the exchange of CTAB (Au-Br) with PEG (Au-S and C-O-C) along with 
the conjugation of RGD (amide II, III, and Phe ring) on GNWs. 
5.3.2. The impact of CTAB removal and RGD conjugation on cytotoxicity of GNWs 
To evaluate the impact of CTAB removal and conjugation of RGD on the cytotoxicity of the 
GNWs, we performed control experiments, where CMs were cultured with 0, 1, 10, and 50 μg/mL 
of GNW-CTAB, pGNW-COOH and pGNW-RGD for 48 hr, and viability and metabolic activity of 
the cells were further assessed. The Live/Dead fluorescent images and quantified viability data 
(Figure 5.5A. and 5.5B.) confirmed that all three types of GNWs did not induce cytotoxicity at 
concentration of 1 μg/mL. However, viability of CMs significantly decreased as a function of 
GNW-CTAB concentration (~60% and ~42% at 10 and 50 μg/mL) in comparison with the pure 
CMs culture (~89%). In contrast, PEGylated and RGD conjugated GNWs did not induce any 
cytotoxic effect on CMs at any concentration. Similar trend was observed in terms of metabolic 
activity of CMs, when cultured with the GNWs. The Alamar Blue signal significantly dropped at 10 
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and 50 μg/mL concentrations of GNW-CTAB, however, no changes were evident for pGNW-
COOH and pGNW-RGD groups compared to the pure CMs culture. These results clearly showed 
the substantial impact of the CTAB removal on improving the biocompatibility of GNWs. In 
addition, no major differences in the CMs viability were observed between PEGylated and RGD 
conjugated GNWs. These findings indicated that CTAB was the major cause of cytotoxicity of the 
GNW-CTAB, consistent with previous studies (Alkilany, 2009; Khlebtsov, 2011). Conjugation of a 
cell adhesive peptide, such as RGD (Rask, 2010; Vacharathit, 2011), did not significantly 
influence the biocompatibility of PEGylated GNWs (pGNW-COOH).  
 
Figure 5.5. A) Live/Dead fluorescent images, B) quantified viability and C) metabolic activity of 
CMs after 48 hr exposure to GNW-CTAB, pGNW-COOH, pGNW-RGD. 
5.3.3. The development and characterization of scaffold-free cardiac microtissues  
Scaffold-free cardiac microtissues were formed by culturing CMs on concave microwells 
with ultra-low cellular adhesion affinity. Without the presence of a scaffolding biomaterials and 
consequently cell-scaffold interactions, the cell-cell interactions become dominant (Baar, 2005; 
Desroches, 2012). Enhanced cell-cell interactions result in self-assembly of spherical 
microtissues, known as cardiac spheroids. In this study, we utilized agarose hydrogel to fabricate 
concave microwells (Figure 5.6A.) due to the cell repellent nature of agarose hydrogel (Tanaka, 
2016). CMs mixed with pGNW-COOH and pGNW-RGD were loaded into the agarose microwell 
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array (Figure 5.6A.), and their size were monitored for 7 days of culture. The number of CMs per 
individual microtissues was selected to be ~1300 to achieve microtissues with 150 μm.  
 
Figure 5.6. A) Schematic illustrating the fabrication procedure of scaffold-free cardiac 
microtissues embedded with GNWs. B) Size of cardiac microtissues over 7 days of in vitro 
culture. C) Phase-contrast images of cardiac microtissues on day 1 and 7. Scale bars are 20 μm. 
Previous studies have demonstrated that cardiac spheroids with similar number of cells 
can be injected through a standard clinical catheter with minimal damage and higher viability 
(Emmert, 2013). The size of cardiac microtissues (all conditions) decreased significantly from 
~200 μm on day 1 to ~150 μm on day 3 and reached to approximately 120-130 μm on day 7 
(Figure 5.6B.). The major size reduction was occurred during the first 3-4 days of culture and the 
size of microtissues did not significantly decrease afterwards. Furthermore, incorporation of 
pGNW-COOH and pGNW-RGD did not influence the size of microtissues across culture period. 
Similar results have been also reported by previously published studies for SiNW-embedded 
cardiac microtissues (Y Tan, 2017; Y Tan, 2015). Phase-contrast images of microtissues on day 
1 and 7 (Figure 5.6C.) demonstrated the transition of CM aggerates with randomly organized on 
day 1 to spherical cardiac microtissues on day 7.  
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5.3.4. Effect of GNWs on contractility, electrical excitability, and maturation of 
scaffold-free microtissues  
The contractility and electrical excitability of the cardiac microtissues were assessed by 
measuring the fractional shortening of beating microtissue and the excitation voltage threshold, 
respectively. To investigate the impact of GNWs on the electrical excitability of cardiac 
microtissues, excitation voltage threshold was tested using external electrical field stimulation 
(Navaei, 2016a; Tandon, 2009). As demonstrated in Figures 5.7A. and 5.7B., no significant 
differences in the excitation voltage threshold were detected for 1 and 2 Hz frequencies across 
CMs only, CM-COOH5&10, and CM-RGD5&10 groups on both day 4 and 6 of culture. The 
excitation thresholds across all microtissues were 7-8 V for 1 and 2 Hz on day 4 and 8-9 V on day 
6. This can be attributed to the global propagation of the external electric field stimuli within the 
microtissues and culture medium in the stimulation chamber. Therefore, investigating the 
influence of conductive nanomaterials on the electrical excitability and conduction velocity of 
scaffold-free cardiac microtissues requires other measurement techniques with higher reading 
precision (i.e. sampling rate) and resolution, such as microelectrode array (Reppel, 2004) or 
patch clamp (Wilders, 2006).  
Contractility of the microtissues was investigated by measuring their fractional shortening 
(diameter) following the applied electrical stimulation. As it is shown in Figure 5.7C., all groups of 
microtissues with and without embedded conductive nanomaterials showed 1-1.5% shortening in 
diameter (both days 4 and 6) after induced contractions compared to their relaxed state. This 
data indicated that incorporation of GNWs and conjugation of RGD did not improve the contractile 
functioning of the CMs. The cardiac maturation of microtissues was measured using ICC and WB 
to investigate the impact of conductive nanomaterials on the expression of contractile proteins 
(SAC and cTnI) and electrical gap junctions (Cx43). Since, the contractility of microtissues under 
electrical stimulation (Figure 5.7.) were similar between different concentrations of the GNWs (5 
and 10 μg/mL), only the highest concentration (10 μg/mL) was considered for ICC and WB 
analyses. The immunostained images (Figure 5.8A.) showed well-expression of Cx43 gap 
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junctions within CMs across all conditions. Additionally, the positive expression of SAC proteins 
was observed within all types of microtissues. The WB results (Figure 5.8B.) were also in 
agreement with ICC images, illustrating no statically significant differences in terms of cardiac 
specific markers across different experimental groups (i.e. pGNW-COOH and pGNW-RGD).  
  
Figure 5.7. A & B) Excitation voltage threshold of the microtissues on day 4 and 6. C) Contraction 
amplitude measured as fractional shortening of microtissues stimulated by electric field at 1 Hz 
with 10 V on day 4 and 6.  
Similar observations were also reported by Tan (Y Tan, 2017; Y Tan, 2015) for hiPSC-
derived cardiac microtissues embedded with electrically conductive SiNWs. They demonstrated 
that SiNWs did not enhance the contractility of hiPSC-derived cardiac microtissues with similar 
number of cells (i.e. 1000 per spheroid). Although, it was shown that there was a statistically 
significant difference between the contraction amplitude of pure (~1.2%) and SiNW-embedded 
(~1.5%) microtissues, the fold change was also negligible. Notably, the expressions of SAC and 
Cx43 as well as the formation of sarcomere structures were significantly enhanced with higher 
number of cells (3000 per spheroid). However, a caveat in generating relatively large-size 
microtissues (>150 μm) has been demonstrated to be the difficulty in catheter or syringe-based 
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delivery (Emmert, 2013). Therefore, although electrically conductive nanomaterials have been 
shown to improve the maturity of hiPSC-derived CMs (Veerman, 2015) through enhancing the 
expressions of cardiac-specific proteins (SAC, cTnI, and Cx43), however, this scenario was not 
observed in our work based on the use of primary rat-derived CMs. This highlights the critical 
influence of cell type along with conductive nanomaterials to establish mature microtissues.  
 
Figure 5.8. A) Immunostaining fluorescent images of SAC (green) and CX43 (red) within CMs 
only, CM-COOH10 and CM-RGD10 groups on day 7. Yellow arrows locate the embedded GNWs 
within the microtissue. DAPI represent nuclei. Scale bars are 20 μm. B) Quantified relative protein 
expression level of SAC, Cx43 and cTnI on day 6. 
5.3.5. Electrophysiology of CMs only and GNW-embedded cardiac microtissues  
The electrophysiological response of CMs in the presence of electrically conductive GNWs 
was further assessed using microelectrode array (Graudejus, 2011; Kang, 2014; Yu, 2009), an 
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aspect that has not been addressed thus far in previous studies. Figure 5.9. demonstrates the 
representative recorded spontaneous FP signals from 28-electrode sMEA (Figure 5.9A-C.) and 
measured CV across all conditions (Figure 5.9D. and 5.9E.). The averaged CV (cm/sec) on day 4 
was 17.63 for CMs only, 16.92 for CM-COOH5, 17.05 for CM-COOH10, 15.69 for CM-RGD5 and 
19.24 for CM-RGD10. There were no significant differences detected across GNW-embedded 
groups compared to pure CMs culture (i.e. control group). Furthermore, the analyzed results 
showed statistically similar CV values for both 5 and 10 μg/mL of GNWs. The CV results on day 6 
(Figure 5.9E.) were also followed similar trend as day 4. Although the measured CVs for CM-
COOH5 (15.91 cm/sec), CM-COOH10 (13.25 cm/sec), CM-RGD5 (16.21 cm/sec) and CM-
RGD10 (13.61 cm/sec) were slightly higher than the CMs only (9.14 cm/sec), statistical analysis 
did not demonstrate any significant differences among them. Our measurements of CVs using the 
BMSEED platform were consistent with other previously reported values, usually ranging from 18 
to 22 cm/sec for rat CMs (N. Bursac, 1999; N. Bursac, 2002; Fast, 1994; Papadaki, 2001; 
Trantidou, 2015). Although, all the sMEA wells were coated with gelatin prior to cell loading, the 
robust contractions of CMs led to CMs detachment for longer period of culture beyond 6 days. 
Electrophysiological assessment of CMs’ indicated that, first, incorporation of electrically 
conductive GNWs (5 and 10 μg/mL) within CMs did not improve cardiac CV neither on day 4 nor 
6 of culture. Second, conjugation of RGD, as a cell adhesive peptide, on the PEGylated GNWs 
(pGNW-RGD) did not also lead to a substantial increase in the CV in comparison with the non-
conjugated GNWs (pGNW-COOH).  
Cardiac CV is tightly regulated with the expression level and distribution of connexin gap 
junctions (King, 2013; Rohr, 2004). It has been shown that CMs with non-physiological 
expressions of connexins demonstrate significantly slow CV (Guerrero, 1997; Kirchhoff, 1998). 
Therefore, it was possible that the potential impact of the embedded GNWs on enhancing the CV 
among CMs were neglected due to the well-expression of connexin gap junctions in all 
experimental conditions (Figure 5.8.). Therefore, we further utilized heptanol to block the 
connexin gap junctions in CMs (Gizurarson, 2012; Takens-Kwak, 1992; G. Tse, 2016) and further 
assessed CV across different conditions. Heptanol experiment was performed for CMs only, CM-
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COOH10 and CM-RGD10 conditions on day 4 of culture due to similar CV results (Figure 5.9D. 
and 5.9E.) obtained for the both GNWs concentrations (5 and 10 μg/mL). Since 0.5 mM did not 
induce any reduction in the CV and 4 mM rapidly ceased the spontaneous contractions of CMs 
(data not shown). Therefore, 1 and 2 mM heptanol concentrations were selected for the 
experiment.  
 
Figure 5.9. The representative FP signals recorded using 28-electrode sMEA for A) CMs only, B) 
CM-COOH10 and C) CM-RGD10 on day 4 of culture. D & E) Conduction velocity of CMs 
monolayer cultured with and without pGNW-COOH and pGNW-RGD on day 4 and 6 of culture. F 
& G) The percentage of conduction velocity reduction due to the addition of gap junction blocker 
(heptanol) after 10 and 20 min on day 4 of culture. The numbers on the bar graphs are p values 
for CM-COOH10 and CM-RGD10 with respect to CMs only.  
Figures 5.9F. and 5.9G. demonstrate the percent of reduction in CV after addition of 1 and 
2 mM heptanol for all groups. CV was decreased as a function of exposure time and 
concentration of heptanol. Specifically, the average reduction of CV of across all groups was 2-4 
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fold higher for 2 mM heptanol (~32% after 10 min and ~38% after 20 min) compared to 1 mM 
concentration (~9% after 10 min and ~16% after 20 min). These observations are consistent with 
the previously published studies (Gizurarson, 2012; Keevil, 2000; Gary Tse, 2012). In the case of 
GNW-embedded samples, similar levels of CV reduction were measured for 1 mM (CMs only 9%, 
CM-COOH10 8% and CM-RGD10 11%) and 2 mM (CMs only 35%, CM-COOH10 40% and CM-
RGD10 21%) heptanol after 10 min. Furthermore, CV reductions after 20 min heptanol exposure 
appeared to be lower for CM-COOH10 (12% for 1 mM and 40% for 2 mM) and CM-RGD10 (12% 
for 1 mM and 24% for 2 mM) groups compared to CMs only (25% for 1 mM and 50% for 2 mM). 
However, statistical analysis did not show any significant differences (Figure 5.9F. and 5.9G.).  
The electrophysiology investigation in this study was mainly focused on the potential 
impact of conductive GNWs on enhancing the velocity of action potential propagation (CV) 
among CMs. It was rationalized that the GNWs can be localized within the intercellular 
microenvironment to enhance the propagation of electrical signal within CMs. However, our 
findings did not show any substantial improvement regarding CV in both coupled and uncoupled 
connexin conditions. On the other hand, it has been theoretically demonstrated that electrical 
charges induced by the action potentials, generated by a group of CMs, can be transmitted 
through conductive nanomaterials to remote CMs (physically separated), resulting in the 
membrane depolarization (Y Wu, 2018). However, the effective signal transmission through 
conductive nanomaterials between two groups of CMs depends on several factors, including 
number of cells, surface roughness, nanomaterials conductivity, etc. The attachment strength of 
CMs’ membrane to the conductive nanomaterials (i.e. sealing resistance) has been shown to play 
a key role in transmission of electrical signal between cells. In this regard, an effective electrical 
current transmission within CMs only occurs in case of firm cell-nanomaterial attachment 
conditions (sealing resistance of 1014 Ω/sqr) (Y Wu, 2018). Therefore, the location of conductive 
nanomaterials in respect to the CM’s plasma membrane can dictate the ultimate electrical 
enhancing outcomes (e.g. CV). In our study, it is speculated that the incorporated GNWs were 
internalized by CMs and did not locate on the cell membrane or extracellular microenvironment, 
which further led to no significant enhancement of CV in presence of GNWs.  
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5.4. Conclusion 
In this study, electrically conductive cardiac microtissues embedded with functionalized 
GNWs were developed to address the current limitation of cell-based therapies for treatment of 
MI. The ultralong CTAB-capped GNWs with aspect ratio of ~46 were synthesized and then the 
CTAB coating bilayer was exchanged using a 2-step ethanol assisted procedure with SH-PEG-
COOH to maximize the biocompatibility of the nanomaterials. PEGylated GNWs were further 
functionalized with RGD sequence to promote their adhesion affinity to the cells. DLS 
measurements and Raman spectroscopy results confirmed successful CTAB-PEG exchange as 
well as the conjugation of RGD on GNWs. Live/Dead fluorescent images and Alamar Blue results 
demonstrated a significant increase in biocompatibility of GNWs by removing CTAB. The 
developed GNW-embedded cardiac microtissues were further tested for contraction amplitude, 
electrical excitability, cardiac-specific protein expression and conduction velocity. Our finding 
indicated that incorporation of electrically conductive GNWs did not lead to higher fractional 
shortening and lower excitation voltage threshold of CM microtissues. In addition, ICC and WB 
characterizations revealed similar expression levels of cardiac markers (SAC, Cx43, and cTnI) for 
both pure CM and CM-GNW microtissues. Lastly, the electrophysiology of CMs was assessed 
using microelectrode array. The analyzed data demonstrated that the incorporation of electrically 
conductive GNWs did not improve the conduction velocity of action potential among CMs. Also, 
the percentage of conduction velocity reduction in both CM and CM-GNW microtissues were 
similar in presence of gap junction uncoupler (heptanol), indicating that incorporation of 
electrically conductive nanomaterials did maintain the conduction velocity. Despite the promising 
results on cardiac maturation and enhanced contraction amplitude of hiPSC-derived CMs induced 
by other (rGONFs and SiNWs) conductive nanomaterials (Park, 2015; Y Tan, 2017), we did not 
observe similar outcomes using GNWs and NRVCMs. It is speculated that the inducing cardiac 
maturation using conductive nanomaterials can be a cell-dependent process. In addition, it is 
possible that the GNWs were internalized by NRVCMs and did not locate on the cell membrane 
or extracellular microenvironment, which further led to no significant enhancement of CV among 
CMs. 
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CHAPTER 6 
PNIPAAM-BASED BIOHYBRID INJECTABLE HYDROGEL FOR CARDIAC TISSUE 
ENGINEERING 
6.1. Introduction 
Bioengineered injectable hydrogels enhance the efficacy of conventional cell-based 
transplantation for treatment of myocardial infarction (H Wang, 2010). Despite the minimally 
invasive nature of cell-based therapy, this strategy often suffers from low cell retention and lack of 
integration with the native myocardium (Leor, 2000; Müller-Ehmsen, 2002; Reinecke, 2002a). 
Encapsulating exogenous cells within hydrogel-based matrices generates an ideal 
microenvironment for growth and retention of transplanted cells localized to the infarct region 
(Karen L. Christman, 2006; Lu, 2008; Zimmermann, 2009). Although there have been significant 
advances in the development of these technologies, current injectable cell delivery hydrogels do 
not easily allow accessible tuning of mechanical robustness (Ifkovits, 2010) and cell binding 
motifs (S. Fernandes, 2012; Giraud, 2012). To date, numerous studies have utilized different 
natural and synthetic biomaterials for the delivery of cells into the infarct region (Cutts, 2015; 
Hasan, 2015; H Wang, 2010). Naturally-derived materials provide bioactive sites that enable cell 
adhesion and migration, as well as eventual degradation of the scaffold (Nicodemus, 2008; 
Singelyn, 2011; H Tan, 2010). Fibrin, a blood component, has been used in pioneer studies as a 
matrix to induce angiogenesis, preserve cardiac function, and reduce infarct region expansion (K. 
L. Christman, 2004a; Karen L. Christman, 2004b; Ryu, 2005). Collagen, an ECM protein that has 
abundant cell-binding motifs, has also been widely used to support cell delivery and survival, 
retention, infiltration, and myocardium remodeling (Dai, 2009; Kutschka, 2006; Suuronen, 2006). 
Matrigel (Kofidis, 2004), chitosan (Lü, 2009; Lu, 2008), gelatin (Annabi, 2013; Kharaziha, 2013; 
Nakajima, 2015), alginate (Ceccaldi, 2012), and ECM-derived matrices (Seif-Naraghi, 2013; M. 
Shevach, 2015) are among other alternatives that have been used as suitable scaffolding 
biomaterial for myocardial regeneration and repair. Although natural based biomaterials promote 
sufficient cell-matrix interactions, they often suffer from batch-to-batch variability, high 
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immunogenicity, and low tunability of ligand density and mechanical properties (Little, 2008; 
Romano, 2011). On the other hand, synthetic biomaterials, such as self-assembling peptides 
(SAP) (Davis, 2005), poly(lactic acid) and poly(glycolic acid) (C-C Huang, 2012a), PNIPAAm (Cai, 
2015; X Li, 2014; T Wang, 2009), and PEG-based copolymers (X-J Jiang, 2009) enable precise 
control of mechanical and chemical properties with added benefits of industrial-scale production. 
However, the structure of synthetic biomaterials should be further tailored to incorporate sufficient 
cell binding motifs. In this regard, a mixture of a synthetic based matrix and a natural hydrogel 
offers unique beneficial aspects for tissue engineering applications and specifically cardiac 
regeneration. 
We aim to develop a suitable biohybrid injectable hydrogel for cardiac tissue engineering 
through combining a naturally-derived biopolymer with a tunable synthetic polymer. In particular, 
the proposed hydrogel matrix (Figure 6.1.) comprised of a thiol-modified gelatin (Gel-S) 
component to offer a desirable ECM-like bioactive scaffold with adequate cell binding motifs 
(Heffernan, 2015; Nakajima, 2015). The synthetic component was a PNIPAAm-based copolymer 
composing of Jeffamine® M-1000 acrylamide (JAAm) and HEMA (Heffernan, 2016). PNIPAAm 
forms a thermosensitive injectable hydrogel (Schild, 1992), and JAAm increases the gel state 
equilibrium water content (Overstreet, 2013a; Overstreet, 2013b) to enhance nutrition and gas 
exchange (Annabi, 2010). After free radical polymerization of PNIPAAm, JAAm, and HEMA, the 
acrylation of HEMA component (Heffernan, 2016) resulted in the combination of the natural and 
synthetic components (PNJ-Gelatin), PNIPAAm-JAAm-HEMA (PNJHAc) and Gel-S. Prior to 
biological studies, the two components were mixed to initiate chemical crosslinking by Michael 
type reaction (Elbert, 2001). Subsequently, the increase in the temperature induced a physical 
crosslinking of the hydrogel due to the thermosensitive nature of PNIPAAm (Schild, 1992). The 
synthesized biohybrid hydrogel ultimately featured dual chemical and thermal crosslinkability, 
mechanical tunability, and suitable bioactivity. 
So far, most of the studies utilizing hydrogel-based matrices for cardiac tissue engineering 
encompass few in vitro analyses with mono-culture of CMs before in vivo assessments (Cai, 
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2015; Karen L. Christman, 2004b; Dai, 2009; C-C Huang, 2012a; Ifkovits, 2010; Kutschka, 2006; 
Lu, 2008; Nakajima, 2015; T Wang, 2009). Although these studies have generated significant in 
vivo findings on the regeneration of infarcted region, we believe that there should be expanded in 
vitro investigations with co-culture of CMs and CFs to comprehensively analyze the performance 
of the cell-embedded hydrogel matrix prior to in vivo studies. Specifically, due to the abundance 
of resident CFs within the infarct region, it is crucial to find out whether the synthesized hydrogel 
is capable of accommodating CFs, and what is the subsequent role of infiltrated CFs on the 
overall functionalities of the formed 3D tissue (Souders, 2009). Therefore, we performed 
extensive in vitro mono- and co-culture studies comprising of cell survival, cytoskeleton and 
cardiac-specific markers organization, gene expression, as well as tissue-level beating behavior. 
We hypothesize that the synthesized PNJ-Gelatin biohybrid hydrogel provides a suitable 
microenvironment to support the functionalities of cardiac cells, ultimately leading to enhanced 
repair and regeneration of injured myocardium. 
6.2. Experimental Methods 
6.2.1. Materials 
3,3′ Dithiopropionic acid (DTPA), HPLC grade tetrahydrofuran (THF), anhydrous methanol, 
anhydrous ethanol, acetone, HEMA, 2,2′-Azobisisobutyronitrile (AIBN), acryloyl chloride, 
hydrazine hydrate (HH), hexane, concentrated sulfuric acid, ethyl ether, 1 N hydrochloric acid 
(HCl), 1 N sodium hydroxide (NaOH), sodium chloride (NaCl) gelatin type A from porcine skin, 
EDC, and 5,5′-dithiobis-2-nitrobenzoic acid (Ellman’s reagent) were purchased from Sigma 
Aldrich (St. Louis, MO, USA). Dithiothreitol (DTT) was purchased from Gold Biotechnology (St. 
Louis, MO, USA). NIPAAm was obtained from Tokyo Chemical Industry Co. (Portland, OR, USA). 
Jeffamine® M-1000 was gifted by Huntsman Corporation (Salt Lake City, UT, USA). 
6.2.2. Polymer synthesis 
NIPAAm monomer was recrystallized from hexane, and AIBN initiator was recrystallized 
from methanol. Jeffamine® M-1000 acrylamide (JAAm) was synthesized in a reaction with 
Jeffamine® M-1000 and acryloyl chloride (Heffernan, 2016; Overstreet, 2013a). Poly(NIPAAm-co-
110 
 
JAAm-co-HEMA), or PNJH was synthesized by free radical polymerization. Briefly, NIPAAm (7.5 
g), JAAm (2 g), and HEMA (0.5 g) monomers were co-dissolved in THF, heated to 65 °C, and the 
reaction was initiated with AIBN (83 mg). After 18 h, the PNJH product was re-dissolved in 
acetone, precipitated in cold ethyl ether, filtered, and vacuum dried. Poly(NIPAAm-co-JAAm-co-
HEMA-acrylate), or PNJHAc, was synthesized by converting hydroxyl groups on the HEMA 
monomer to reactive acrylates, previously reported by Heffernan et al. (Heffernan, 2015; BH Lee, 
2006). Briefly, PNJH was dried overnight at 60 °C under vacuum and then dissolved at 10 wt% in 
THF with TEA (2.11 mL). The reaction was initiated by adding acryloyl chloride (1.21 mL) 
dropwise to the stirring solution while on ice. The product was precipitated in cold ether, filtered, 
and vacuum dried. PNJHAc was further purified by dialysis against diH2O (3500 MWCO) for 3 
days. The lyophilized polymer was stored at −20 °C. Dithiopropionic dihydrazide (DTPH) was 
prepared from DTPA using an established procedure (Vercruysse, 1997). Thiolated gelatin (Gel-
S) was synthesized from gelatin and DTPH using EDC chemistry based on previously reported 
studies (Heffernan, 2015; Shu, 2003). To confirm the syntheses, proton nuclear magnetic 
resonance (1H NMR) spectra were recorded for PNJHAc and Gel-S with D2O as the solvent (400 
MHz Varian liquid state NMR, Agilent Technologies, Santa Clara, CA, USA), while Ellman’s 
reagent test was used to measure the degree of thiolation (Ellman, 1959). 
6.2.3. Preparation and physical characterization of the hydrogel matrix 
To prepare the hydrogel samples for physical characterization, PNJHAc was dissolved 
(57.1 mg/mL) in DPBS. Subsequently, 40 mg/mL Gel-S in acidic DPBS (pH 3) was prepared at 
37 °C for 5 min. The Gel-S solution was titrated with NaOH to increase the pH to 7, and then the 
two solutions were mixed to form the final product. SEM (XL30 ESEM-FEG, USA) was utilized to 
evaluate the macroporous structure of the biohybrid hydrogels. Freshly made and hydrated (24 h 
at 37 °C in DPBS) samples were frozen in liquid nitrogen followed by lyophilization. Ten SEM 
images were acquired to analyze the porosity and pore size distribution of the hydrogel constructs 
using NIH ImageJ software. Briefly, the images were thresholded and the void area was 
calculated. In addition, pore size was quantified using the line tool. To evaluate swelling behavior 
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of the PNJ-Gelatin biohybrid, hydrogel constructs were prepared and immediately soaked in vials 
of 5 mL DPBS and relocated at 37 °C for 48 h. The swollen hydrogels were removed at different 
time points and weighed. The swelling ratio defined as below (Equation 6.1.): 
𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 𝑟𝑟𝑟𝑟𝑟𝑟𝑆𝑆𝑟𝑟 = M𝑤𝑤𝑤𝑤𝑤𝑤−M𝑑𝑑𝑑𝑑𝑑𝑑
M𝑤𝑤𝑤𝑤𝑤𝑤
      (1) 
where, Mwet is the mass of hydrated hydrogel and Mdry is the mass of fresh hydrogel. Three 
identical samples were selected for each time point. Rheology was completed to quantify the 
viscoelastic characteristics of the temperature responsive polymer during both chemical (Michael-
addition induced) and physical (temperature induced) crosslinking. Rheology solutions were 
prepared by separately dissolving PNJHAc (57.1 mg/mL) and Gel-S (40 mg/mL) in pH 3 DPBS. 
The solutions were then combined, titrated to ∼pH 7 with 1 N NaOH, vortex mixed for 15 s, and 
positioned on a parallel plate rheometer (Anton Paar MCR-101). The storage and loss modulus in 
the solution and gel states were evaluated by a multistep temperature-controlled procedure. In 
the first step, a time sweep was performed for 4 h at 25 °C to measure the gelation of PNJHAc 
and Gel-S. Next, the sample was subjected to controlled (0.5 °C/min) and sustained heating (37 
°C for 1 h) followed by quick cooling back to room temperature (25 °C for 1 h) to measure the 
reversible physical crosslinking of the PNJ-Gelatin hydrogel. To simulate the biophysical cues 
that cultured cardiac cells sense during the preparation and the first 12 h of culture, we performed 
a separate rheology measurement at 25 °C for 15 min (the sample preparation time) followed by 
immediate temperature increase to 37 °C for 12 h. In all experiments, an oscillatory 0.5% shear 
strain deformation was performed a frequency of 1 Hz, and normal force control was utilized to 
maintain constant contact between the gel and rotating head. The LCST of PNJ-Gelatin following 
enzymatic digestion with collagenase was evaluated by cloud point measurement. PNJ-Gelatin 
was dissolved at 0.1 wt% in PBS at pH 7.4 in cuvettes and heated in a water bath from 25 to 37 
°C in 1 °C increments and 40-75 °C in 5 °C increments. Samples were maintained at each 
temperature for at least 120 s before each measurement. Absorbance at 450 nm was recorded 
with a UV/Vis spectrometer (Pharmacia Biotech Ultrospec 3000). The LCST, which is defined as 
the temperature at 50% of the maximum absorbance, was then collected. To assess hydrolytic 
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degradation, hydrogel constructs were prepared and immediately placed in vials of 5 mL DPBS at 
37 °C. At different time points, constructs were immersed in liquid nitrogen, followed by 
lyophilization. Remaining mass percentage was defined as the lyophilized mass to the original 
one. Three identical samples were selected for each time point. 
6.2.4. Cell harvesting and culture 
NRVCMs were isolated from 2-day old pups according to the previously established 
protocol (Saini, 2015) accepted by the Institution of Animal Care at Arizona State University. The 
isolated cardiac cells were separated into CMs and CFs by pre-plating the cell suspension for 1 h 
and allowing CFs to attach to the tissue culture flask, due to their higher adhesive nature 
compared to CMs (Saini, 2015; SR Shin, 2013). After 1 h, the harvested media, mainly containing 
CMs, was collected and used for further experimentation. We precisely isolated the ventricular 
tissue to minimize the presence of endothelial or smooth muscle cells, from the aorta region of 
the heart, within the isolated CMs population. However, the isolated CMs may still contain a few 
numbers of endothelial cells due to the presence of capillaries within the myocardial tissue. CMs 
and CFs were cultured in cardiac media containing DMEM (Gibco, USA), 10% FBS (Gibco, USA), 
L-Glutamine (1%) (Gibco, USA), and 100 units/mL of penicillin-streptomycin. Isolated cardiac 
cells were cultured under a static condition (no external electrical stimulation) and the cell culture 
media was changed every other day. 
6.2.5. Preparation of the biohybrid cell-laden hydrogel 
To prepare the cell-laden injectable PNJ-Gelatin biohybrid hydrogel, CMs (mono-culture 
condition) or a 2:1 ratio of CMs-CFs (co-culture condition) were dispersed (35 × 106 cells/mL) in a 
solution of supplemented cardiac media containing 30% FBS and PNJHAc (57.1 mg/mL). Next, a 
7.5 μL drop of cardiac cell suspension was placed on top of a sterile 18 × 18 mm2 glass slide. 
Subsequently, a 7.5 μL Gel-S in cardiac media prepared at 40 mg/mL was mixed with the cell 
suspension with a final cell number of 525,000 CMs in mono-culture and 350,000 CMs and 
175,000 CFs in co-culture conditions (Figure 6.1.). The prepared samples were chemically 
crosslinked in a 24-well plate at room temperature (25 °C) for 10 min followed by the addition of 
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0.5 mL of warmed cardiac media (37 °C) to initiate the physical crosslinking. The well plates were 
placed in humidified cell culture incubator (37 °C and 5% CO2) and subsequently cultured for a 
period of 9 days. 
 
Figure 6.1. The schematic displaying the fabrication procedure of the proposed injectable PNJ-
Gelatin hydrogel with encapsulated CMs and CFs. 
6.2.6. Cell viability assay 
The survival of encapsulated cells within the PNJ-Gelatin hydrogel was evaluated on day 1 
and 7 of culture, using a Live/Dead assay kit (Life technologies, USA). Briefly, three individual 
samples of biohybrid hydrogels were selected for each type of culture (mono- and co-culture) and 
Z-stack fluorescent images were acquired using an inverted microscope (Observer Z1, Zeiss, 
Germany) equipped with ApoTome.2 (Zeiss, Germany). The viability percentage was defined as 
number of viable cultured cardiac cells (green) divided by total number of cells. 
6.2.7. F-actin staining and Fast Fourier Transform (FFT) analysis 
F-actin fibers were stained to visualize the cytoskeleton organization of cultured cells within 
the PNJ-Gelatin hydrogel in both mono- and co-culture groups on day 7 of culture. First, the cells 
were fixed in 4% PF for 30 min. Next, 1% (v/v) Triton x-100 was used to permeabilize the plasma 
membrane of the cells for 45 min at 25 °C. Afterwards, the fixed cells were blocked in 1% (v/v) 
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BSA (Sigma Aldrich, USA) for 1 h at 4 °C. Finally, the cells were stained with Alexa Fluor-488 
phalloidin (1:40 dilution in 1% BSA, Life technologies, USA) for 1 h and counterstained with DAPI 
(1:1000 dilution) for 30 min. A fluorescent microscope equipped with ApoTome.2 was utilized to 
take Z-stack fluorescent images through the samples. FFT images were further obtained and 
analyzed by means of ImageJ software (NIH) to assess the local organization of the F-actin 
fibers. To analyze the actin coverage area, the collected regions of interests, (ROIs) (300 × 300 
μm2), were quantified using NIH ImageJ software (n > 10). 
6.2.8. Immunostaining of cardiac specific-markers 
To investigate the phenotype of cultured cardiac cells (on day 7 of culture), immunostaining 
method was utilized according to previously developed protocols (Kharaziha, 2013). Briefly, cells 
were fixed in 4% PF for 40 min followed by treatment with 0.1% Triton x-100 for 45 min at room 
temperature. Next, the cardiac cells were blocked in 10% goat serum for 2 h at 4 °C. Afterwards, 
the fixed cells were stained with primary antibodies against SAC, Cx43 (Abcam, USA) and cTnI 
(Developmental Studies Hybridoma Bank) (1:100 dilution in 10% goat serum) and placed in cold 
room (4 °C) for 24 h. After the primary staining, samples were washed five time with DPBS (5 min 
intervals) and stained overnight with secondary antibodies (Life Technologies, USA) comprised of 
Alexa Fluor-488 for SAC and cTnI, and Alexa Fluor-594 for Cx43 (1:200 dilution in 10% goat 
serum). Next, cells were stained with DAPI (1:1000 dilution in DPBS) for 30 min to label the 
nuclei. Finally, the stained samples were mounted and imaged (20× and 40×) using a ZEISS 
fluorescent microscope equipped with ApoTome.2. The average coverage area (n > 12) for 
cardiac-specific proteins was assessed similar to F-actin coverage analysis using NIH ImageJ 
software. 
6.2.9. Quantitative polymerase chain reaction (QPCR) 
QPCR technique was used to evaluate the expression of certain cardiac specific genes 
(CTNT, CX43, ACTN1, and MLC2v) for both culture groups. Samples were selected at two 
considered time points (day 1 and 7 of culture encapsulated within the PNJ-Gelatin hydrogel). For 
cell-laden matrices, the hydrogels were immersed in collagenase (Worthington Biochemical 
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Corp., USA) solution (1 mg/mL) for 1 h at 37 °C to collect the encapsulated cardiac cells. After 
degradation of the hydrogel, the cell suspension was centrifuged at 1000 rpm for 5 min and the 
resulting supernatant was discarded. In the case of freshly isolated cells, the cell suspension was 
centrifuged at 1000 rpm for 5 min. RNA was isolated from cells using the NucleoSpin® RNA Kit 
(Clontech). Reverse transcription was performed with iScript Reverse Transcription Supermix for 
RT (BioRad). Quantitative PCR was carried out using TaqMan® Assays or SYBR® green dye on 
a BioRad CFX384 Touch™ Real-Time PCR Detection System. For the QPCR experiments run 
with TaqMan® Assays, a 10 min gradient to 95 °C followed by 40 cycles at 95 °C for 5 s and 60 
°C for 30 s min was used. For QPCR experiments run with SYBR® green dye, a 2 min gradient to 
95 °C followed by 40 cycles at 95 °C for 15 s and 60 °C for 1 min was used. Gene expression 
(Appendix Table B.1.) was normalized to 18S rRNA levels. ΔCt values were measured as Cttarget − 
Ct18s. All experiments were accomplished with two technical replicates and three biological 
replicates. Relative fold changes in gene expression were quantified using previously established 
technique (VanGuilder, 2008). Data were presented as the average of the biological replicates ± 
standard error of the mean (SEM). 
6.2.10. Evaluation of spontaneous tissue-level contraction 
The spontaneous beating of CMs was monitored and measured every day during the 
culture period (9 days) using real-time optical microscopy. After detection of synchronous tissue-
level (2.5 × 2.5 mm2) beating, videos (n > 12) were captured by using an inverted microscope 
equipped with an AxioCam MRm camera (Zeiss, Germany). Furthermore, representative beating 
signals were acquired using a custom written MATLAB code (SR Shin, 2013). The amplitude and 
frequency variation indexes were calculated based on an original procedure developed by the 
authors. In detail, the collected beating signals of subsets (n = 5, 0.5 × 0.5 mm2) for each sample 
(n = 4, 2.5 × 2.5 mm2) were processed using MATLAB software to find the significant peaks. A 
significant peak was defined as below (Equation 6.2.): 
𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑟𝑟𝑆𝑆𝑟𝑟 𝑝𝑝𝑆𝑆𝑟𝑟𝑝𝑝𝑝𝑝 ≥ ((|𝐴𝐴𝐴𝐴𝑝𝑝𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 − 𝐴𝐴𝐴𝐴𝑝𝑝𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀|) + 𝐴𝐴𝐴𝐴𝑝𝑝𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀)   (2) 
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where AmpMedian and AmpMean were the median and mean amplitudes respectively. Next, the 
collected significant peaks (n > 500) were normalized based on their average. The absolute 
difference between the normalized values and 1 was calculated to obtain the amplitude variation 
index. In the case of the frequency variation index, the related time for each significant peak was 
acquired and peak-to-peak time differences were calculated. Subsequently, the time differences 
were normalized to their average and the absolute difference between the normalized values and 
1 was considered as the frequency variation index. Finally, the calculated indexes (n > 20) were 
compared between mono- and co-culture groups. 
6.2.11. External electrical stimulation 
The response of the encapsulated cells (CMs and CFs), within the PNJ-Gelatin hydrogels, 
to external electrical stimulation was evaluated based on previously established protocol 
(Tandon, 2009). Briefly, a custom-made chamber was assembled using two carbon electrodes (5 
mm) with 1 cm spacing attached to a plastic petri dish (6 mm diameter) by silicon adhesive 
(Appendix Figure B.3A.). Platinum wires were connected to the carbon electrodes (at the 
opposite ends of each electrode) and all connections were sealed using silicon adhesive. The 
entire chamber was washed with ethanol (70%) and put under UV light for 1 h for sterilization. To 
assess cardiac cells’ response to the external electrical stimulation, pulsatile electrical signals (BK 
PRECISION 4052) with 3 ms duration at three different frequencies (1, 2, and 3 Hz) was applied 
in both mono- and co-culture conditions. The minimum required voltage to obtain contraction of 
CMs was defined as the excitation threshold. 
6.2.12. Statistical analysis 
The data was analyzed using t-test and ANOVA statistical methods. The results for 
viability, cytoskeleton, and cardiac specific markers coverage areas were reported as mean ± 
standard deviation (SD). To determine a statistically significance difference between the groups, 
we used Tukey’s multiple comparison test, with a p-value < 0.05 considered to be significant. All 
the statistical analyses were performed by GraphPad Prism software (v.6, GraphPad San Diego). 
117 
 
6.3. Results 
6.3.1. Preparation and characterization of PNJ-Gelatin hydrogel 
The PNJ-Gelatin hydrogel was obtained by mixing PNJHAc and Gel-S prepolymer 
solutions at room temperature, which resulted in an orange solution followed by forming a soft gel 
after 120 s. Figure 6.2A. shows the viscoelastic characteristics of the hydrogel during the 
chemical crosslinking between PNJHAc and Gel-S. As can be seen in the graph, the storage 
modulus (G′) increased over time and leveled out at approximately 4 h, indicating completion of 
chemical crosslinking. There was a sharp increase in G′ (870 Pa) within the first hour of 
crosslinking, followed by a gradual increase to 1260 Pa up until 4 h. Furthermore, the hydrogel 
mainly exhibited elastic-behavior due to the negligible loss modulus (G″, 19 Pa after 4 h). To 
further investigate the impact of the thermosensitivity of the NIPAAm component, the dynamic 
modulus was measured during a temperature ramp from 25 °C to 37 °C. As shown in Figure 
6.2B., the rise in temperature induced an increase in the dynamic modulus of the PNJ-Gelatin 
hydrogel from 1260 to 2450 Pa, which indicated the occurrence of physical crosslinking. The 
dual-crosslinking (chemical and physical) nature of the biohybrid hydrogel was confirmed by 
dropping the temperature to 25 °C (Fig. 2C), which resulted in the same storage modulus (4 h) 
shown in Figure 6.2A. Furthermore, the simulated rheology measurement (Figure 6.2D.) revealed 
that the cultured cells initially experienced a slight increase in the modulus up to 90 Pa within the 
first 15 min. Upon temperature increase occurring from the placement of the hydrogel samples in 
the incubator, the modulus increased as expected due to the crosslinking of PNIPAAm. To 
investigate the fate of the LCST after degradation of the gelatin, the PNJ-Gelatin hydrogel was 
degraded utilizing collagenase and cloud point measurements were taken of the degraded PNJ-
Gelatin. The results indicated that LCST was 55 °C (Appendix Figure B.1.) after enzymatic 
degradation, which is a temperature outside of physiological range. Therefore, it could be 
possible to utilize this degradation mechanism similar to previously developed degradable 
PNIPAM-based hydrogels (Zhanwu Cui, 2007).  
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Figure 6.2. The viscoelastic behavior of PNJ-Gelatin hydrogel solutions at (A) room temperature 
(25 °C for 4 h), followed by measuring during controlled (0.5 °C/min) and (B) sustained heating 
(37 °C for 1 h), and finally during (C) rapid cooling back to room temperature (25 °C for 1 h). (D) 
Changes in storage modulus of the PNJ-Gelatin hybrid hydrogel according to the temperature 
increase from 25 °C (preparation temperature) to 37 °C (incubation temperature). G′: storage 
modulus, G″: loss modulus. 
Figure 6.3A. illustrates the level of water content within the hydrogel constructs. Initially, 
the hydrogels swelled to 1.2 times their initial mass. After 48 h, hydration decreased to a stable 
level of 80%. Moreover, to investigate the macroporous architecture of the PNJ-Gelatin 
constructs, samples were characterized by SEM before and after hydration (24 h). Figure 6.3B. 
displays the hydrogel porosity percentage as an indicator of void spaces within the constructs. As 
can be seen, the porosity percentage slightly increased after hydration from 71.1% ± 1.5 to 75.6% 
± 2.4. Furthermore, based on the SEM images (Figure 6.3C. and 6.3D.), the macroporous 
structures appeared to collapse and disorganize before hydration; however, once hydrated, 
morphology of the pores became more open, intact, and organized. These findings indicated that 
the absorbed water penetrated throughout the construct and inflated the pores. It was speculated 
that the average pore diameter would increase due to the higher hydration content, however no 
differences were observed (data not shown). Instead, the pore size distribution range expanded 
after hydration while maintaining the same average pore diameter (Figure 6.3E.).  
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Figure 6.3. (A) The change in water content level (%) of the hydrogel during 48 h of hydration. (B) 
The percent of porosity, (C) and (D) Low and high magnification SEM micrographs showing 
macroporous architecture, and (E) pore size distribution of lyophilized hydrogel before and after 
hydration (24 h). 
6.3.2. 3D cell culture and survival 
To demonstrate the capability of the PNJ-Gelatin hydrogel as a 3D microenvironment 
promoting cardiac cell adhesion, spreading, and survival, we encapsulated CMs (mono-culture) 
and a 2:1 ratio of CMs-CFs (co-culture) within the hydrogel matrix for a period of 9 days. We 
selected this ratio of CMs to CFs based on our recent study where we found the best viability, cell 
spreading and tissue-level functionalities (Saini, 2015). Z-stack images (Figure 6.4A.) confirmed 
successful fabrication of a homogenous 3D (150 μm thick) construct. Figure 6.4B. illustrates the 
changes in cell morphology as a function of time regardless of culture type. Phase contrast and 
fluorescent images were used to highlight the cell morphology (Figure 6.4B.) as well as cell 
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viability (Figure 6.4C.). Both cell types encapsulated within the hydrogel matrix adopted a round 
morphology on day 1 of culture (Figure 6.4B.).  
 
Figure 6.4. (A) The depth coding image (scale bar is 100 μm) of encapsulated cardiac cells within 
PNJ-Gelatin hydrogel (top-view & cross-section) (day 1). (B) The phase-contrast (scale bars are 
100 μm) and fluorescent images (green (live) and red (dead)) of mono- and co-culture groups 
illustrating cell morphology at days 1 and 7 of culture. Insets on phase-contrast (scale bars are 50 
μm) and stained images show the magnified images (inset #1 and 2 show CFs and CMs 
respectively; inset #3 and 4 display small protrusions in CMs). (C) Quantified viability (%) of both 
mono- and co-cultured groups at days 1 and 7. (n = 3; *p < 0.05).  
The synthesized matrix supported the gradual spreading of both cells in the two culture 
conditions as a function of time. However, on day 4, the co-culture group demonstrated a higher 
number of elongated cardiac cells, whereas mono-culture mostly exhibited cells with round 
morphology (Appendix Figure B.2.). In addition, round and elongated cardiac cells formed 
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clusters in the co-culture group in comparison to separated arrangements of the cells in the 
mono-culture. By day 7, the CMs and CFs in the both culture groups exhibited higher numbers of 
elongated and spread cells in comparison to the first day (Figure 6.4B.). In particular, CFs 
demonstrated a larger cell area (Figure 6.4B., co-culture inset #1) compared to CMs (Figure 
6.4B., mono-culture inset & co-culture inset #2). Interestingly, CMs in the co-culture exhibited 
small protrusions, which were rarely seen in mono-culture (Figure 6.4B., co-culture inset #3 & 4). 
Overall, the cells exhibited well-connected structures in co-culture condition as compared to the 
mono-culture. Figure 6.4C. represents the quantitative results of the cell viability where both 
culture groups exhibited high levels of cell survival. Particularly, mono- and co-culture groups 
resulted in approximately 80% overall cell viability on day 1, while the average overall cell viability 
increased to 85% for mono-culture and 90% for co-culture by day 7. There were no statistically 
significant differences among the culture days for mono-culture. In contrast, due to the 
proliferative nature of CFs (Saini, 2015; Sigel, 1996), co-culture group exhibited an increase in 
overall cell viability (t-test (two tailed); p < 0.05). 
6.3.3. Assessment of cytoskeleton organization 
F-actin fibers were stained on day 7 of culture to determine the cytoskeleton organization 
and morphology of the cells in mono- and co-culture groups. Co-culture of the cells produced an 
intact and dense organization of cytoskeleton (F-actin) compared to mono-culture, which 
exhibited a discrete and loosely packed arrangement of F-actin fibers (Figure 6.5A.). These 
observations were consistent with phase contrast images demonstrating pronounced network of 
connected cells in the co-culture condition. Furthermore, FFT analysis was performed on 20x and 
40x images to assess alignment of F-actin fibers (Figure 6.5A., FFT insets). There was no overall 
tissue-level alignment, however, numerous local alignments were detected across both culture 
conditions. FFT images (dashed rectangles, subsets of 40x images in Figure 6.5A.) of small cell 
clusters illustrated the local cellular alignment. Additionally, the actin area coverage was analyzed 
within both culture conditions. As can be seen in Figure 6.5B., a significant difference (p < 0.05) 
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in terms of actin coverage was observed between the culture groups pointing to the contributions 
of CFs in assembling a dense cell organization in co-culture condition (Saini, 2015). 
 
Figure 6.5. (A) F-actin fibers (green) stained images in both culture groups representing the 
cytoskeleton organization at 20x and 40x magnifications; FFT images (inset) indicate fiber 
alignment within the formed 3D cardiac tissue. The magnified spots and related inset FFT images 
illustrate the local alignment of F-actin fibers. (B) The average coverage area (μm2) of the F-actin 
fibers at day 7 of culture (n > 10; *p < 0.05).  
6.3.4. Analyses of cardiac-specific markers 
SAC, cTnI, and Cx43 were stained to assess cardiac cells phenotype within the PNJ-
Gelatin biohybrid hydrogel. Figure 6.6A. represents the immunostained images of both mono- 
and co-culture groups at day 7. As can be seen in the co-culture images, the sarcomeric 
structures demonstrated defined, uniaxial, and extended arrangements. Moreover, a 
homogenous distribution pattern of Cx43 was observed for co-culture in comparison to the 
disarrayed expression of these gap junctions in mono-culture condition. In addition, the 
fluorescence coverage area (Figure 6.6B.), correlating to the architecture and distribution of 
expressed cardiac proteins, was quantified based on 20x immunostained images. SAC and Cx43 
displayed statistically (t-test (two tailed); p < 0.05) higher coverage area in co-culture condition.  
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Figure 6.6. (A) The immunostained images (day 7) of mono- and co-culture groups illustrating the 
structure and distribution of SAC, cTnI, and Cx43 at two different magnifications (20x, 40x). (B) 
The average coverage area (μm2) of SAC and Cx43 proteins at day 7 (n > 12; *p < 0.05). 
The cells exhibited a well distribution of cTnI in both culture conditions. Overall, the 
presence of CFs assisted CMs to connect and form cell-cell junctions (as indicated by Cx43), 
producing well-distributed and connected clusters of cells. To demonstrate that encapsulation and 
subsequent culture of cardiac cells within the PNJ-Gelatin hydrogel did not alter their gene 
expression profile, we performed QPCR analysis on day 1 and 7. This analysis revealed that 
there were no statistically significant (t-test (two tailed); p > 0.05) changes in expression of CMs 
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specific genes including cTNT, MLC2v, ACTN1, and Cx43 in both the mono- and co-culture 
condition over the course of 7 days of culture (Figure 6.7.). 
 
Figure 6.7. Evaluation of the cardiac specific gene expression within PNJ-Gelatin hydrogel. The 
expression level of CTNT, CX43, ACTN1, and MLC2v genes at two different time points (day 1 
and 7) for (A) mono-culture and (B) co-culture. 
6.3.5. Beating behavior of the encapsulated cardiac cells 
Beating behavior of cardiac cells was examined by analyzing the number of tissue-level 
(2.5 × 2.5 mm2 field of view) synchronous contraction in a daily manner. The results in Figure 
6.8A. and 6.8B. show the average number of beats per minute (BPM) within both mono- and co-
culture groups. In mono-culture, the encapsulated cardiac cells started beating individually on day 
3 (Appendix C.15.). As the cells came into contact with each other, they demonstrated a 
synchronized beating behavior starting at day 6 of culture (57 ± 19 BPM) (Figure 6.8A.; Appendix 
C.16.). These observations were consistent with network formation of the cells based on the 
phase contrast and fluorescence images (Figure 6.4B.). The BPM reached the highest value (92 
± 42 BPM, p < 0.05) on day 7 followed by a significant decline to 36 ± 28 BPM by day 9. 
Additionally, the beating behavior was not maintained uniformly over the culture period (unstable 
trend represented by the blue line). On the other hand, the co-culture group (Figure 6.8B.) 
exhibited synchronous beating as early as day 3 of culture (39 ± 20 BPM) (Appendix C.17. and 
C.18.) and maintained a stable trend (represented by the blue line) in terms of BPM up to day 9 
(30 ± 8 BPM) (Appendix C.19.). To further investigate contraction signal synchrony in terms of 
amplitude and frequency, the tissue-level field of view (2.5 × 2.5 mm2) was subdivided in to 0.5 × 
0.5 mm2 subsets. Figure 6.8C. and 6.8D. show beating signals of subsets within a single 
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representative field of view. As can be seen, the mono-culture signals displayed high fluctuations 
in peak to peak amplitude and period whereas co-culture condition exhibited uniform signals.  
 
Figure 6.8. The average number of beats per minute (BPM) for (A) mono- and (B) co-culture 
groups from day 3 to 9 of culture. (C) and (D) represent beating signals of five different subsets 
(0.5 × 0.5 mm2) within hydrogel sample (2.5 × 2.5 mm2) at day 7. The quantified (E) amplitude 
and (F) frequency variations represented as indexes comparing the synchrony of beating for 
mono- and co-culture groups. 
Furthermore, similar frequencies between subset signals were observed for co-culture, 
whereas such behavior was not seen in mono-culture of the CMs. These findings indicated that 
the different subset areas within one field of view for the co-culture group were in synchrony 
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compared to the mono-culture condition. Moreover, amplitude and frequency variation indexes 
were developed to further quantitatively analyze the tissue-level synchrony. Amplitude and 
frequency variations were found to be significantly lower in co-culture compared to mono-culture, 
indicating higher tissue-level synchrony in the co-culture condition (Figure 6.8E. and 6.8F.). 
6.3.6. External electrical stimulation 
To investigate the response of encapsulated CMs and CFs within the PNJ-Gelatin hydrogel 
to external electrical stimulation, samples were treated by pulsatile electrical signals at day 7. 
Appendix Figure B.3. shows the assembled chamber and the excitation threshold for both mono- 
and co-culture groups. Despite lower excitation threshold for the co-culture of the cells, no 
significant differences were detected between the two culture groups for the applied frequencies 
(1, 2, and 3 Hz). In addition, only individual areas within the hydrogel samples responded to the 
external electrical field and started to contract. 
6.4. Discussion 
Although current hydrogels provide a desirable matrix for the delivery of exogenous cells to 
the infarct region, the majority of developed biomaterials suffer from well-tuned properties, such 
as lack of cell-adhesion motifs (Heffernan, 2016; Hunt, 2014; Jongpaiboonkit, 2008) or robust 
mechanical properties (Little, 2008; Romano, 2011). Particularly, a large body of the previous 
work on injectable hydrogels has been concentrated on animal studies without extensive in vitro 
analyses on functionalities of cardiac cells to define an optimal culture condition (Fujimoto, 2009; 
X Li, 2014; Wall, 2010). Moreover, most of the earlier studies focused on the use of only CMs 
rather than co-culture conditions with CFs, being the most abundant cell within the myocardium 
after CMs (Souders, 2009). For instance, Li et al. (X Li, 2014) utilized CNTs modified PNIPAAm 
for cardiac regeneration applications. They performed minimal in vitro studies prior to in vivo 
work, demonstrating that the presence of CNTs significantly promoted cellular adhesion and 
spreading. In another study by Wall et al. (Wall, 2010), semi-interpenetrating hydrogels of 
p(NIPAAm)-co-Polyacrylic acid (pAAc) hydrogels with matrix metalloproteinase labile crosslinkers 
were developed for transplantation of bone marrow-derived MSCs and treatment of cardiac 
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injuries. Cellular proliferation was investigated within the proposed matrices, as a function of 
mechanical stiffness and RGD concentration, to select a suitable matrix prior to in vivo work. Cui 
et al. (H Cui, 2014) presented an injectable matrix using PolyNIPAM-based copolymers and 
electroactive tetraaniline (TA) for transplantation of rat cardiac myoblast within the infarct region. 
They performed material characterization and viability testing before animal studies. Wagner’s 
group (Fujimoto, 2009) also developed a copolymer made of N-isopropylacrylamide (NIPAAm), 
acrylic acid (AAc) and hydroxyethyl methacrylate-poly(trimethylene carbonate) (HEMAPTMC) 
(poly(NIPAAm-co-AAc-co-HEMAPTMC)) for cardiac regeneration upon myocardial infarction. 
They performed extensive characterizations to define the optimal monomer ratios with respect to 
gelation, solubility and degradation of the material. In vitro viability studies (rat vascular smooth 
muscle cells) was performed prior to in vivo testing. Therefore, it is crucial to perform extensive in 
vitro analyses on cardiac function before continuing to in vivo experimentation. Likewise, there is 
a critical need to discover whether the synthesized injectable hydrogel will accommodate the 
resident CFs within the infarct region as well as determining the subsequent influences of CFs on 
tissue-level functionalities. 
In this work, a biohybrid injectable hydrogel was developed from gelatin and PNIPAAm-
based copolymers to address these limitations. Gelatin, a naturally-derived biomaterial, was 
chosen to provide a suitable microenvironment with high bioactivity for cell growth and spreading 
(Nakajima, 2015; Nicodemus, 2008; Singelyn, 2011; H Tan, 2010), while PNIPAAm was selected 
to induce physical crosslinking and obtain sufficient mechanical robustness for the 
accommodation of dynamic tissue-level beating (Cai, 2015; X Li, 2014; T Wang, 2009). The 
synthesized hydrogel provided a dual-crosslinkable matrix, where the thiols and acrylates initiated 
a chemical gelation along with a secondary physical crosslinking to induce mechanical 
enhancement. The rheology results (Figure 6.2.) supported the chemical and physical 
crosslinking nature of the PNJ-Gelatin injectable hydrogel. Because the standard rheology 
approach may not represent the exact biophysical cues that the cells feel during the sample 
preparation, we devised a simple test to simulate the viscoelastic behavior of the biohybrid 
hydrogel with cells during the initial 12 h of culture. As seen in Figure 6.2D., the cells experienced 
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the chemical crosslinking first, followed by the hydrogel physical crosslinking once the samples 
were placed inside the incubator. However, these results still may not fully represent the actual 
biophysical cues, due to many other factors that influence the final modulus, such as hydrogel 
swelling, degradation, and ECM deposition (Banerjee, 2006). 
The ECM-like macroporous structures, provided by PNJ-Gelatin hydrogels, make these 
types of biomaterials a desirable candidate for cell growth. Typically, PNIPAAm-based hydrogels 
exhibit low water content equilibrium, which can limit nutrient and gas exchange within the 
hydrogel structure (Heffernan, 2016). To that regard, gelatin and JAAm were included as the key 
components within the PNJ-Gelatin hydrogel, which consequently resulted in enhanced water 
retention (Overstreet, 2013a). After hydration, the porous structures of the hydrogel increased 
slightly, indicating the retention of water (Figure 6.3B.). The difference in the water content can be 
equated to the hydrogel porous structures becoming more uniform and open (Figure 6.3D.) along 
with the increase in the range of pore diameters (Figure 6.3E.). Therefore, the material 
characterizations ensured suitable and tunable properties for cellular delivery based on the 
natural/synthetic nature of the proposed hydrogel matrix. 
An ideal cell delivery hydrogel needs to provide a suitable microenvironment to enhance 
cardiac cell biological functions and promote cell survival, spreading, cytoskeletal organization, 
and specific markers expression (Hasan, 2015; Paul, 2014). The PNJ-Gelatin was used to 
encapsulate two different cell culture systems (CMs and 2:1 CMs-CFs) to assess the 
performance of the synthesized hydrogel for cardiac tissue engineering. We used 2:1 culture ratio 
based on our earlier optimization studies (Saini, 2015). In this work, both culture groups 
demonstrated high cell viability and spreading within the 3D PNJ-Gelatin hydrogel (Figure 6.4.). 
These findings can be attributed to the high bioactivity of gelatin (Heffernan, 2015; Nakajima, 
2015), adequate pore size distribution, and water content (Annabi, 2010), which are required for 
sufficient cell infiltration and nutrition, waste, and gas exchange within the 3D (10 × 10 × 0.2 mm3) 
matrix. The co-culture group exhibited a significant increase in viability by day 7 which can be 
associated to the highly proliferative nature of CFs (Souders, 2009). This is also reflected in the 
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day 7 images (Figure 6.4B.) of co-culture, where there appeared to be a network of elongated 
cells located between the round cells. The findings from the viability and cell spreading analyses 
could be attributed to the incorporation of a highly bioactive component (gelatin) within the 
synthetic, PNIPAAm-based hydrogel. Gelatin not only provided sufficient cell adhesion motifs, but 
it also offered a high level of bioactivity as well as inducing high water retention that was overall 
missing in PNIPAAm. In addition, we performed hydrolytic degradation of the hydrogel. Our data 
indicated a sharp decrease in the molecular mass after 1 day, but the trend stabilized for the next 
few weeks (Appendix Figure B.4.). We concluded that this decrease was not degradation, but 
uncrosslinked products being released from the material. Nonetheless, gelatin was able to be 
degraded enzymatically (Nakajima, 2015), but the PNIPAAm-based components did not contain 
any degradable monomers. After enzymatic degradation, it was expected that LCST would have 
increased due to gelatin chains breaking down and separating the NIPAAm components resulting 
in NIPAAm units with short hydrophilic gelatin tails. In addition, the increase in LCST beyond 
physiological temperatures means that the polymer may become soluble within the body and 
cleared. However, the molecular weight of the byproducts was not investigated and may result in 
toxicity if too high. For future work, our group has a plan to improve the degradability of the PNJ-
Gelatin hydrogel by incorporation of biodegradable components from our previous studies 
(Overstreet, 2013a). 
The resulting cell specific characteristics (Figures 6.5., 6.6. and 6.7.) and functionalities 
(Figure 6.8.) within the PNJ-Gelatin highlighted the potential of the proposed hydrogel as an 
efficient and bioactive cardiac cell delivery system and further revealed the dissimilarities 
between the two investigated cell culture conditions (CM and 2:1 CM-CF). First, phenotypic 
differences in the distribution and structures of cytoskeleton and cardiac specific proteins were 
observed across both cultured cell systems (Figures 6.5. and 6.6.). The presence of CFs can be 
accredited to these differences by providing structural support as well as mechanical, electrical, 
and biochemical cues (Banerjee, 2006; Souders, 2009). Primarily, distributions of F-actin, SAC, 
and Cx43 proteins in co-culture were more uniformly organized contrary to the discrete 
arrangement in mono-culture. In this regard, CFs may have enhanced cell-cell and cell-ECM 
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mechanical interactions by amplifying the availability of cadherin- and integrin-based anchoring 
points as demonstrated in our and other previous works (Banerjee, 2006; Baxter, 2008; Kohl, 
2003; Saini, 2015). This resulted in enhanced spreading of cardiac cells, which increased the 
coverage area of F-actin (Figure 6.5B.) and SAC (Figure 6.6B.). Furthermore, CFs facilitate cell-
cell electrical coupling by contributing Cx43 gap junctions (Camelliti, 2005; Camelliti, 2004; 
Chilton, 2007), which is reflected by the homogenous distribution (Figure 6.6A., 40x) and higher 
coverage area in co-culture condition (Figure 6.6B.). Secondly, QPCR analysis revealed that 
encapsulation and subsequent culture of CMs, either alone or with CFs, in the PNJ-Gelatin 
hydrogel had no effect on their gene expression profile. Third, incorporation of CFs with CMs 
gave rise to a dramatic difference in beating behavior, which correlates to cardiac cell and tissue 
functions (Kaneko, 2011; Souders, 2009). We have observed that as CMs reached to each other 
and formed clusters of cells as they began to contract. However, such behavior was more 
pronounced in the presence of CFs, as helper cells. To that regard, the mechanical and electrical 
signaling provided by the CFs was speculated to induce higher cell-cell coupling (Banerjee, 2006; 
Camelliti, 2004; Chilton, 2007; Kohl, 2003), which resulted in earlier tissue-level contractions, as 
well as relatively stable average BPM in co-culture condition (Figure 6.8A. and 6.8B.). In addition, 
the CFs engaged in signal propagation within the formed cardiac tissue, as demonstrated by the 
synchronous contraction signals (Figure 6.8C. and 6.8D.) taken from the different areas (0.5 × 0.5 
mm2) of a single hydrogel sample (2.5 × 2.5 mm2). Such behavior was also quantitatively 
represented as amplitude and frequency variation indexes, which determined tissue-level (2.5 × 
2.5 mm2) synchrony (Figure 6.8E. and 6.8F.). The mono-culture group mostly demonstrated 
asynchronous beating fashion, which can cause low action potential signal propagation upon 
injection within the host myocardium. These observations are indeed consistent with our previous 
work on the development of microtissues embedded with the co-cultures of the CMs and CFs 
(with optimized ratio of 2:1) within a gelatin methacrylate (GelMA) hydrogel (Saini, 2015). 
However, CMs in mono-culture did not spread or exhibit any spontaneous contraction in GelMA 
hydrogel. Such differences further indicated that the proposed hydrogel exhibits superior 
properties and can be used as a suitable matrix to supports cardiac cells functionalities in both 
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mono-culture and co-culture conditions. The influence of paracrine signaling between CMs and 
CFs is subject of our future studies. Furthermore, we intend to test the in vivo functionalities of the 
cell-embedded hydrogel matrix in our future work. 
External electrical stimulation setup (Appendix Figure B.3.) was employed to assess the 
response of cardiac cells to the electrical stimulation. Both mono- and co-culture groups reacted 
to the applied stimulation similarly and no significant differences were observed. Furthermore, the 
inclusion of CFs in co-culture, which resulted to a significant synchronous contraction compared 
to the mono-culture condition, did not facilitate the propagation of external electrical pulses 
throughout the hydrogel constructs. 
6.5. Conclusion 
In this study, we synthesized PNJ-Gelatin hydrogel as an injectable matrix for cardiac cells 
delivery and tissue engineering applications. The proposed material featured chemical 
crosslinking to combine gelatin to the thermo-responsive PNIPAAm in a time dependent manner 
to induce a mechanically robust injectable hydrogel. Furthermore, incorporation of gelatin and 
JAAm into the hydrogel offered bioactivity and higher water content leading to excellent cell 
survival, adhesion, spreading, cytoskeletal and cardiac specific markers organization. The two 
cultured groups within the PNJ-Gelatin hydrogel demonstrated desirable phenotypic and 
functional outcomes, which illustrated the potential of the injectable matrix for cardiac tissue 
engineering and cell delivery applications. In addition, the synthesized matrix was able to home 
CFs (often found within the infarct region) to enhance the overall functionalities of the cell-
embedded hydrogel. Particularly, the co-culture group exhibited higher synchronous tissue-level 
contractions, which could be attributed to the structural and distribution differences of cardiac 
specific markers (SAC and Cx43) as well as cytoskeleton organization (F-actin fibers). 
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CHAPTER 7 
SUMMARY AND FUTURE PERSPECTIVE 
7.1. Summary of Findings 
7.1.1. Specific aim1: Development of gelatin-GNM cardiac patches with enhanced 
contractile and electrical functionalities 
Under specific aim1, we designed and fabricated electrically conductive GelMA-GNR 
hydrogels for engineering scaffold-based cardiac tissues. We performed material characterization 
to determine the impact of embedded GNRs on electrical, mechanical and topographical 
properties of GelMA-GNR hydrogels. We also conducted extensive in vitro cellular assessments 
to investigate the influence of incorporated GNRs on maturation, contractility and excitability of 
the conductive cardiac tissues. Lastly, we performed a mechanistic study to dissect the impact of 
enhanced mechanical stiffness and nano-scale topographies of GelMA-GNR hydrogels on 
maturation and excitability of engineered cardiac tissues from the role of hydrogel electrical 
conductivity.  
Initially (in chapter 2), we determined that the incorporation of GNRs within GelMA matrix 
enhanced electrical conductivity and mechanical stiffness (Young’s modulus) of the hydrogel. In 
addition, we demonstrated that the embedded GNRs were localized on the surface of GelMA 
matrix, which led to generation of nano-scale topographies. Cardiomyocytes seeded on GelMA-
GNR hydrogels exhibited excellent cell retention and viability. The increased cell adhesion 
resulted in the formation of an integrated tissue layer on GelMA-GNR hydrogels. Immunostained 
images of integrin β-1 confirmed the improved cell-matrix interaction on GNR-embedded 
hydrogels. In addition, formation of uniaxially aligned sarcomeres and homogenous distribution of 
Cx43 gap junctions were observed on GelMA-GNR hydrogels. GelMA-GNR hydrogels supported 
synchronous tissue-level beating of cardiomyocytes, demonstrated by fluorescent detecting of 
calcium transients among CMs. Lastly, conductive GelMA-GNR cardiac tissues demonstrated 
significantly higher electrical excitability (i.e. lower excitation threshold) as compared to pure 
GelMA hydrogels.  
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Next (in chapter 3), we introduced anisotropic surface micropatterns (50 μm wide 
microgrooves) on GelMA-GNR hydrogels to develop engineered cardiac tissues with native-like 
cytoarchitecture. F-Actin stained images and fluorescent area coverage data revealed formation 
of uniform and uniaxially aligned cardiac microtissues on GelMA-GNR hydrogels. Immunostaining 
images of cardiac markers, including SAC and Cx43, also showed higher sarcomere alignment 
and enhanced cellular connectivity on GelMA-GNR hydrogels. Microtissues formed on both 
GelMA and GelMA-GNR constructs demonstrated spontaneous contractility from day 4 to 7 of 
culture. However, only conductive GelMA-GNR microtissues showed a consistent response with 
low excitation thresholds in changing beat rate because of electrical stimulation. 
Lastly (in chapter 4), we developed conductive and non-conductive engineered cardiac 
tissues to investigate, side-by-side, the impact of matrix electrical, mechanical and topographical 
characteristics on CMs retention, maturation and excitation threshold. We fabricated four different 
hydrogel groups including 5% GelMA (control group), 20% GelMA (mechanically stiff), GelMA-
SNP (non-conductive with nano-topographies) and GelMA-GNR (conductive with nano-
topographies). Our results demonstrated that GelMA-SNP and GelMA-GNR hydrogels 
significantly improved CMs adhesion affinity as compared to pure GelMA (5% and 20%), 
highlighting the influence of nano-scale topography on cellular adhesion and retention. The 
expressions of cardiac specific proteins demonstrated that both stiffness (20% GelMA) and nano-
scale topographies (GelMA-SNP and GelMA-GNR) promoted the cardiac maturation. The impact 
of increased stiffness and nano-scale topography, induced by incorporation of SNPs and GNRs, 
significantly decreased the excitation threshold. In addition, GelMA-SNP and GelMA-GNR cardiac 
tissues were accommodated external electrical stimuli at higher frequencies in both coupled and 
uncoupled gap junction conditions. Most importantly, no significant differences regarding cell 
retention, cardiac maturation and electrical excitability were observed between conductive 
GelMA-GNR and non-conductive GelMA-SNP tissues. Our findings indicated the prominent 
impact of hydrogel matrix stiffness and nano-scale surface topography on the overall tissue 
function, regardless of electrical conductivity. 
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7.1.2. Specific aim2: Engineering and characterization of electrically conductive 
scaffold-free cardiac microtissues 
Under specific aim2, we engineered scaffold-free cardiac microtissues incorporated with 
GNWs functionalized with RGD to study the impact of conductive nanomaterials on maturation 
and electrophysiology of CMs. We performed western blotting and immunocytochemistry to 
evaluate the role of GNWs on CMs maturation. In addition, we conducted extensive 
electrophysiology experiments to study the influence of embedded functionalized GNWs on 
conduction velocity of CMs in both coupled and uncoupled (heptanol treated) gap junctions.  
We synthesized ultralong GNWs with aspect ratio of ~46, then their cytotoxic CTAB 
coating were exchanged with biocompatible PEG using a customized 2-step ethanol-assisted 
procedure. PEGylated GNWs were functionalized with RGD peptide to promote their adhesion 
affinity to the cells. Live/Dead fluorescent images and Alamar Blue results demonstrated a 
significant increase in biocompatibility of GNWs by removing CTAB. In terms of contractility and 
excitability properties, our finding indicated that incorporation of electrically conductive GNWs did 
not lead to higher fractional shortening and lower excitation threshold of CM microtissues. In 
addition, similar levels of maturation, via analysis of the cardiac specific markers (SAC, Cx43, and 
cTnI), were observed for both CM and CM-GNW microtissues. Lastly, our electrophysiology data 
demonstrated that the incorporation of electrically conductive GNWs did not improve the 
conduction velocity of CMs. Furthermore, the percentage of conduction velocity reduction in both 
CM and CM-GNW were similar in presence of gap junction uncoupler (heptanol), indicating that 
incorporation of electrically conductive nanomaterials did not maintain the CM conduction 
velocity.  
Despite the enhanced cardiac maturation and contraction amplitude of hiPSC-derived CMs 
induced by other conductive nanomaterials (rGONFs and SiNWs), reported in the literature, we 
did not observe similar outcomes using GNWs and NRVCMs. We speculate that enhancing the 
maturation of CMs using conductive nanomaterials can be a cell-dependent process. In addition, 
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it is possible that the GNWs were internalized and did not locate on the cell membrane or 
extracellular microenvironment, which further led to no significant enhancement of CV. 
7.1.3. Specific Aim3: Fabrication and characterization of biohybrid injectable 
PNIPAAm-gelatin hydrogel tissues for cardiac regeneration 
Under specific aim3, we conducted a comprehensive in vitro biological assessment to 
evaluate the suitability of an injectable biohybrid PNIPAAm-Gelatin hydrogel for cardiac tissue 
engineering applications. Specifically, the functionalities of CMs alone and in co-culture with CFs 
were evaluated within the hydrogel matrix. The encapsulated cells demonstrated a high level of 
cell survival and spreading throughout the hydrogel matrix in both culture conditions. A dense 
network of stained F-actin fibers illustrated the formation of an intact and 3D cell-embedded 
matrix. Furthermore, immunostaining and gene expression analyses revealed mature phenotypic 
characteristics of cardiac cells. Notably, the co-culture group exhibited superior structural 
organization, spontaneous contractility and cell–cell synchronicity. The outcome of this study is 
envisioned to open a new avenue for extensive in vitro characterization of injectable matrices 
embedded with 3D mono- and co-culture of cardiac cells prior to in vivo experiments. 
7.2. Significance and Contributions 
In this dissertation, the overarching objective was to develop electrically conductive cardiac 
tissues to study the role of GNMs on maturation and electrophysiology of CMs. In this regard, we 
utilized integrated micro- and nanoscale technologies to engineer two classes of conductive 
cardiac tissues, scaffold-based and scaffold-free, to conduct our study. The significance of our 
work is mainly categorized to 1) dissecting the role of matrix conductivity on maturation and 
electrical excitability of scaffold-based cardiac tissues from matrix mechanical and topographical 
properties, and 2) identifying the impact of sole presence of conductive GNWs on conduction 
velocity of CMs.  
Scaffold-based GelMA-GNR cardiac tissues: Incorporation of conductive nanomaterials 
within scaffold leads to a combinatorial enhancement of all electrical, mechanical, and 
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topographical characteristics. However, to date, none of the studies focusing on the development 
of conductive cardiac tissues have aimed to answer the critical question that, could non-
conductive nanomaterials induce synchronized electrical and contractile functionalities among 
CMs by only enhancing the cardiac maturation rather than inducing the exogenous electrical 
conductivity?  
In this dissertation, for the first time, we developed conductive and non-conductive 
engineered cardiac tissues to comprehensively investigate, side-by-side, the impact of matrix 
electrical, mechanical, and topographical characteristics on retention, maturation and excitation 
threshold of CMs. Our findings demonstrated the prominent impact of hydrogel matrix stiffness 
and nano-scale surface topography on maturation and excitability of engineered cardiac tissues, 
regardless of matrix electrical conductivity. 
Scaffold-free CM-GNW cardiac microtissues: Despite the promising outcomes 
demonstrating the potential of conductive nanomaterials to enhance the maturation of CMs, the 
impact of nanomaterials’ electrical conductivity on signal propagation and electrophysiology of 
cells/tissues has not been investigated. Therefore, we developed electrically conductive cardiac 
microtissues embedded with functionalized GNWs with RGD peptide to study CM contraction 
amplitude, maturation and electrophysiology.  
In this dissertation, for the first time, we comprehensively investigated the direct influence 
of electrically conductive GNWs on conduction velocity of CMs using microelectrode array. Our 
finding indicated that embedded GNWs did not improve conduction velocity of CMs. Also, the 
percentage of conduction velocity reduction were similar in presence of a gap junction uncoupler 
(heptanol), indicating that incorporation of GNWs did maintain the conduction velocity. 
The outcomes of our work have been presented as peer-reviewed journal articles, book 
chapter, patent and oral/poster presentations in national and international conferences. Summary 
of our contributions are listed in below. 
 
137 
 
Journal articles: 
1- Ali Navaei et al., PNIPAAm-based biohybrid injectable hydrogel for cardiac tissue 
engineering, Acta Biomaterialia (2016). 
2- Ali Navaei et al., Gold nanorod-incorporated gelatin-based conductive hydrogels for 
engineering cardiac tissue constructs, Acta biomaterialia (2016). 
3- Ali Navaei et al., Electrically conductive hydrogel-based micro-topographies for the 
development of organized cardiac tissues, RSC Advances (2017). 
4- S. Liu, Ali Navaei, X. Meng, M. Nikkhah, J. Chae, Wireless Passive Stimulation of 
Engineered Cardiac Tissues, ACS Sensors (2017). 
Book chapter: 
1- L. Karperien, Ali Navaei, B. Godau, A. Dolatshahi-Pirouz, M. Akbari, M. Nikkhah, Chapter 5: 
Nanoengineered biomaterials for cardiac regeneration, Nanoengineered Biomaterials for 
Regenerative Medicine, Elsevier (2018). 
Talk/poster conferences: 
1- Ali Navaei et al., Gold nanorod incorporated gelatin-based hybrid hydrogels for myocardial 
tissue engineering, BMES Annual Meeting, Tampa, FL (2015), Platform presentation.     
2- Ali Navaei et al., Nanoengineered hybrid hydrogels for cardiac tissue engineering, NHLBI 
Symposium on Cardiovascular Regenerative Medicine, Bethesda MD, (2015), Poster 
presentation.   
3- Ali Navaei et al., Nanoengineered hybrid hydrogels for cardiac tissue engineering, 4th Nano 
Today Conference, Dubai, UAE, (2015), Platform presentation.   
4- Ali Navaei et al., PNIPAAm-based biohybrid injectable hydrogel for cardiac tissue 
engineering, World Biomaterials Congress, Montreal, Canada, (2016), Platform presentation. 
5- Ali Navaei et al., Nanoengineered hydrogel topographies for the development of organized 
cardiac tissues, BMES Annual Meeting, Minneapolis, MN (2016), Poster presentation. 
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6- Ali Navaei et al., Nanoscale decoration of cardiac microtissues using functionalized gold 
nanowires for cell-based therapies, BMES Annual Meeting, Phoenix, AZ (2017), Poster 
presentation.   
7- Ali Navaei et al., Electrically conductive hybrid hydrogels with anisotropic topographical 
features for engineering functional cardiac tissues, TERMIS, Kyoto, Japan (2018). Platform 
presentation. 
Patent: 
1- M. Nikkhah and Ali Navaei, Gold nanorod incorporated gelatin-based hybrid hydrogels for 
cardiac tissue engineering and related methods, US20170143871A. 
7.3. Project Challenges  
We have encountered several challenges during this work that may have delayed our 
progress, however, enriched our knowledge and expertise significantly. For example, we had 
challenges regarding PEGylation and RGD conjugation of GNWs, since there was not any 
reported protocol specifically for ultralong GNWs, elsewhere. The difficulties were including 
extensive aggregation of GNWs during CTAB-PEG exchange process. A minimum concentration 
of free CTAB in the GNMs colloidal solutions is required for effective PEGylation. However, as the 
concentration of free CTAB decreases, the probability of GNMs aggregation increases. Based on 
these facts, we designed a 2-step PEGylation process. In the first step, the concentration of free 
CTAB was kept at its CMC (1 mM at room temperature in DIW) to provide just enough CTAB 
molecules to protect GNWs from aggregation during PEGylation. Afterwards, we performed a 
second PEGylation step with 20% ethanol to complete the CTAB removal by preventing the 
bilayer coating formation of CTAB on GNWs. Our biocompatibility results demonstrated 
substantial improvement of viability and metabolic activity of CMs when cultured with PEGylated 
GNWs as compared to GNW-CTAB. 
Another challenge that we have faced was related to the electrophysiology assessment of 
scaffold-free cardiac microtissues. Our initial attempt was based on the use of external electric 
field stimulation technique by a custom-designed chamber consisting of two carbon electrodes 
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connected to a function generator. However, due to the global propagation of the electric field 
stimuli within microtissues and culture medium in the stimulation chamber, we were not able to 
assess the influence of GNWs on the electrical excitability and conduction velocity of scaffold-free 
cardiac microtissues. To address this challenge, we utilized a microelectrode array (MEA) 
platform developed by BMSEED LLC, as the measurement technique with high reading precision 
and resolution. We had spent extensive effort on optimizing the surface coating of MEA chamber 
to achieve a stable and tight attachment of CMs on the microelectrodes to obtain field potential 
signals with high signal to noise ratio. In addition, due to the lack of universal data 
acquisition/analysis software for BMSEED MEA, we had allocated significant efforts on the large-
scale data processing and analysis using other available software including OriginPro, MATLAB 
and Microsoft Excel.  
Analyzing the spontaneous contractility of pure GelMA and GelMA-GNR cardiac tissues 
was among other challenges that we have encountered. Initially, we had considered spontaneous 
beats per minute (i.e. BPM) as a quantifiable parameter to evaluate the contractile maturation of 
engineered cardiac tissues. However, we later had observed high levels of randomness regarding 
beating frequency among similar samples (i.e. technical replicates) in the same experimental 
condition (0, 0.5, 1 or 1.5 mg/mL GNRs). In some cases, there were samples that did not exhibit 
any spontaneous beating at the time of measurement, while other samples in the same group 
were beating robustly. Therefore, we rationalized that the spontaneous beating frequency (i.e. 
BPM) can be used as a qualitative parameter to evaluate the overall suitability of scaffolding 
biomaterials (e.g. hydrogels) for engineering cardiac constructs, however, it may not be an 
appropriate metric for solid conclusions regarding tissue maturation and contractile functioning.  
We have utilized electric field stimulation to assess the excitability of engineered GelMA-
GNR tissues by measuring excitation voltage threshold. The use of field stimulation enabled us to 
measure tissue-level excitability of cardiac constructs. Despite the significance of our work, there 
are still important electrophysiological parameters, including membrane depolarization threshold 
and action potential propagation velocity, which cannot be investigated using the electric field 
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stimulation chamber. Therefore, utilization of other procedures, such as voltage sensitive 
fluorescent dyes along with point stimulation using bipolar microelectrodes, can provide more 
comprehensive understanding about the impact of scaffold conductivity on electrophysiology of 
engineered cardiac tissues. 
7.4. Future Perspective 
In the context of developing conductive cardiac tissues to enhance the maturation and 
electrical coupling (i.e. synchronicity) of CMs, several promising in vitro studies have been 
reported. However, there is still a significant knowledge gap regarding the extent of electrical 
integration of conductive tissues with the native myocardium in MI-induced animal models (i.e. in 
vivo studies) in comparison with non-conductive tissues. In this regard, the use of 
characterization methods, such as electrocardiography (ECG) or optical mapping of Langendorff-
perfused whole heart, could provide valuable information on the organ-level electrical activity of 
the native myocardium upon implantation of conductive cardiac tissues. The fate of utilized 
conductive nanomaterials, after in vivo implantation of engineered tissues, is another very 
important factor that needs to be investigated. After degradation of scaffolding biomaterial, the 
released nanomaterials could be distributed within the heart itself or other tissues/organs (e.g. 
blood vessels or lung), which could potentially lead to unwanted side effects. In this regard, 
biodistribution as well as long-term cytotoxicity and immunogenicity assessments, using in vivo 
animal models (e.g. rats and pigs), are necessary to shed more light on the biosafety of 
conductive nanomaterials. In our opinion, we believe that such in vivo experiments are vital for 
the future clinical translation of electrically conductive cardiac patches and cell-based therapies 
for treatment of MI. 
In our opinion, it is critically necessary for future studies to thoroughly investigate the 
localization and fate of conductive nanomaterials. Additionally, since we focused our studies on 
RNVCM, the impact of nanomaterials on electrophysiology and electrical integration of stem cells 
derived CMs in vitro, needs to further be investigated. Below, we have briefly described our 
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insights for design of experiments, specifically for scaffold-free conductive microtissues, to 
investigate the interactions between nanomaterials and cells. 
Localization and fate of nanomaterials: Transmission electron microscopy (TEM) can be 
used for probing nanomaterials within the microtissues. TEM enables us to measure the 
endocytosed nanomaterials as well as nano-scale localization of nanomaterials within 
extracellular environment. However, this technique is relatively expensive, especially if multiple 
time point measurements are required, and it cannot be performed on live cells. Another method 
for tracking nanomaterials is fluorescent labeling and microscopy. Nanomaterials, such GNMs, 
can be tagged with fluorescent dyes using EDC/NHS or Streptavidin/Biotin chemistries, which 
enables the fluorescent tracking at both live and fixed cells/microtissues. Despite the advantage 
of live imaging and relatively facile technical procedure of fluorescence tracking, there are still 
challenges associated with this technique. Specifically, 3D probing of intact microtissues can be 
challenging due to the large size of cellular cluster (e.g. 150 μm diameter). In addition, precise 
localization of labeled nanomaterials requires secondary fluorescent staining of other cellular 
compartments, such as plasma membrane, early/late endosomes and lysosomes, to probe intra- 
or extracellular location of nanomaterials.  
In vitro electrophysiology: To assess the impact of conductive nanomaterials on 
electrophysiology of stem-cell derived CMs, different approaches and measurement techniques 
can be utilized. First, the direct influence of nanomaterials on cell membrane resting potential and 
excitation threshold can be measured using patch clamp or voltage sensitive fluorescent dyes. 
These techniques provide direct measurement of cell membrane electrical activity and can be 
used to determine conduction velocity within cells. Despite the significance, technical difficulties, 
include use of high speed cameras, micro-manipulator handling system and risk of extensive 
phototoxicity. Second approach to investigate the electrophysiology of cardiac cells can be 
focused on in vitro assessment of electrical integration between nanomaterial-embedded and 
pure cardiac cells/microtissues. For example, a monolayer of quiescence CMs (i.e. minimal 
spontaneous contractile and electrical activity) can be prepared as the model for the host tissue. 
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Afterwards, nanomaterial-embedded microtissues, the cardiac graft, are seeded on the host 
monolayer and electrical integration of the graft with the host can be assessed using voltage 
sensitive dye or microelectrode array.  
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Figure A.1. Schematic illustration showing the GNRs synthesis steps by using a seed-mediated 
method. 
 
Figure A.2. A) TEM micrographs of a thin layer (dashed area) of GelMA-GNR hybrid hydrogels 
(0.5 and 1 mg/mL) demonstrating that GNRs (white arrows) were successfully embedded within 
the hydrogel matrix (dashed areas). B) EDX spectrum of GelMA-GNR hybrid hydrogel (1.5 
mg/mL) further confirming the presence of gold (Au) and GelMA elements. 
 
Figure A.3. Representative force-indentation distance curves of pure GelMA and GelMA-GNR 
hybrid hydrogels. 
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Figure A.4. A) Representative Force-Indentation Distance curves of pure 20% GelMA (wt/v) 
hydrogel illustrating B) similar mechanical stiffness compared to GelMA-GNR hybrid hydrogels (1 
and 1.5 mg/mL of GNRs) and significantly higher stiffness than pure 5% GelMA (wt/v). C)  Phase-
contrast image of CMs seeded on 20% GelMA (wt/v) hydrogel on day 1 of culture. D) Quantified 
cell retention on day 1. E) A representative fluorescent image demonstrating the dead (red) and 
live (green) cardiomyocytes on 20 % GelMA (wt/v) control hydrogel at day 1along with F) 
quantified cell survival data. 
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Figure A.5. Phase-contrast optical microscopy images of cultured cardiomyocytes on top of 
hybrid GelMA-GNR and pure GelMA hydrogels at day 1, 4, and 7 illustrating cell retention and 
spreading over the culture period. Scale bars represent 250 µm. 
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Figure A.6. A) Z-stack immunostained images of cardiac-specific markers within GelMA-GNR 
hybrid hydrogel with 0.5 and 1 mg/ml of GNRs. Representative immunostained images showing 
the expression of SAC (green) and Cx43 (red) on day 1, 3 (arrows showing sarcomeres 
formation) and 7; B) Immunostained images of cTnI (green) on day 1 and 7 of culture for GelMA-
GNR (0.5 and 1 mg/mL) hybrid hydrogel constructs. 
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Figure B.1. The relative cloud point (a/amax(%)) for enzymatically degraded PNJ-Gel hydrogel. 
 
Figure B.2. Phase-contrast (scale bars represent 100 µm) mono- and co-culture groups 
illustrating cell morphology at day 4of culture. 
 
 
Figure B.3. External electrical stimulation setup. A) Photograph of the fabricated chamber and B) 
the excitation threshold (V) for different applied frequencies (1, 2, and 3 Hz) for mono- and co-
culture groups (day 7). 
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Figure B.4. Hydrolytic degradation profile of the synthesized hydrogel. 
Table B.1. 
The TaqMan primers which were used for qPCR analysis 
TaqMan Primers 
Target Name Cat No 
cTNT Rn01483694_m1 
Cx43 Rn01433957_m1 
MLC2v Rn02769676_s1 
GAPDH Rn01775763_g1 
Table B.2. 
The SYBR primers which were used for qPCR analysis 
SYBR Primers 
Target 
Name 
FWD Sequence RVS Sequence 
18S GCAATTATTCCCCATGAACG GGCCTCACTAAACCATCCAA 
ACTN1 CACCACCGCTGAACGTGAAA AGTCTCAGGACAGCGGAAAC 
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Supplementary videos are readable using media players in Windows operating system. 
Chapter 2: 
C.1. Representative video of synchronous beating of CMs cultured on pure GelMA 
hydrogel at day 7. 
C.2. Representative video of synchronous beating of CMs cultured on 0.5 mg/mL GelMA-
GNR hybrid hydrogel at day 7. 
C.3. Representative video of synchronous beating of CMs cultured on 1 mg/mL GelMA-
GNR hybrid hydrogel at day 7. 
C.4. Representative video of synchronous beating of CMs cultured on 1.5 mg/mL GelMA-
GNR hybrid hydrogel at day 7. 
C.5. Representative video of synchronous contraction of the centimeter scale 1 mg/mL 
GelMA-GNR hybrid tissue at day 7. 
C.6. Representative video of synchronous contraction of the centimeter scale 1.5 mg/mL 
GelMA-GNR hybrid tissue at day 7.  
C.7. Representative video illustrating spontaneous Ca2+ puffs of cells on GelMA (5%) and 
GelMA-GNR hybrid hydrogels. 
C.8. Representative video of CMs beating on GelMA (5%) at three different frequencies (1, 
2, and 3 Hz) applied by an external pulse generator.   
C.9. Representative video of CMs beating on GelMA-GNR (0.5 mg/mL) at three different 
frequencies (1, 2, and 3 Hz) applied by an external pulse generator.   
C.10. Representative video of CMs beating on GelMA-GNR (1 mg/mL) at three different 
frequencies (1, 2, and 3 Hz) applied by an external pulse generator.   
C.11. Representative video of CMs beating on GelMA-GNR (1.5 mg/mL) at three different 
frequencies (1, 2, and 3 Hz) applied by an external pulse generator.   
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Chapter 3: 
C.12. Representative video of synchronous beating of CMs cultured on GelMA hydrogels 
at day 7. 
C.13. Representative video of synchronous beating of CMs cultured on GelMA-GNR 
hydrogels at day 7. 
C.14. Representative video of CMs beating on GelMA and GelMA-GNR at three different 
frequencies (0.5, 1, and 2 Hz) applied by an external pulse generator. 
Chapter 6: 
C.15. Representative video of synchronous beating of CMs (mono-culture) cultured within 
PNJ-Gelatin hydrogel at day 3. 
C.16. Representative video of synchronous beating of CMs (mono-culture) cultured within 
PNJ-Gelatin hydrogel at day 6. 
C.17. Representative video of synchronous beating of co-culture of the cells (CMs and 
CFs) within PNJ-Gelatin hydrogel at day 3.  
C.18. Representative video (low magnification) of synchronous beating of co-culture of the 
cells (CMs and CFs) within PNJ-Gelatin hydrogel at day 3. 
C.19. Representative video (low magnification) of synchronous beating of co-culture of the 
cells (CMs and CFs) within PNJ-Gelatin hydrogel at day 9. 
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